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Background: Illicit drug use increases the risk of poor physical and mental health. There are few effective
drug prevention interventions.
Objective: To assess the acceptability of implementing and trialling two school-based peer-led drug
prevention interventions.
Design: Stage 1 – adapt ASSIST, an effective peer-led smoking prevention intervention to deliver information
from the UK national drug education website [see www.talktofrank.com (accessed 29 August 2017)]. Stage 2 –
deliver the two interventions, ASSIST + FRANK (+FRANK) and FRANK friends, examine implementation and
refine content. Stage 3 – four-arm pilot cluster randomised control trial (cRCT) of +FRANK, FRANK friends,
ASSIST and usual practice, including a process evaluation and an economic assessment.
Setting: Fourteen secondary schools (two in stage 2) in South Wales, UK.
Participants: UK Year 8 students aged 12–13 years at baseline.
Interventions: +FRANK is a UK informal peer-led smoking prevention intervention provided in Year 8
followed by a drug prevention adjunct provided in Year 9. FRANK friends is a standalone informal peer-led
drug prevention intervention provided in Year 9. These interventions are designed to prevent illicit drug use
through training influential students to disseminate information on the risks associated with drugs and
minimising harms using content from www.talktofrank.com. Training is provided off site and follow-up
visits are made in school.
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Outcomes: Stage 1 – +FRANK and FRANK friends intervention manuals and resources. Stage 2 – information
on the acceptability and fidelity of delivery of the interventions for refining manuals and resources. Stage 3 –
(a) acceptability of the interventions according to prespecified criteria; (b) qualitative data from students,
staff, parents and intervention teams on implementation and receipt of the interventions; (c) comparison
of the interventions; and (d) recruitment and retention rates, completeness of primary, secondary and
intermediate outcome measures and estimation of costs.
Results: +FRANK and FRANK friends were developed with stakeholders [young people, teachers (school
management team and other roles), parents, ASSIST trainers, drug agency staff and a public health
commissioner] over an 18-month period. In the stage 2 delivery of +FRANK, 12 out of the 14 peer supporters
attended the in-person follow-ups but only one completed the electronic follow-ups. In the pilot cRCT, 12
schools were recruited, randomised and retained. The student response rate at the 18-month follow-up was
93% (1460/1567 students). Over 80% of peer supporters invited were trained and reported conversations
on drug use and contact with trainers. +FRANK was perceived less positively than FRANK friends. The
prevalence of lifetime illicit drug use was 4.1% at baseline and 11.6% at follow-up, with low numbers of
missing data for all outcomes. The estimated cost per school was £1942 for +FRANK and £3041 for FRANK
friends. All progression criteria were met.
Conclusions: Both interventions were acceptable to students, teachers and parents, but FRANK friends
was preferred to +FRANK. A limitation of the study was that qualitative data were collected on a
self-selecting sample. Future work recommendations include progression to a Phase III effectiveness trial
of FRANK friends.
Trial registration: Current Controlled Trials ISRCTN14415936.
Funding: This project was funded by the National Institute for Health Research (NIHR) Public Health
Research programme and will be published in full in Public Health Research; Vol. 5, No. 7. See the NIHR
Journals Library website for further project information. The work was undertaken with the support of the
Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement
(DECIPHer). Joint funding (MR/KO232331/1) from the British Heart Foundation, Cancer Research UK,
the Economic and Social Research Council, the Medical Research Council, the Welsh Government and the
Wellcome Trust, under the auspices of the UK CRC, is gratefully acknowledged.
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Plain English summary
Approximately 24% of 15-year-olds in England have used an illicit drug. Illicit drug use increasesthe risk of poor physical and mental health. This study adapted an effective peer-led smoking
prevention intervention (ASSIST) to prevent illicit drug use using information from the UK national drug
education website, Talk to FRANK [www.talktofrank.com (accessed 29 August 2017)]. With stakeholders
[young people, teachers (SMT and other roles), parents, ASSIST trainers, drug agency staff and a public
health commissioner] we developed, tested and refined two peer-led drug prevention interventions,
ASSIST + FRANK and FRANK friends to be delivered in schools to UK Year 9 students (aged 13–14 years).
After the interventions had been refined, we conducted a study in 12 high schools in South Wales.
Schools were randomly allocated to receive ASSIST + FRANK, FRANK friends, ASSIST or usual practice.
A survey was given to all young people whose parents had agreed for them to take part to measure illicit
drug use. A total of 1567 young people were recruited to the study. In-depth interviews with school staff,
parents and young people explored their views on the interventions. The results showed that it is feasible
and acceptable to deliver the interventions. The study was not designed to show conclusively whether
ASSIST + FRANK or FRANK friends prevented drug use, but both were viewed positively. In general, FRANK
friends was viewed more positively than ASSIST + FRANK. The research shows that there should now be a
much bigger study to examine whether or not FRANK friends can prevent illicit drug use in young people.
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Scientific summary
Background
In the latest Global Burden of Disease Study, drug use disorders were ranked 14th in the causes of
disability-adjusted life-years (DALYs) in 10- to 14-year-olds, fifth in 15- to 19-year-olds and second in
20- to 24-year-olds. In the UK, the lifetime prevalence of illicit drug use increases sharply between 11 and
15 years of age, from 6% to 24%, with the most commonly used drugs being cannabis, glues, gasses
and aerosols (GGAs). The harms of cannabis to health include an increased risk of dependency, psychotic
experiences and poor memory, and the inhalation of GGAs increases the risk of sudden sniffing death.
Other harms of possession of a controlled drug include a criminal caution or conviction, restricted
opportunities for employment and school exclusion.
Systematic reviews of peer-led drug prevention interventions have found that there is currently insufficient
evidence to recommend their use in a school setting. An informal peer-led intervention, ASSIST, has been
shown to be effective in preventing smoking in school-aged children. In the ASSIST intervention, influential
UK Year 8 (aged 12–13 years) students are trained to disseminate non-smoking norms through conversations
with school friends. Influential students are identified through a process of nomination by their peers. The
17.5% of students who receive the most nominations are invited to training. We proposed adapting the
ASSIST intervention to develop two peer-led drug prevention interventions to deliver information on illicit drug
use from the UK national drug education website [see www.talktofrank.com (accessed 29 August 2017)].
Objectives
The objectives of this study were to:
1. refine the ASSIST logic model to drug prevention and develop the ASSIST + FRANK (+FRANK) and
FRANK friends interventions
2. test the feasibility of the +FRANK and FRANK friends interventions in one school each and
i. assess the acceptability of the intervention to trainers, students, parents and school staff and explore
the barriers to and facilitators of implementation
ii. explore the fidelity of intervention delivery by +FRANK and FRANK friends trainers and
peer supporters
iii. refine the interventions
3. conduct a pilot cluster randomised controlled trial (cRCT) of the +FRANK and FRANK friends
interventions to
i. assess the feasibility and acceptability of the refined interventions to trainers, students, parents and
school staff
ii. assess the fidelity of intervention delivery by trainers
iii. compare the feasibility and acceptability of the interventions
iv. assess trial recruitment and retention rates
v. pilot outcome measures
vi. record the delivery costs and pilot methods for assessing cost-effectiveness
4. determine the design, structures, resources and partnerships necessary for a full-scale trial to take place.
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Methods
Design and setting
In stage 1 we reviewed the evidence on the prevalence of drug use in the UK and ASSIST intervention
materials and consulted with stakeholders {young people, teachers [school management team (SMT) and
other roles], parents, ASSIST trainers, drug agency staff and a public health committee} to develop
+FRANK and FRANK friends. Stage 2 consisted of delivering these interventions in one school each;
interviewing peer supporters and teachers, observing delivery and making changes to address issues with
implementation. Stage 3 involved a four-arm parallel external pilot cRCT with young people in Year 9
(aged 13–14 years) in 12 schools across South Wales. Three schools were allocated to receive the ASSIST
intervention to investigate any potential indirect effects of a smoking prevention intervention on drug use.
An integrated process evaluation examined the context, delivery and receipt of the interventions. An
assessment of intervention costs was also undertaken.
School recruitment
Schools were those eligible to receive the ASSIST intervention, delivered by Public Health Wales (PHW), in
2014–15. As part of the Welsh Government’s Tobacco Control Action Plan, PHW was funded to deliver
the ASSIST intervention to 50 schools a year. The Welsh Government provided PHW with a list of 160 out
of a possible 220 schools eligible for the ASSIST intervention, which they informed PHW were selected on
the basis of having a high percentage of children in receipt of free school meals (FSMs). Schools were in
relatively deprived areas according to the Welsh Index of Multiple Deprivation (WIMD). The Welsh
Government did not provide the exact cut-off points applied for FSMs or the WIMD to exclude schools.
From this list PHW recruited schools from the counties of Cardiff, Newport, Torfaen, Blaenau Gwent,
Rhondda Cynon Taf, Merthyr Tydfil and Caerphilly, inviting those that had not received the ASSIST
intervention in the past 2 years first. Of the 72 schools in these counties, 40 had not received the ASSIST
intervention in the last 2 years and formed our sampling frame. Schools were sent a project information
sheet, reply envelope and form indicating that they should contact PHW or KM if they wished to take part.
Participant recruitment
Parents/guardians were informed by letter to contact the school if they did not wish their child to
participate in the trial. Parents who did not want their child to participate were able to opt their child out
of data collection. All participants were informed of their right to withdraw from the study and were asked
to provide written consent.
Data collection process
The consent procedure and questionnaires were self-reported in school halls or classrooms under
examination conditions. All data were collected by fieldworkers. A baseline survey of students took place
between 17 September and 20 October 2014. A follow-up survey took place 18 months later between
22 March and 5 May 2016. Schools were paid £300 for staff cover for data collection after the 18-month
follow-up.
Randomisation
Schools were randomly allocated to one of four arms: +FRANK, FRANK friends, ASSIST and usual practice.
Allocation was conducted by the study statistician, blind to the identity of the schools, and schools were
optimally allocated by the median percentage of students in receipt of FSMs (below/above median) and
median school size (below/above median).
Outcomes
The outcomes in stage 1 were the draft intervention logic models, manuals and resources for +FRANK
and FRANK friends. In stage 2, after delivery of the interventions in one school each, the outcomes were
a list of refinements to the intervention resources. In stage 3, the external pilot cRCT, outcomes were
operationalised as progression criteria.
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In the pilot cRCT the progression criteria were (1) ≥ 75% of Year 8 ASSIST peer supporters are recruited
and retrained as +FRANK peer supporters in Year 9; (2) PHW staff deliver the additional +FRANK training
in full in all three intervention schools; (3) ≥ 75% of +FRANK peer supporters report having at least one
or more informal conversations with their peers at school about drug-related risks/harms; (4) ≥ 75% of
+FRANK peer supporters report at least one contact with PHW staff, either during a follow-up visit or by
e-mail or text; (5) randomisation occurs as planned and is acceptable to school management teams (SMTs);
(6) a minimum of five out of six intervention schools and two out of three schools from the comparison
arms participate in the 18-month follow-up; and (7) the student survey response rates are acceptable at
baseline (≥ 80%) and follow-up (≥ 75%). The same progression criteria were applied to FRANK friends,
except criterion 1 applied only to the recruitment of peer supporters.
The indicative primary outcome for use in a (potential) future trial of intervention effectiveness was lifetime
drug use. Students were asked to report their use of 10 illicit drugs across the lifespan. Indicative
secondary outcomes were the lifetime use of tobacco and alcohol, as well as dependency on cannabis and
tobacco, and the frequency of heavy episodic alcohol use.
Statistical analysis
Statistical analyses were largely descriptive. We presented the percentages of missing values and
distributions of all categorical and continuous variables. Exploratory effectiveness analysis using multilevel
regression models adjusting for minimisation variables was conducted. All analyses used intention-to-treat
populations.
Assessment of costs
The costs of +FRANK and FRANK friends were estimated using information from PHW on the basic salary,
national insurance and superannuation for +FRANK and FRANK friends trainers. All expenses incurred
during the intervention were documented.
Process evaluation
The process evaluation examined the feasibility and acceptability of the two interventions from the
perspectives of peer supporters, school teachers, intervention delivery staff, parents and a public health
commissioner. Two members of the research team observed the delivery of all intervention activities across
all sites to examine fidelity of delivery.
Qualitative data collection and analysis
All interview recordings were fully transcribed. A framework analysis was employed to examine data
against the research objectives and progression criteria, while maintaining flexibility to incorporate
emergent themes.
Results
Objective 1: refine the ASSIST logic model to drug prevention and develop the +FRANK
and FRANK friends interventions
Two peer-led drug prevention interventions were developed. The process took 18 months and included
42 activities, including consultations with stakeholders, experts and ASSIST delivery staff. The evidence
review of population-based prevalence studies showed that the prevalence of lifetime drug use more than
doubled between 13 (11%) and 15 (24%) years of age and that only cannabis and GGAs had a prevalence
of > 1%. This led us to target delivery to UK Year 9 students (age 13–14 years) and focus the intervention
content on cannabis and GGAs.
This evidence and the ASSIST intervention materials were used to coproduce +FRANK and FRANK friends
with stakeholders. +FRANK was designed as an adjunct to follow on from ASSIST (which is delivered in UK
Year 8) in five stages: re-engage Year 8 ASSIST peer supporters in Year 9 to continue and extend their
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role; recruitment; 1 day of off-site training on the effects and risks of drugs, minimising harms and the law
using information from the UK national drug education website, Talk to FRANK; a 10-week intervention
period in which supporters have informal conversations with their peers, supported by two face-to-face
and two electronic follow-up sessions with trainers; and an acknowledgement of peer supporters.
FRANK friends is a standalone informal peer-led intervention to prevent drug use in UK Year 9 secondary
school children. It has the same format as +FRANK except for three features. First, in the FRANK friends
intervention Year 9 students nominate influential students in their year and the 17.5% of students with
the most nominations are invited to a recruitment meeting. Second, the off-site training occurs over
2 days, with additional communication skills training. Third, there are four face-to-face follow-up visits.
This design replicates that used in the ASSIST intervention.
Objective 2: test the feasibility of the +FRANK and FRANK friends interventions in one
school each
In the feasibility testing of +FRANK, we carried out seven structured observations, collected 34 evaluation
forms and conducted 13 interviews with peer supporters and trainers. Twelve of the 14 peer supporters
attended follow-ups 1 and 4, which were delivered in person. Only one peer supporter completed the
electronic follow-up sessions. Across the 15 activities, five were delivered in full, eight had minor deviations
and two were not delivered at all.
In the feasibility testing of FRANK friends, we carried out 15 structured observations, collected evaluation
forms of the training from 47 peer supporters and trainers, conducted 13 interviews with peer supporters,
trainers and teachers (including SMTs), and held five focus groups with 14 peer supporters. Between
16 and 21 of the 26 trained peer supporters attended each of the four follow-up sessions. Across the
25 activities, 13 were delivered in full, nine had minor deviations and three were not delivered at all.
Interviews with trainers found that some activities were too long and others were too short and that the
sequencing of activities could be improved.
We made the following refinements to the +FRANK intervention: the electronic follow-up sessions and
the final face-to-face follow-up were removed, leaving three face-to-face follow-up sessions. For both
interventions we made slight changes to the content and sequencing of the training activities and the
instruction manual.
Objective 3: conduct a pilot cluster randomised controlled trial of the +FRANK and
FRANK friends interventions
In the external pilot cRCT, all progression criteria for the +FRANK and FRANK friends interventions
were met.
Feasibility and acceptability of the interventions to trainers, students, parents and
school staff
The process evaluation involved 66 interviews. Independent structured observations of the delivery of all
intervention activities were made by two members of the research team.
In the +FRANK arm, 92% of peer supporters were recruited and retrained and 92% of peer supporters
reported at least one conversation and all reported a contact with intervention delivery staff. In the FRANK
friends arm, 82% of peer supporters were trained and 94% of peer supporters reported at least one
conversation and all reported a contact with intervention delivery staff.
The qualitative analysis suggested that the interventions were acceptable to students, teachers
and parents.
Assessment of the fidelity of delivery of the interventions by trainers
All +FRANK and FRANK friends intervention activities were delivered as intended.
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Comparison of the feasibility and acceptability of the +FRANK and FRANK
friends interventions
The process evaluation indicated that the hypothesised intervention logic may not hold as well for the
+FRANK intervention as for the FRANK friends intervention. In the three +FRANK schools, students
completed the peer nomination process in Year 8 and Year 9. Around one-third of +FRANK peer
supporters were not nominated as the most influential by their peers in Year 9. This meant that other
students who were perceived to be influential in Year 9 were not trained to be peer supporters. Trainers
also reported feeling rushed to deliver the content in the +FRANK intervention as training took place over
1 day, whereas training for the FRANK friends intervention took place over 2 days.
Assessment of trial recruitment and retention rates
The 12 schools recruited were randomised and were retained at the 18-month follow-up. In total, 93% of
eligible students were recruited at baseline and were retained at the 18-month follow-up.
Survey
We found low rates of missing data for almost all variables. The highest rate of incomplete data (23%)
was for the Cannabis Abuse Screening Test (CAST), a measure of cannabis dependency at baseline. There
was also some evidence at baseline of floor effects, with medians of 0.0 on the Heaviness of Smoking
Index (HSI) and 0.5 on the Fagerström Test for Nicotine Dependence (FTND). At follow-up, median scores
were 2.0 on the FTND and 0.0 on the HSI.
The prevalence of lifetime drug use was 4.1% at baseline. The most commonly used drugs were cannabis
(2.4%) and GGAs (2%). At the 18-month follow-up, the prevalence of lifetime drug use was 11.6%. The
most commonly used drugs were cannabis (8.0%), GGAs (4.0%), legal highs (1.7%) and cocaine (1%).
The intraclass correlation coefficient (ICC) for lifetime drug use at follow-up for the comparison between
usual practice and +FRANK was very small (< 1 × 10–8) and for the comparison between usual practice and
FRANK friends was 0.003.
Compared with the usual practice arm, the odds of lifetime drug use at the 18-month follow-up were
lower in the +FRANK arm [12.4% vs. 13.4%; odds ratio (OR) 0.96, 95% confidence interval (CI) 0.58 to
1.59] and the FRANK friends arm (9.3% vs. 13.4%; OR 0.70, 95% CI 0.39 to 1.24). The overall direction
of effects across the hypothesised intermediary and outcome variables indicated a positive, although
non-significant, effect for FRANK friends and a mixed pattern for +FRANK.
Delivery costs and pilot methods for assessing cost-effectiveness
The estimated cost per school was £3041 (£20.69 per student) for the FRANK friends intervention and
£1942 (£13.87 per student) for the +FRANK intervention.
Objective 4: determine the design, structures, resources and partnerships necessary for
a full-scale trial to take place
For the definitive trial we propose a two-arm (FRANK friends vs. usual practice) cRCT (randomisation at the
school level) with integrated economic and process evaluations. The primary outcome will be lifetime illicit
drug use. The secondary outcome measures will be all those used in the 18-month follow-up in the
external pilot cRCT, except for the FTND and HSI.
Conclusions
The +FRANK and FRANK friends peer-led drug prevention interventions were acceptable to peer
supporters, teachers and parents. It was feasible to conduct a cRCT of these interventions in the school
setting with young people age 13–14 years. The process evaluation indicated that the FRANK friends
intervention was preferred over the +FRANK intervention. Qualitative and statistical evidence suggests
there should be a follow-on full-scale cRCT of FRANK friends.
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Chapter 1 Background to the research
Definitions of illicit drug use and legislative framework governing use
Illicit drugs are those for which non-medical use is prohibited by international drug control treaties.1
This includes plant-based substances (e.g. cannabis, cocaine, heroin) and synthetic substances such as
amphetamine-like stimulants, novel psychoactive substances and prescription opioids. In the UK, illegal
drugs are controlled substances defined in the 1971 Misuse of Drugs Act2 or determined to be capable of
producing a psychoactive effect and not exempted by the 2016 Psychoactive Substances Act.3 Glues, gases
and aerosols (GGAs) also face restrictions on sales to those aged < 18 years under the Cigarette Lighter
Refill (Safety) Regulations 19994 and Anti-social Behaviour Act 2003.5 Henceforth, GGAs will be classified
as illicit drugs.
The prevalence of illicit drug use in school-age adolescents
In the UK, over the past 10 years there has been a steady decline in the number of students aged
11–15 years in England who report ever having tried drugs, from 26% in 2004 to 15% in 2014.6 In 2014,
10% of 11- to 15-year-olds had used drugs in the last year, a decrease from 18% in 2004. The proportion
who have ever used drugs increases with age: in 2014, 6% of 11-year-old children reported having used
drugs, which increased to 24% for 15-year-olds.6 The proportion of children using drugs in the last month
increases with age, reaching 12% in 15-year-olds. In total, 8% of 11- to 15-year-olds had tried cannabis,
6.8% had tried GGAs and 1% had tried cocaine, ecstasy and magic mushrooms.6
Direct harms to health associated with illicit drug use
The latest Global Burden of Disease Study found that the risk factors for disability-adjusted life-years
(DALYs) attributable to drug use disorders in young people had increased between 1990 and 2013.7
One DALY represents the loss of the equivalent of 1 year of full health. Across 188 countries, drug use
disorders were ranked 14th in the causes of DALYs in 10- to 14-year-olds; fifth in 15- to 19-year-olds
(behind alcohol misuse, unsafe sex, iron deficiency and unsafe water), up from sixth in 1990; and second
in 20- to 24-year-olds (behind alcohol misuse), up from fourth in 1990.
In the UK, the direct harms to health associated with drug use in school-age children are mainly attributable
to cannabis and GGA use. Around 10% of cannabis users will become dependent on it8 and it is the
primary reason for seeking specialist drug treatment in the UK in those aged < 18 years.9 In 2014/15,
13,454 (73%) 11- to 18-year-olds receiving specialist drug treatment did so primarily for cannabis use.9
The proportion of young people seeking treatment for cannabis use has been on an upwards trend since
2005/6 (from 55%, n = 9043). The median age at first treatment was 16 years.9
A number of cohort studies have shown that regular cannabis users have lower attendance rates and are
more likely to leave school10,11 and have a lower level of educational achievement.12 In the Avon Longitudinal
Study of Parents and Children (ALSPAC) birth cohort,13 lifetime cannabis use by 15 years of age was
associated with a 2-point lower mathematics General Certificate of Secondary Education (GCSE) score, a
48% increased risk of not attaining five or more GCSEs and a threefold increased risk of leaving school, or
having no qualifications, after adjusting for prior key stage 2 results, parental substance misuse, gender and
concurrent drug and tobacco use. Stronger associations were found for weekly cannabis use.13 This is
consistent with case–control studies, which have found poorer verbal learning, memory and attention in
those who regularly use cannabis than in those who do not.14
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Indirect harms of drug use for health
Illicit drug use may indirectly affect health by limiting opportunities for employment and educational
attainment resulting in exclusion from school.
In the UK, in 2014/15 there were 607 (3% of all offences) proven offences (defined as a reprimand,
warning, caution or conviction) that were drug related among 10- to 14-year-olds, increasing to 6922
cases (10.3%) in 15- to 17-year-olds.15 There were 142 guilty verdicts delivered at courts attributable to
drug offences among 10- to 14-year-olds (5.5% of all indictable offences), increasing to 2480 (17.2%)
among 15- to 17-year-olds.15 All offences and convictions are subject to disclosure to a potential employer
under the Rehabilitation of Offenders Act 197416 if the role requires, such as when working with children
or vulnerable adults, within law, health-care and pharmacy professions and in some senior management
posts and when matters of national security are involved. The exact impact of drug convictions on
employment is not known.
In 2014/15 there were 480 permanent (10%) and 7900 fixed-period (3.3%) drug- and alcohol-related
exclusions in state-funded secondary schools in England.17 These data do not disaggregate between illicit
drug use and alcohol use.
Evidence on the effectiveness of school-based drug prevention
In response to a commissioning brief published by the National Institute for Health Research (NIHR) inviting
applications to examine using peer support to prevent illicit drug uptake in young people (reference
12/3060), we conducted a scoping review of relevant systematic reviews and randomised controlled trials
(RCTs). The effectiveness of school-based drug prevention has been examined in a 2014 Cochrane
systematic review.18 In this review, 51 RCTs of universal (i.e. provided to all) school-based prevention
interventions were identified, with only two studies from the UK. The interventions reviewed showed, on
average, no protective effect on drug use after 12 months. In terms of what types of interventions are
effective, interventions that aim to increase knowledge did not lead to changes in drug use behaviour,
whereas those aiming to increase social competences (i.e. teaching self-management, social skills,
problem-solving, skills to resist media and interpersonal influences, how to cope with stress) or based on
social influence theories (i.e. correcting overestimates of the prevalence of drug use, increasing awareness
of media, peer and family influences, practising refusal skills) increased knowledge about drugs but had
small and inconsistent effects on drug use at ≥ 12 months. The six studies that examined interventions
using components from both social competence and influence approaches had a small beneficial effect
on preventing cannabis use, but no effect on hard drug use (defined as heroin, cocaine or crack) after
12 months. The authors noted that many studies did not describe the randomisation method or account
for clustering (non-independence between children in the same school) in their analyses, despite all being
cluster RCTs (cRCTs).18
A second systematic review examined the effectiveness of peer-led interventions to prevent tobacco,
alcohol or illicit drug use in 11- to 21-year-olds.19 Pooled data from the three school-based RCTs reporting
a drug use outcome (976 students, 38 schools) suggested that peer-led interventions had a small
protective effect on cannabis use at ≥ 12 months. One study in this review, the Towards No Drug Abuse
Network (TND-Network) study, which involved nominated peers delivering lessons on drug use, found a
small reduction in monthly cannabis use.20 In a subgroup of students whose friends had already used
substances (calculated as a composite of tobacco, alcohol, cannabis and cocaine use), an iatrogenic effect
was found whereby monthly cannabis use slightly increased. Contamination was potentially an issue in this
study, as classes rather than year groups or schools were allocated. Another school-based drug abuse
prevention trial, the European Drug Addiction Prevention (EU-Dap) trial, reported no effect on drug use at
18 months in the peer-led intervention arm,21 but implementation of the intervention in this arm was poor,
with only 8% of centres implementing all seven sessions and 71% not conducting any meetings at all.
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These reviews identified a number of methodological weaknesses in the evidence base, including small
sample sizes, contamination, inadequate reporting of randomisation and outcomes and a failure to
account for clustering in cRCTs.18 Interventions using a combination of social influence and social
competence training have had small beneficial effects on knowledge and cannabis use at 12 months’
follow-up.18 Two peer-led RCTs have shown a small beneficial effect of peer-led interventions on
preventing and reducing cannabis use.19 There were some limitations in the design of these interventions,
including the iatrogenic effects in one peer-led study20 and low levels of implementation in another
study.21 This suggests that a more careful approach to intervention design and refinement is needed.
In these reviews, no drug prevention interventions were implemented in a UK educational setting.
Rationale for the current study
The rationale for this study was to develop, refine and conduct a pilot cRCT of a new school-based peer-led
drug prevention intervention. Specifically, in our study we aimed to adapt an existing, effective, peer-led
smoking prevention intervention (ASSIST) that uses components of social influence and competence
programmes to deliver information on illicit drug use from the UK national drug education website
[see www.talktofrank.com (accessed 29 August 2017)].
ASSIST
The ASSIST intervention is an evidence-based, informal peer-led smoking prevention intervention based on
diffusion of innovations theory22 that aims to diffuse and sustain non-smoking norms via secondary school
students’ social networks in Year 8 (age 12–13 years).23 It is part of the tobacco control plans of the
Scottish24 and Welsh25 Governments and is recommended by the National Institute for Health and Care
Excellence.26 In the UK, > 120,000 students have taken part in the ASSIST intervention and an estimated
2200 young people have not taken up smoking because of ASSIST who otherwise would have done so.
The five stages of ASSIST, as currently delivered, are listed in Table 1.
Talk to FRANK
The Talk to FRANK website (see www.talktofrank.com) was set up by the UK Department of Health and
the Home Office in 2003 to provide up-to-date, youth-friendly information and advice on the risks of illicit
drug use. Between January and December 2014 there were 5.1 million visits to the FRANK website.27 In
2013, 18% of 11- to 15-year-olds (increasing from 5% of 11-year-olds to 33% of 15-year-olds) reported
that the website was a source of helpful information about drugs.28 The FRANK website is the most
commonly cited source of information by teachers (78%) for preparing lessons on drugs.6
Information is provided using a number of interactive methods including videos showing the effects of
specific drugs, regular updates on the legality and mechanism of effect of new drugs, an A-Z guide of
drugs and a frequently asked questions (FAQs) section. Highly rated FAQs include those on the long-term
effects of cannabis, the levels of drug use associated with dependence, criminal consequences and the
half-life of specific drugs. FAQs are also tailored to young people, parents and health professionals.
Support is offered through the website with instant messaging, live chat (available at specific times during
the day), an online forum, a confidential 24-hour telephone service and an e-mail or text service. Trained
advisors operate this free service and local help can also be found by entering a postcode.
CASE+
There was a previous attempt to adapt the ASSIST intervention to prevent cannabis use. An unpublished
feasibility trial (CASE+) in six Scottish secondary schools found little change in intentions to use cannabis in
732 students aged 12–13 year over a 3-month follow-up (Munro A, Bloor M. A Feasibility Study for a
Schools-based, Peer-led, Drugs Prevention Programme, Based on the ASSIST Programme: the Results.
Centre for Drug Misuse Research Occasional Paper. Glasgow: University of Glasgow; 2009). The
intervention included an extra day of education solely on cannabis use in addition to the 2 days of training
on smoking in the ASSIST intervention. However, the study had several limitations: (1) no drug use data
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were collected, (2) 3 months’ follow-up is not long enough to ascertain a likely effect of the intervention
over longer periods and (3) the intervention content was solely related to cannabis use.
The process evaluation indicated that, although implementation fidelity and acceptability to school staff was
high, students were overwhelmed with the amount of information that they received in the extra day of
training on cannabis. The peer supporters also rarely had conversations about cannabis but focused on
smoking, because only a few students were experimenting with cannabis at age 12/13 years and there was
sensitivity around discussing cannabis use as it is illegal. We decided to adapt the ASSIST model to deliver the
information from the FRANK website rather than CASE+ as it has a database of information on illicit drugs
and not just cannabis. The FRANK website has demonstrated a large number of hits per year and teachers
and young people use it, such that it provides an accessible drug education resource that updates.
Study design
This study was conducted in three stages. Stage 1 involved the development of two new school-based
peer-led drug prevention interventions: ASSIST + FRANK (+FRANK) and FRANK friends. Stage 2 involved
the delivery of the interventions in one school each, conducting a process evaluation and using this
information to refine the interventions. Stage 3 was a four-arm pilot cRCT (+FRANK, FRANK friends,
TABLE 1 Outline and content of the ASSIST intervention
Stage Primary focus Core tasks
1 Nomination of peer
supporters
l Ask students to identify influential peers using three questions: ‘Who do you
respect in Year 8 at your school?’, ‘Who are good leaders in sports or other
group activities in Year 8 at your school?’ and ‘Who do you look up to in
Year 8 at your school?’
l Invite the 17.5% of students with the most nominations to a recruitment meeting
2 Recruitment of peer
supporters
l Meet with nominees to explain the role of a peer supporter
l Students who smoke can be peer supporters only if they commit to trying to
stop smoking
l Seek parental consent for training course participation
3 Training of peer supporters l The overall aim is to enable peer supporters to engage in informal
conversations with peers about the effects of smoking and the benefits of
not smoking
l 2-day training session outside school, facilitated by external trainers
experienced in youth work and health promotion
l Provide information about the risks of smoking and the benefits of remaining
smoke free
l Develop communication skills, including verbal and non-verbal communication
skills, co-operation and negotiation and ways of giving and receiving
information
l Enhance students’ personal development, including their confidence and self-
esteem, empathy and sensitivity to others, assertiveness, decision-making and
prioritising skills, attitudes to risk-taking and exploration of personal values
l Methods used to include role plays, student-led research, small group work
and discussion and games
4 Intervention period l 10-week peer-led intervention in which supporters have informal conversations
with their peers about smoking when travelling to and from school, during
breaks, at lunchtime and after school in their free time and log a record of
these conversations in a pro-forma diary
l Four follow-up school visits by trainers to meet with peer supporters to provide
support, troubleshooting and monitoring of peer supporters’ diaries
5 Acknowledgement of peer
supporters’ contribution
l Presentation of certificates to all peer supporters
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ASSIST and usual practice) with an embedded process evaluation. The ASSIST arm was used to investigate
any potential indirect effects of a smoking prevention intervention on drug use.
Aim and objectives
The overall aim of this study was to assess the feasibility, acceptability and fidelity of delivery of the
+FRANK and FRANK friends interventions to inform a full-scale RCT.
The objectives were to:
1. refine the ASSIST logic model to drug prevention and develop the ASSIST + FRANK and FRANK
friends interventions
2. test the feasibility of the +FRANK and FRANK friends interventions in one school each and
i. assess the acceptability of the intervention to trainers, students, parents and school staff and explore
the barriers to and facilitators of implementation
ii. explore the fidelity of intervention delivery by +FRANK and FRANK friends trainers and
peer supporters
iii. refine the interventions
3. conduct a pilot cRCT of the +FRANK and FRANK friends interventions to
i. assess the feasibility and acceptability of the refined interventions to trainers, students, parents and
school staff
ii. assess the fidelity of intervention delivery by trainers
iii. compare the feasibility and acceptability of the interventions
iv. assess trial recruitment and retention rates
v. pilot outcome measures
vi. record the delivery costs and pilot methods for assessing cost-effectiveness
4. determine the design, structures, resources and partnerships necessary for a full-scale trial to take place.
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Chapter 2 Methods
Design
The three stages of the project are described in Figure 1.
Setting
The study took place in seven local authorities in South Wales (Cardiff, Newport, Torfaen, Blaenau Gwent,
Rhondda Cynon Taf, Merthyr Tydfil and Caerphilly). With a projected population of 1,155,800 in 2016,
these local authorities represent 36.9% of the Welsh population.29 Fourteen out of the 72 secondary
schools across the seven local authorities participated. Two schools received one of the interventions each
in stage 2. Twelve schools were involved in stage 3, the pilot cRCT.
Ethics approval and monitoring
The study was granted ethics approval by Cardiff University School of Social Sciences Research Ethics
Committee (reference SREC/1103). NHS research and development (R&D) approval was also granted, as
Public Health Wales (PHW) staff delivered the interventions (reference 2013PHW0015).
18-month follow-up
Stage 1: adapt ASSIST intervention manual and Talk to FRANK content to
develop intervention materials for +FRANK and FRANK friends
Stage 2: train PHW staff, deliver +FRANK and FRANK friends in
one school each, collect process data and refine intervention
Stage 3: pilot trial – 12 schools recruited and randomised into four-arm trial (3 : 3 : 3 : 3)
with embedded process evaluation
PHW deliver ASSIST to Year 8 in six schools
Consent participants and collect baseline data in Year 8
Train PHW ASSIST staff to deliver +FRANK and FRANK friends
PHW deliver +FRANK and FRANK friends to Year 9 in six schools
FIGURE 1 Study schema. Note: stages did not take place in chronological order. The ASSIST intervention was
delivered in Year 8 and the baseline data collection for the pilot trial (stage 3) took place before the piloting of
the +FRANK and FRANK friends interventions. Dashed lines indicate stages that were part of the pilot cRCT.
PHW, Public Health Wales.
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Trial monitoring
The ongoing conduct and progress of the study was monitored by an independently chaired Trial Steering
Committee (TSC). The membership included independent scientific experts, representation from the
Department of Health, policy leads for children and young people in PHW and a parent representative.
Interventions
We present here an outline of each intervention provided at the time of the submission of the proposal for
funding. The content of the activities and the method of delivery had yet to be developed. Both interventions
underwent revision during stages 1 and 2.
+FRANK: an informal peer-led drug prevention adjunct to ASSIST
+FRANK is an informal peer-led intervention to prevent drug use in UK Year 9 secondary school children.
A summary of the +FRANK intervention is provided in Table 2.
FRANK friends: an informal peer-led drug prevention intervention
FRANK friends is a standalone informal peer-led intervention to prevent drug use in UK Year 9 secondary
school children. It replicates the format of the ASSIST intervention in the peer nomination process, the
2 days of off-site training and the four face-to-face follow-up visits. The +FRANK intervention includes only
1 day of off-site training. The additional day of training in the FRANK friends intervention is mainly spent
developing communication skills, which are covered in training for the ASSIST intervention. A summary of
the FRANK friends intervention is provided in Table 3.
TABLE 2 Outline and content of the +FRANK intervention
Stage Primary focus Core tasks
1. Re-engagement of ASSIST
peer supporters
l ASSIST Year 8 peer supporters invited in Year 9 to continue and extend
their role
2. Recruitment l Explain the role of a +FRANK peer supporter
l Parental consent sought for participation in the training course
3. Training of peer supporters l 1-day training event held out of school, facilitated by the PHW ASSIST delivery
team, who are experienced in youth work and health promotion
l Provide information on the effects and risks associated with specific drugs,
minimising potential harms and the law from the Talk to FRANK website
l Peer supporters revisit communication skills
l How to access the Talk to FRANK website by smartphone or by text
l Methods used to achieve these aims included participatory learning activities
such as role plays, student-led research, small group work and discussion
and games
4 Intervention period l 10-week intervention in which supporters have informal conversations with
their peers on the harms of drug use when travelling to and from school,
during breaks, at lunchtime and after school in their free time and log a record
of these conversations in a pro-forma diary
l Two face-to-face follow-up school visits in person were made by the PHW
delivery team to provide support, trouble shooting and monitor peer
supporters’ diaries
l Two electronic follow-ups were sent via a preferred method (e-mail or text), as
well as notifications of when information on new drugs or news was added to
the Talk to FRANK website
5 Acknowledgement of peer
supporters’ contribution
l Presentation of certificates to all peer supporters
l Presentation of £20 gift vouchers to peer supporters who handed in their diary
METHODS
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Stage 1: development of the +FRANK and FRANK friends interventions
We used a three-phase multimethod framework to guide the adaptation of the ASSIST smoking
prevention intervention to develop content, resources and delivery methods for the +FRANK and FRANK
friends interventions (Figure 2).30 The methods used at each stage allowed for integration of the scientific
literature with key stakeholders’ knowledge and expertise. Key stakeholders included people with direct
experience or knowledge of youth drug taking, recipients of the existing ASSIST smoking prevention
intervention, intended recipients of the newly developed interventions and those who delivered any
existing drug prevention interventions within the setting (i.e. schools) or who provided intervention
resources (e.g. financing, staffing).
Phase 1: evidence review and stakeholder consultation
Evidence review
We conducted a scoping review of systematic reviews and RCTs of school-based drug prevention. We also
examined the latest population-based randomly sampled surveys on the prevalence of illicit drug use in
school-age children in the UK.
Consultations with young people
We gathered multiple perspectives about drug use and existing drug education to tailor the intervention
content to increase acceptability within the school context and population. Our aim was to maximise
acceptability and reduce problems with implementation. This involved a range of methods.
TABLE 3 Outline and content of the FRANK friends intervention
Stage Primary focus Core tasks
1. Nomination of peer
supporters
l Students are asked to complete a questionnaire to identify influential peers
using three questions: ‘Who do you respect in Year 9 at your school?’, ‘Who
are good leaders in sports or other groups activities in Year 9 at your school?’
and ‘Who do you look up to in Year 9 at your school?’
l The 17.5% of students with the most nominations are invited to a
recruitment meeting
2. Recruitment l Explain the role of a FRANK friends peer supporter
l Parental consent sought for participation in the training course
3. Training of peer supporters l 2-day training event held out of school, facilitated by the PHW ASSIST delivery
team, who are experienced in youth work and health promotion
l Provide information on the effects and risks associated with specific drugs,
minimising potential harms and the law from the Talk to FRANK website
l Peer supporters practise communication skills including listening, negotiation
and ways of giving information and how to talk with their peer group about
drugs, including aspects of confidentiality
l How to access the Talk to FRANK website by smartphone or by text
l Methods used to achieve these aims included participatory learning activities
such as role plays, student-led research, small group work and discussion
and games
4 Intervention period l 10-week peer-led intervention in which supporters have informal conversations
with their peers on drugs when travelling to and from school, during breaks,
at lunchtime and after school in their free time and log a record of these
conversations in a pro-forma diary
l Four follow-up school visits by intervention delivery staff to meet with peer
supporters to provide support, troubleshooting and monitoring of peer
supporters’ diaries
5 Acknowledgement of peer
supporters’ contribution
l Presentation of certificates to all peer supporters
l Presentation of £20 gift vouchers to peer supporters who handed in their diary
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Focus groups with young people
Six focus groups were conducted with 47 young people aged 13–15 years, who were purposively sampled
from three schools, a youth centre and a student referral unit. A semistructured topic guide was used with
broad open-ended questions relating to participatory task-based activities using resources based on the
Talk to FRANK website.
Interviews with the ASSIST intervention delivery team
Interviews were conducted with five members of the PHW ASSIST delivery team.
Structured observations of current practice
Structured observations of all five stages of ASSIST intervention delivery were conducted (n = 8), as well as
one observation of the ASSIST ‘Train the Trainers’ course.
Stakeholder consultation
A range of informal consultations was also conducted with young people and practitioners, one with five
volunteers from a young people’s public involvement group aged 16–19 years; one with seven young
people aged 13–15 years; one with five recipients of the ASSIST intervention aged 12–13 years; and nine
individual consultations with health professionals working for drug agencies (n = 4), with young people
(n = 4) or both (n = 1).
Audio recordings from interviews and focus groups were transcribed verbatim and analysed using thematic
analysis. Researcher field notes from observations and informal consultations were combined with the data
from the interviews and focus groups. An a priori coding framework focused on assessing the acceptability
of the content and delivery of the intervention. An element of flexibility was maintained in coding such that
data that did not fit the framework were also captured in an inductive manner. This approach to analysis
has been described in detail elsewhere.31 The findings from the analyses fed into the coproduction of
intervention content during phase 2.
Phase 2: coproduction
An intervention development group (IDG) was established consisting of members of the research team and
the PHW ASSIST delivery team. The PHW team had delivered the ASSIST intervention to > 350 schools
over a period of 7 years and so had extensive experience of intervention delivery within schools. The aim of
the IDG was to adapt the ASSIST intervention materials to deliver information from the Talk to FRANK
website, informed by the findings from phase 1.
Coproduction of intervention content took the form of an action research cycle over a series of meetings
of the IDG at which findings from stage 1 were considered, ideas were presented by all members,
feedback on ideas was sought and refinements were made and presented again, until the final content
was agreed. Five face-to-face meetings were held over the course of a 4-month period. These were
supplemented by communications by e-mail when face-to-face meetings were not possible or when
matters arose that required discussion between meetings.
Phase 3: prototyping
After a first draft of the +FRANK and FRANK friends interventions had been developed, the manuals and
resources (e.g. fact sheets on the effects of cannabis on mental health) underwent expert review. Two
experts were asked to examine key uncertainties identified during phases 1 and 2. The lead author of the
ASSIST cRCT23 examined the fit of the activities with diffusion of innovations theory,22 on which the ASSIST
intervention was based. The lead trainer of DECIPHer IMPACT (Bristol, UK), the company that licenses
ASSIST, and reviewers examined the age appropriateness of the activities and the suitability of the timings
and sequencing of activities.
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Preliminary feedback on acceptability and feasibility was collected during training of the PHW intervention
delivery staff. Training involved the delivery of the two interventions to the IDG. Feedback was also sought
from ASSIST trainers at a DECIPHer IMPACT ‘Train the Trainer’ course. The interventions were also
delivered to a young people’s public involvement group (aged 16–19 years). Feedback was sought from
young people on each activity, with a particular emphasis on relevance for their age group and interest in
and engagement with the content.
Stage 2: delivery and refinement of the +FRANK and FRANK
friends interventions
The +FRANK and FRANK friends interventions were delivered in one school each. The aim was to conduct
a detailed process evaluation examining the acceptability and feasibility of the intervention from the
perspective of teachers [contact and school management team (SMT) members], peer supporters and
trainers within the school context.
Figure 3 provides an overview of the process and methods used to refine the intervention content and
delivery mechanism.
Public Health Wales identified eligible +FRANK schools for the initial feasibility testing as the schools were
required to have received the ASSIST intervention in Year 8. Eligible FRANK friends schools were required
to have not received the ASSIST intervention in Year 8. The order of invitation was not determined by any
defined method. The interventions were delivered over two different terms because of a lack of capacity in
the PHW team to deliver them concurrently. The +FRANK intervention was delivered first followed by the
FRANK friends intervention. Information was collected to determine acceptability and feasibility to inform
refinements to the intervention manuals and associated resources in preparation for the pilot trial. This
involved a range of methods.
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FIGURE 3 Framework for refining the intervention content and delivery mechanism.
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Structured observations, evaluation forms and interviews
Independent structured observations were undertaken by two researchers of all intervention activities,
including recruitment, re-engagement, training and follow-up visits. Observation forms captured whether
or not objectives for the sessions and learning outcomes for activities were met using a traffic light system.
Green indicated that the activity had been fully delivered with all objectives met, amber indicated minor
deviations in delivery and red highlighted that activity objectives had not been met. The timings of the
activities delivered were also recorded along with notes on any deviations to the timetable and/or activity
instructions. Trainers completed self-assessment forms following each delivery episode to capture their
perceptions of the delivery for each aspect of intervention delivery and training.
Evaluation forms were completed by peer supporters and trainers at the end of the off-site training days
and final follow-up visit. Interviews were conducted with peer supporters, trainers, contact teachers and
members of the SMT after the last follow-up. Interviews with peer supporters were conducted individually,
in pairs or in small groups, to suit the requirements of the school. Additional interviews were conducted
with trainers and students after delivery in the two schools that took part in the initial feasibility testing.
Interviews were conducted with peer supporters using a semistructured topic guide to explore all parts of the
interventions, particularly what did and did not work, with a view to identifying areas for potential refinement.
Interviews with school staff explored the intervention delivery, methods and processes. Interviews with SMT
members explored their awareness and understanding of the interventions, the information that they had
received and their overall impressions of the intervention. Audio recordings of interviews were transcribed
verbatim and anonymised at the point of transcription. This included removing personal names, school names
and any other identifying information. Qualitative data analysis was facilitated by the use of NVivo 10 (QSR
International, Warrington, UK), a qualitative data analysis software programme.
A framework analysis was employed.32 A coding matrix was used to index and categorise data, with
categories and themes being predetermined based on the research objectives (e.g. feasibility of delivery of
the intervention components, acceptability of the intervention components to peer supporters) and with
any unexpected themes identified being added. Data collected from the structured observations and
self-assessments were organised in descriptive ‘chunks’ for each component/activity within the interventions.
Identification of recurring and salient themes was examined against this framework. Two coders agreed on
the framework and then referred to an additional two independent members of the research team to
discuss/resolve any discrepancies and reach a consensus. To agree on refinements to intervention resources
and delivery mechanisms, the results were shared with the Trial Management Group (TMG) and IDG.
Stage 3: external pilot cluster randomised controlled trial
The external pilot trial was a parallel, four-arm cRCT with school as the unit of randomisation. The
investigator team, students and staff were unblinded and fieldworkers were blinded. The primary aim of
the pilot trial was to assess the feasibility and acceptability of the intervention and trial methods and
gather data to plan a future full-scale trial. This included estimating rates of eligibility, recruitment and
retention at the 18-month follow-up, as well as the acceptability, reliability and rates of completion of pilot
primary and secondary outcome measures.
Eligibility criteria and recruitment
The pilot trial was embedded within the 2014/15 delivery of the ASSIST intervention by PHW. As part of
the Welsh Government’s Tobacco Control Action Plan, PHW was funded to deliver the ASSIST intervention
to 50 schools a year. The Welsh Government provided PHW with a list of approximately 160 schools
eligible for the ASSIST intervention out of the 220 secondary schools in Wales. The Welsh Government
informed PHW that schools were selected on the basis of having a high percentage of children in receipt
of free school meals (FSMs) and schools were in relatively deprived areas according to the Welsh Index of
Multiple Deprivation (WIMD).33 The Welsh Government did not provide the exact cut-off points applied for
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FSMs or the WIMD to exclude schools. From this list PHW recruited schools from the counties of Cardiff,
Newport, Torfaen, Blaenau Gwent, Rhondda Cynon Taf, Merthyr Tydfil and Caerphilly, inviting those that
had not received the ASSIST intervention in the past 2 years. Out of the 72 schools in these counties,
40 had not received the ASSIST intervention in the last 2 years and formed our sampling frame. These
schools were sent a project information sheet, reply envelope and form asking them to contact PHW or
the principal investigator if they wished to be involved in the study. Non-responders were followed up with
a reminder and telephone call from the study manager (KM). All interested schools were visited by the
study manager to discuss the study in more detail.
Consent
Head teachers signed a memorandum of understanding before taking part in the study describing the
roles and responsibilities of both the intervention delivery and the research teams and the timeline of
intervention delivery and assessments. Letters were sent to parents/guardians asking them to contact the
school if they did not wish their child to participate in the trial. Parents who did not wish their child to
participate were able to opt their child out of data collections. Written consent detailing the right to
withdraw was sought from all participants. At all data collection points, age-appropriate information
sheets were provided, together with a verbal explanation by researchers on the right to withdraw.
Sample size
As this was a pilot trial a power calculation was not required. The estimated sample size at baseline was
1440 students across 12 schools (n = 360 per arm), chosen to provide some information on variability
within and between schools at baseline and follow-up. This sample was not anticipated to provide
adequate power to detect a statistically significant difference across groups. However, the sample was
used to indicate the likely response rates and permit estimates [with 95% confidence intervals (CIs)] of
intraclass correlation coefficients (ICCs) of drug prevalence in anticipation of a larger cRCT.34
Randomisation
Schools agreed to take part prior to randomisation. The study used an assignment ratio of 1 : 1 : 1 : 1.
Allocation was conducted by the study statistician, blind to the identity of schools, and minimised on the
median percentage of students in receipt of FSMs (below/above median) and median school size (below/
above median) to balance the randomisation. Optimal allocation was used to carry out the randomisation.35
Interventions
The +FRANK and FRANK friends interventions delivered in the external pilot cRCT are described in Tables 2
and 3, respectively. Delivery of the +FRANK and FRANK friends interventions occurred between September
and November 2015. In the +FRANK arm, peer nomination was repeated to examine the proportion of
students nominated in Year 8 who were renominated in Year 9.
Usual practice
Children participated in their usual personal, social, health and economic education (PSHE) lessons
provided by the schools. All schools followed a national PSHE curriculum, which may include education on
drug use and smoking.
Quantitative data collection process
The consent procedure and questionnaires were self-reported. All data were collected by fieldworkers.
Questionnaires were completed in school halls or classrooms under examination conditions. Researchers,
fieldworkers and dedicated school staff helped children with literacy problems and special educational
needs. Baseline data collection took place between 17 September and 20 October 2014, prior to
randomisation. Follow-up data collection took place 18 months later between 22 March and 5 May 2016.
To increase response rates, additional collections were made for students who were absent. Schools were
paid £300 for staff cover for the data collections after the 18-month follow-up.
METHODS
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Outcome measures
The main study outcomes were operationalised as progression criteria. Progression criteria were agreed by
the TMG, TSC and NIHR Public Health Research (PHR) Research Funding Board. Assessment methods used
a mix of quantitative and qualitative data. Table 4 shows the research questions that the progression
criteria addressed, the data collection methods and the sources of data used.
TABLE 4 Progression criteria, data collection methods and data examined
Research question Progression criteria Data collection method Data examined
1. Was it feasible to
implement the +FRANK
intervention in (at least)
two out of three
intervention schools?
≥ 75% of Year 8 ASSIST
peer supporters are
recruited and retrained as
+FRANK peer supporters in
Year 9
Attendance records Percentage of students who
completed ASSIST training
in Year 8 attending the
recruitment and training sessions
for +FRANK
PHW staff delivered the
+FRANK training in full in
all three intervention
schools
Structured observations of
training and follow-up
sessions
Number of predefined learning
outcomes met at training and
follow-up sessions
Interviews with trainers Facilitators of and barriers to
delivering the intervention
activities
2. Was it feasible to
implement the FRANK
friends intervention in
(at least) two out of three
intervention schools?
≥ 75% of Year 9 students
nominated are recruited
and trained as FRANK
friends peer supporters
Attendance records Percentage of students who
were nominated to be FRANK
friends peer supporters
attending the recruitment and
training sessions
PHW staff delivered the
FRANK friends training in
full in all three intervention
schools
Structured observations of
training and follow-up
sessions
Number of predefined learning
outcomes met at training and
follow-up sessions
Interviews with trainers Facilitators of and barriers to
delivering the intervention
activities
3. Was the intervention
acceptable to students
trained as +FRANK
peer supporters? and
4. Was the intervention
acceptable to students
trained as FRANK friends
peer supporters?
≥ 75% of +FRANK and
FRANK friends peer
supporters report having at
least one or more informal
conversations with their
peers at school about
drug-related risks/harms
l Peer supporter diaries
l Peer supporter
evaluation forms
l Interviews/focus groups
with peer supporters
l Percentage of peer supporters
completing a diary entry for
a conversation
l Percentage of peer
supporters reporting on
evaluation forms
having conversations
l Acceptability of having
conversations with peer
group about the harms
of drugs
≥ 75% of +FRANK and
FRANK friends peer
supporters report ongoing
contact with PHW staff
throughout the year
through follow-up visits
l Attendance records
l Records of telephone
number/e-mail
contacts provided
l Interviews/focus groups
with peer supporters
l Attendance levels at
follow-up visits
l Percentage of peer
supporters who provided a
telephone number/e-mail
address to receive reminders
l Acceptability of attending
follow-up sessions back
in school and receiving
reminders by text/e-mail
continued
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Self-reported outcome measures
The self-report questionnaires included items to assess the anticipated primary outcome in a future full-scale
trial, the lifetime prevalence of illicit drug use, using questions from the ALSPAC cohort.36 At baseline,
students were asked whether they had ever tried 10 drugs that had a > 1% prevalence in 13- to 14-year-olds
in the 2013 Smoking, Drinking and Drug use survey,37 with an additional ‘other’ open response category.
At follow-up an additional seven drugs were added. Street names were also provided for all drugs and a
fictitious drug (semeron) was used to examine false responding. We also examined a number of potential
secondary outcomes in this population: frequency of use of each drug in the past 12 months, last 30 days
and last week; cannabis dependence using the Cannabis Abuse Screening Test (CAST);38,39 lifetime smoking
and weekly smoking status (weekly defined as smoking at least one or more cigarette a week40); number of
cigarettes smoked every day; nicotine dependence using the Fagerström Test for Nicotine Dependence
(FTND)41 and Heaviness of Smoking Index (HSI);41,42 lifetime alcohol consumption; the frequency of heavy
episodic alcohol use using the Adolescent Single Alcohol Question (A-SAQ), which is a modified version of
the modified Single Alcohol Screening Questionnaire;43 and health-related quality of life, using the Child
Health Utility-9 Dimensions (CHU-9D) measure.44,45
Self-reported measures of intermediary factors
To examine the hypothesised mechanisms of action described in the logic models, we examined a number
of intermediary factors. These included the perceived lifetime prevalence of drug use in Year 9, the
frequency of drug offers, conversations with friends about drugs and visiting the Talk to FRANK website,
ever having talked to a peer supporter about drugs, whether students would get help for themselves or a
friend from the Talk to FRANK website if they had a problem and knowledge about drugs calculated as
the number of correct answers from eight true or false questions about drugs (see Appendix 1, Table 16).
TABLE 4 Progression criteria, data collection methods and data examined (continued )
Research question Progression criteria Data collection method Data examined
5. Was the +FRANK
intervention acceptable to
the majority of SMTs,
other school staff and
parents? and 6. Was
the FRANK friends
intervention acceptable
to the majority of SMTs,
other school staff and
parents?
l Interviews with parents
l Interviews with
school staff
l Acceptability of peer-led
interventions; the peer
nomination process;
attending off-site training;
having conversations with
peers about the harms
of drugs; recording
conversations in a diary;
having follow-up sessions in
school time
l Facilitators of and barriers
to organising the peer
nomination process;
organising attendance at
training day(s); scheduling
follow-up sessions; booking
rooms for follow-up sessions
l Interviews with parents
l Interviews with
school staff
7. Were the trial design
and methods acceptable
and feasible?
Randomisation occurred
as planned and was
acceptable to SMTs
Interviews with SMT staff l Allocation occurred on time
l Acceptability of randomisation
A minimum of five out of
six intervention schools and
two out of three schools
from the comparison arms
participate in the 18-month
follow-up
Study records l Study records
Student survey response
rates are acceptable at
baseline (80%+) and
follow-up (75%+)
Attendance records l Percentage of students
completing the student
survey at baseline and
follow-up
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Statistical analysis
Statistical analyses were largely descriptive. The eligibility, recruitment and retention rates for schools and
students were summarised using a Consolidated Standards of Reporting Trials (CONSORT) diagram (see
Figure 7).46,47 The data collected for trial participants were summarised by trial arm and combined across
arms. To examine the acceptability of potential outcome measures the percentage of missing values are
reported for all variables. Categorical variables were summarised using the percentage in each category.
Numerical variables were summarised using the mean, standard deviation (SD) and a five-number summary
(minimum, 25th percentile, median, 75th percentile, maximum). We present mean and median values to
examine the shape of each distribution. We estimated the percentage of recanted responses, whereby
individuals indicated having never used a drug at follow-up but indicated that they had used at baseline,
as a measure of reliability. Comparisons were made between those who completed the study and those
who dropped out of the study. ICCs were calculated. Exploratory effectiveness analyses using multilevel
linear and logistic regression models adjusting for gender, age, FSM entitlement and residence with an
adult in employment were conducted for indicative outcome and intermediary variables. We fitted an
interaction term to examine effects in students who had and had not used drugs at baseline. If the ICC
was < 1 × 10–8, a single-level model was used. All analyses used intention-to-treat populations.
Cost analysis
We estimated the cost of delivering the +FRANK and FRANK friends interventions. The cost and cost-
effectiveness of the ASSIST intervention has been previously reported.48 We aimed to provide preliminary
evidence on the likely affordability of these interventions and also pilot methods of data collection.
We focused on additional costs, over and above those of usual practice, that would be incurred by the
public sector (i.e. PHW and schools/education authorities). We did not track or cost the resources used in
development or the feasibility testing of the +FRANK or FRANK friends interventions (i.e. stages 1 and 2) as
once manuals and resources are developed these are sunk costs. We also excluded the costs of the ‘Training
the Trainers’ session as these are artificially high in a pilot trial setting where the training costs are spread over
a small number of schools. However, it is important to recognise that some costs associated with updates to
the intervention and PHW staff training, because of staff turnover, would be needed if the intervention is
used routinely.
We recorded the time spent and other costs of administrating (e.g. contacting schools, arranging venues)
and delivering (e.g. intervention days and follow-up sessions) the intervention. The cost of delivering the
intervention was predominantly for room hire, catering, PHW staff time, transport costs and intervention
consumables (e.g. text messaging service). PHW estimated unit costs for PHW staff time and transport, as
well as expenses incurred for room hire, catering, student transport (i.e. coach hire) and consumables.
Process evaluation
The process evaluation examined the feasibility and acceptability of the two interventions from the
perspectives of peer supporters, schoolteachers, intervention delivery staff, parents and a public health
commissioner. Researcher notes were taken at each stage of intervention delivery, including the training of
intervention delivery staff, nomination of peer supporters, training of peer supporters and post-intervention
delivery (to assess objectives 3a–c; see Chapter 1).
Two staff members conducted structured observations to assess whether the defined learning outcomes of
all intervention activities were met. Observations of the delivery of all intervention activities, across all sites,
were made by two members of the research team to examine the fidelity of intervention delivery.
In each school, one member of the SMT plus the contact teacher, head of year or PSHE lead were
interviewed. Post-intervention interviews were also conducted with a purposive sample of peer supporters
in schools with the highest and lowest prevalence of drug use. All interviews were audio recorded, fully
transcribed and anonymised and electronically stored on a secure server. Table 5 provides an outline of the
methods used at each stage of the process evaluation in the external pilot, as well as the issues examined.
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Qualitative data analysis
Thematic analysis was employed in the qualitative analysis.32 The deductive coding framework developed in
stage 2 feasibility testing was adapted to examine the feasibility and acceptability of the intervention against
progression criteria. We used a coding matrix to index and categorise data, with categories and themes being
predetermined based on the research objectives (e.g. feasibility of delivery of the intervention components,
acceptability of the intervention components to peer supporters), with flexibility maintained so that any
unexpected themes identified from the data could also be added. A sample of six transcripts was coded and
compared and regular data analysis meetings were held by the qualitative research team to discuss emerging
themes and ensure consistency in coding. Analysis was conducted using NVivo 10 software to assist with
the systematic coding of data to identify patterns in the narrative provided by teachers, peer supporters,
students, parents and schools.
Changes to the protocol
There were no major changes to the protocol.49 In the statistical analysis section we stated that we would
adjust for baseline levels in the analysis of lifetime drug, smoking and alcohol use at the 18-month follow-up.
However, we did not adjust for lifetime measures of use at baseline or conduct subgroup analyses in
baseline users. This is because with lifetime measures adjustment creates a situation of perfect prediction.
As baseline users can only remain users at 18 months, estimates for students who report lifetime use at
baseline cannot be calculated. A request for a 3-month non-financial extension was granted towards the
end of the study.
TABLE 5 Outline of the process evaluation
Stage Method Issues examined
Recruitment and re-engagement
of influential students
Record of participation Response rates
Researcher observations
Trainer feedback form
Peer supporter training Record of participation Attendance/engagement
Researcher observations Intervention fidelity
Post-training evaluation form
completed by peer supporters
Acceptability to peer supporters
Interviews with trainers Explore acceptability and feasibility of delivering
the intervention training
Follow-up visits Record of participation Retention rates/engagement
Researcher observations Intervention fidelity
Post-intervention evaluation form
completed by peer supporters
Acceptability of content and role as a peer
supporter
Post intervention Interviews with peer supporters Acceptability of intervention content, delivery
method and role of peer supporter
Interviews with teaching staff Acceptability of intervention content and delivery
method and feasibility of intervention delivery
Interviews with trainers Acceptability of intervention content and delivery
method and feasibility of intervention delivery
Interviews with parents Acceptability of intervention content, delivery
method and role of peer supporter
METHODS
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Chapter 3 Results
This chapter presents the results of the study, which are organised according to the three stages of thestudy: (1) development of the +FRANK and FRANK friends interventions, (2) feasibility testing of the
+FRANK and FRANK friends interventions and (3) external pilot cRCT.
Stage 1: development of the +FRANK and FRANK friends interventions
The development process took 18 months and consisted of 42 activities (Figure 4 shows the frequency and
timeline of each activity). The process was iterative and cumulative, with refinements made before
proceeding to the next stage.
Table 6 summarises the results from stage 1.
Phase 1: evidence review and stakeholder consultation
In line with Medical Research Council (MRC) guidance on developing complex interventions,50 we reviewed
the existing literature. Two systematic reviews of school-based drug prevention programmes found small
effects on cannabis use in the short term.18,19 Researchers working on one RCT noted evidence of poor
implementation of interventions21 and, in another peer-led programme, evidence was found of iatrogenic
effects20 (see Chapter 1, Evidence on the effectiveness of school-based drug prevention, for further details).
Population-based studies on the prevalence of drug use in secondary school-aged children in the UK have
shown that the lifetime prevalence of any illegal drug use in England doubled from 6.8% to 12.4% and
then to 23.1% from 13 to 14 to 15 years, respectively.28 The lifetime prevalence of drug use was > 1%
only for cannabis, GGAs, ecstasy, poppers, cocaine, ketamine, mephedrone and magic mushrooms.
Cannabis had the highest lifetime prevalence, which increased from 2.7% to 7.5% and then 18.7% from
age 13 to 14 to 15 years, respectively. GGA prevalence was 3.5%, 4.0% and 4.4% for 13-, 14- and
15-year-olds, respectively. No equivalent data were available in Wales. This informed our decision to deliver
the intervention to UK Year 9 students (aged 13–14 years) and focus the intervention content on cannabis
and GGA use.
Consultations with young people and practitioners in drug charities noted a local issue with steroid use in
older age groups, which was not apparent in prevalence data as these were gathered in England and did
not sample from Welsh schools. This led us to include information on steroids in the interventions.
The consultations and focus groups with young people suggested that 13- to 14-year-olds were relatively
familiar with the potentially harmful effects of drugs on health:
Like we all know weed is bad, we all know what it does to you as well.
Young person 6
Young people were less familiar with the potential legal consequences of being caught in possession of an
illegal drug in the UK:
When it says unlimited fine, does that mean the police can just charge you?
Young person 9
The familiarity of young people with the harmful effects of drugs on health prompted us to expand the
focus to include the harms associated with drugs being illegal and therefore unregulated. These included
the possibility of unexpected effects brought about by consuming an unknown compound, of unknown
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TABLE 6 Results from application of the three-phase framework for coproduction and prototyping
Activity Objectives Results
Phase 1: evidence review and stakeholder consultation
Evidence review Identify target age group for the
interventions and identify target
drugs to focus the intervention
content on
l The 2013 Smoking, Drinking and Drug Use
survey in young people showed that the use
of any drug in the last year almost doubled
from 6.8% at age 13 years to 12.4% at age
14 years and 23.7% at age 15 years,28 largely
because of increases in the use of cannabis
l Target intervention at 13- to 14-year-olds
(Year 9 students)
l Focus intervention content on drugs with a
> 1% prevalence in 13- to 15-year-olds
(cannabis, GGAs, ecstasy, poppers, cocaine,
ketamine, mephedrone and magic mushrooms)
Consultation with young
people’s involvement group
Explore thoughts about drug
education in school, young
people’s conversations about
drugs with friends, awareness of
Talk to FRANK and opinions of
the website
l Drug education is typically didactic and should
be more interactive
l Discussions with peers about drugs are
frequent
l Commonly used drugs at their age are
alcohol, cannabis, poppers, mephedrone,
ketamine and cocaine
l The Talk to FRANK website was viewed
positively, but should be accompanied by
other visual resources
Consultation with Year 9
students
Explore views about drug use in
their age group and ideas about
content for a drug prevention
intervention
l Content suggested included effects of drugs
on the body and the legal consequences of
drug possession
l Specific drugs to focus content on included
cannabis, alcohol, steroids, magic mushrooms
and legal highs
Focus groups with Year 9
students
Explore knowledge and risk
perceptions of drug use and
perceptions of drug use
prevalence in their age group
and the acceptability and age
appropriateness of drug
education messages on the Talk
to FRANK website
l Health risks of cannabis are known
l Legal consequences of cannabis use are less
well known
l Content on the impact of drug use on
educational achievement directly or through
school exclusions if caught in possession
is needed
l Content on the impact of drug use on
parents with regard to worrying about harms
(to health, criminal sanctions, schooling
exclusions), shame brought to the family and
increasing stress would be welcomed
l Attention to the potential iatrogenic effect of
Talk to FRANK messages on amphetamine use
promoting weight loss is required
Consultations with stakeholders
(drug agencies and professionals
who work with young people)
Explore awareness of drug
education resources and support
and views on appropriate
content for a drug prevention
intervention
l Cannabis and alcohol are the most commonly
used drugs by 13- to 14-year-olds
l Novel psychoactive substances (NPSs) are an
increasing concern, particularly synthetic
cannabinoids, but not in 13- to 14-year-olds
l Staff from drug agencies noted a local
problem with anabolic steroids regarding
attendance at needle exchange programmes,
but not used by 13- to 14-year-olds
l Existing drug education for 13- to 14-year-olds
is provided in either classroom-based sessions
or one-off workshops delivered by a specialist
agency or a community police officer
continued
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TABLE 6 Results from application of the three-phase framework for coproduction and prototyping (continued )
Activity Objectives Results
l There are limited drug education resources
available and existing resources such as ‘drugs
box displays’ are expensive. Resources require
regular updates in response to emerging NPSs
and changing trends
Consultations with Year 8
recipients of the ASSIST
intervention
Explore ideas about peer
supporter training and content
for a drug prevention
intervention
l Content suggested included effects of drugs on
the body, how drugs cause ‘highs’, health risks,
legal consequences and harm minimisation
l Specific drugs to focus content on included
cannabis, solvents, magic mushrooms,
cocaine, speed, mephedrone, legal highs
and steroids
Observations of current ASSIST
practice
Identify aspects of the
intervention that work well and
could be adapted for use to
deliver a drug prevention
intervention and with a Year 9
population
l Flexibility in adapting timings and delivery
modes to respond to student engagement
is key for successful delivery of training
l Need for clear objectives, noting which are
essential to deliver
Interviews with the intervention
delivery team
Identify possible influences on
intervention feasibility and
acceptability, for example
explore aspects of the ASSIST
intervention that could be
adapted to deliver a drug
education intervention and for
use with 13- to 14-year-olds, as
well as those that might not
lend themselves to adaptation
l Intervention activities need to be interactive
l Successful implementation of the intervention
requires flexibility in delivery to meet the needs
of different groups
l Some intervention activities required updating
(e.g. the ASSIST activity using postcards
because peer supporters did not know what
they were)
l Some intervention activities might be too
immature for use with 13- to 14-year-olds
l Delivery of messages about the harms of drug
use is much more complex than delivery of
messages about the harms of smoking (more
compounds with different effects)
l Concerns around the amount of knowledge
required to deliver drug prevention
interventions
Phase 2: coproduction
Meetings of the IDG Action research cycle of
assessment, analysis, feedback
and agreement on the core
components of the intervention
required to educate peer
supporters on the harms of drug
use and the skills required to
communicate these to their
peers
l Findings from stage 1 suggested that long-
term harms to health of low levels of cannabis
use are less definitive than those of smoking
l Include content on concerns expressed by
young people and harms associated with drug
use that they did not know about
l Shift focus towards these concerns and away
from harms to health of the most commonly
used drug, cannabis
l Highlight the potential immediate harms to
health from the use of GGAs (i.e. sudden
sniffing death)
l Highlight the harms associated with drugs
being unregulated and illegal: unknown
compound and dose, thus unexpected effects
are likely
l Note the potential consequences of sanctions
imposed by schools (temporary or permanent
exclusion) and poorer educational achievement
l Note the potential consequences of criminal
sanctions with regard to travel and future
career options
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purity and dose. Other concerns that young people voiced included the potential harmful effects of drug
use on family relationships, future education and employment:
I mean that’s your mum, that’s one of your parents, they put a roof over your head. If you get drove
away from them you don’t get food for yourself, you don’t get a roof over your head, you’re out on
the streets. You don’t have anyone to get you a meal or look after you ‘cause you’re on your own.
Young person 29
’Cause then you’re getting a criminal record that’s stopping you from getting a job and loads of stuff.
Young person 19
A number of factors that might influence the engagement of students during peer supporter training were
found in both the interviews with the ASSIST delivery team and the independent observations by the
research team of the delivery of the intervention. In particular, flexibility in delivering intervention activities
to different groups and the need for engaging, interactive content were noted:
We work to the same objectives, but in terms of how we run some activities, we might change them a
bit . . . with different groups you know, how they react to a certain activity you might change it round
to help the running of it.
Trainer 2
Making sure that they’re interactive . . . so they’re up and about, they get moving around, break off
activities, um, just making it as interactive as possible.
Trainer 6
Phase 2: coproduction
During coproduction, the IDG reflected on findings from stage 1 to adapt the content from the ASSIST
intervention or develop new content. In interviews with the ASSIST team it was noted that it was
TABLE 6 Results from application of the three-phase framework for coproduction and prototyping (continued )
Activity Objectives Results
l Mention harms including increasing parental
anxiety, stress and shame
l Draft intervention manuals and associated
resources detailing intervention activities and
how these should be delivered were produced
Phase 3: prototyping
Expert review of intervention
materials
Identify potential problems or
weaknesses in the intervention
materials prior to piloting
l Updating of some intervention activities
was welcomed
l More detail needed in instructions for the
delivery team
l Refining of timings for some intervention activities
Testing of intervention materials
with young people
Delivery of the intervention.
Identification of issues around
the feasibility and acceptability
of the newly developed
intervention content
l Intervention activities were well received
l Refinements included amending wording,
providing more detailed instruction and
objectives and using smaller groups
Training of the intervention
delivery team
Simulation of intervention
delivery. Identification of issues
around the feasibility and
acceptability of the intervention
content
l Need for additional drug education training
l Refinements included amending timings,
clarifying ambiguities in the instructions,
changing the format of delivery, adding extra
content and removing content
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important to provide peer supporters with interesting and memorable facts about smoking that they could
use in conversations with their peers:
So if we can give them facts that sort of link into what they could be talking about with their friends,
it makes it easier for these conversations to happen. In ASSIST, one of the facts they always
remember, is that smoking could affect your ability to get an erection. That is the one that sticks with
them, and you might not have done the training for 10 weeks, and they will still remember that.
Trainer 2
In ASSIST, we know that young people will leave knowing the ingredients of a cigarette, long-term,
short-term health effects, is it guaranteed. We know that you’d go up to any young person that had
done the training and you’d ask them how many ingredients are in a cigarette and they’d be able to
tell you.
Trainer 2
This led us to adapt information from the Talk to FRANK website about the risks of drug use into
memorable factual statements. These key statements were then used across several activities within the
peer supporter training and were added to the peer supporter diaries as a reminder.
Phase 3: prototyping
Expert peer review, independent from the IDG, by the lead author of the ASSIST RCT23 and the lead trainer
at DECIPHer IMPACT, was used to examine and address key areas of uncertainty. The feedback led to
refinements in the timing of the intervention activities and the presentation of instructions in the
intervention manual.
Feedback provided by the trainers at the end of the two training sessions indicated that the training was well
received and that some of the issues that were raised at the end of the first training session, such as concerns
about the need for an encyclopaedic knowledge of drugs, had been addressed during the second training
session. This was achieved by providing additional drug education during the session along with the inclusion
of a ‘new to trainers’ worksheet that trainers could use to demonstrate to peer supporters the difficulty of
keeping track of new drugs and street names. Suggestions raised by trainers for improving activities were
added to the intervention materials during refinement prior to stage 2. A final training session was delivered
to run through the finalised intervention materials and schedules in advance of stage 2 delivery in two
schools so that trainers could become more familiar with the running order of the +FRANK and FRANK
friends training days and the resources required for carrying out the activities.
Stage 2: feasibility testing of the +FRANK and FRANK friends
interventions
+FRANK intervention
Seven structured observations of delivery were completed for the +FRANK intervention, eight self-assessments
were completed by the trainers and 14 +FRANK peer supporters completed an evaluation form at the end of
the off-site training day. At the end of intervention delivery (i.e. after the final follow-up), 12 peer supporters
completed evaluation forms. Interviews were also conducted after intervention delivery with six peer supporters,
three trainers (at the end of the off-site training and the last follow-up), two of the contact teachers and two
members of the SMT.
Recruitment
Of the 18 students invited to be retrained, 13 attended the re-recruitment meeting and 14 attended the
off-site training day.
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In total, 78% of Year 8 ASSIST peer supporters were recruited and retrained as +FRANK peer supporters in
Year 9. Although only 13 students attended the recruitment session, one student who was absent was
provided with details about the programme and was given an opportunity to attend the training via the
contact teacher. The contact teacher stated that those who did not take part did so for a variety of
reasons, including one peer supporter not wanting the responsibility, one not enjoying the ASSIST training,
one having too many commitments and another being absent from school too frequently.
At the recruitment stage of the ASSIST intervention, if a nominated student or his or her parent/guardian
did not want him or her to attend the off-site training, trainers worked down the ranked list of students
with the most nominations and invited the student with the next highest number of nominations. With the
+FRANK intervention it was not possible to substitute students because they must have trained as an
ASSIST peer to be invited to take part in the intervention. This feature of the +FRANK intervention
increases the risk that less than the required 17.5% of the year group are trained as peer supporters.
Acceptability of the +FRANK intervention to peer supporters
Peer supporters felt that the peer nomination process was an acceptable method of recruiting. They
thought that students in receipt of the most nominations were more likely to be listened to.
Recruitment meeting
Most peer supporters noted that having previously participated in the ASSIST intervention was a positive
influence when deciding whether or not to participate in the +FRANK intervention. Familiarity with the
trainers and the peer supporter role encouraged students to become +FRANK peer supporters:
. . . ’cause I like I liked doing it last time and . . . I thought it would be good to do it again.
+FRANK school, peer supporter 5
A few peer supporters indicated that they would have benefited from receiving more information at the
recruitment meeting, about what to expect and the content of the new programme:
I don’t know, made a bit more detail of what we were doing then maybe we like, we’d have more . . .
we’d know whether we’d want to go or not.
+FRANK school, peer supporter 2
Training day
Most of the peer supporters and trainers reported that the +FRANK intervention activities delivered on the
training day were acceptable. Some peer supporters noted that a lot of new information was provided,
which could be challenging for some:
Loads of facts like, I can remember like parts of them, but I can’t remember which one goes
where like.
+FRANK school, peer supporter 1
Interviewer: But maybe it sounds like you need ways of remembering some of that information?
+FRANK school, peer supporter 5: Yeah . . . like writing it down and then just . . . like stick it in my
bag so I can remember it.
Some trainers also noted that too much information was being delivered during the training sessions:
Yeah. And probably there was too much information there because I found they needed a lot of
prompting for that activity. Some of the groups worked quite well and others, unless you were kind of
stood there helping them with the activity they were kind of like what do I do.
Trainer 2
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Some peer supporters compared the +FRANK training with their experiences of the ASSIST training, noting
the lack in the +FRANK training of activities related to practising conversations about drugs and that they
would have liked more opportunities for this:
And they did give us conversation skills like on the smoking course as well but they just didn’t really
explain how to give on the information. And really I think that like . . . like I think what would have
been cool is because on the smoking course we did like an acting thing and I think, even on the drug
course or even on the smoking course as well we could have like acted like bringing up drugs in
conversation. That would have been like a good thing.
+FRANK school, peer supporter 2
Peer supporter conversations and use of the diaries
Eleven out of 14 peer supporters returned their diaries. All 11 diaries noted at least one or more informal
conversation. The majority of conversations were reported as being face-to-face and easy to initiate. Peer
supporters felt that the diaries were helpful in providing a space to record their conversations and could
also be referred to to remind themselves of facts and be shown to others:
They were like, good like easy to talk about, like it wasn’t like, like they always listened, like I had like
my say, they had their say about it.
+FRANK school, peer supporter 1
Um, well obviously in the diaries you had lots of facts in there so if you forgot any while you were
talking just take it out and read through it.
+FRANK school, peer supporter 3
Follow-up sessions
Twelve peer supporters attended the in-person follow-ups 1 and 4. Ten of the 14 peer supporters provided
either an e-mail address or a mobile number for the e-follow-up sessions but students indicated that
they tended not to use their e-mail. Of the peer supporters who provided contact details, five were
e-mailed a task as part of the e-follow-up session. One peer supporter engaged with each of these
e-follow-up sessions.
Structured observations, trainer self-evaluation forms and interviews with peer supporters and trainers
suggested that there were a number of factors influencing the poor attendance at the e-follow-up
sessions. First, there was uncertainty among the peer supporters about why their contact details were
needed. One peer supporter noted that they were not allowed to provide their own mobile number so
gave their parent’s. Others could not remember their number or forgot to complete the tasks. Second, the
school did not provide students with a designated e-mail address and so there was no unified method of
contacting students. Third, one teacher also noted that some students would not have permission from
their parents to provide their e-mail address. Fourth, during observations of delivery by the research team it
was noted that the collection of the details was rushed because of the timing of the follow-up session at
the end of the school day. Fifth, the school also had a no homework policy, which meant that students
were not familiar with completing tasks out of school. Finally, no text messages were sent by the PHW
intervention delivery team because of technical problems with the messaging service. This came to light
only after follow-up 4. Peer supporters indicated that they would have preferred to have someone to
supervise a designated session for completing the e-follow-up tasks and to be able to work as a group,
rather than being left to complete the e-follow-up by themselves:
I didn’t leave anything because I didn’t know my number and I couldn’t remember my e-mail address.
+FRANK school, peer supporter 4
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So many of them haven’t got e-mail addresses . . . asking them for e-mail addresses, you’ll only get a
handful, or they’ll use Mum’s or Dad’s, and it’s not always appropriate.
+FRANK school, teacher 2, SMT
Yeah if we like we all done it at the same time, ’cause like, no one would probably bother to do it,
’cause no one’s here telling us to actually do it.
+FRANK school, peer supporter 1
One peer supporter who completed the e-follow-up tasks indicated that they enjoyed using the website
and was able to think and provide answers in their own time.
I enjoyed answering the questions and reading the information on the website . . . I didn’t feel put on
the spot, I could answer in my own time.
+FRANK school, peer supporter 4
Fidelity of implementation
Of the 15 activities in the +FRANK training day, five were delivered in full, eight had minor deviations from
the manual and two were not delivered at all. Observations highlighted the need to change the timing of
some of the activities as well as amend some of the instructions for trainers, to indicate which tasks are
essential and which are optional.
FRANK friends
Fifteen structured observations were made of delivery of the FRANK friends intervention, nine self-assessments
were completed by the FRANK friends trainers and 26 FRANK friends peer supporters completed an evaluation
form at the end of the second off-site training day. At the end of intervention delivery, 21 peer supporters
completed evaluation forms. Interviews and focus groups were also conducted after intervention delivery with
20 peer supporters, five trainers (at the end of off-site training and the last follow-up), two contact teachers
and two members of the SMT. Five focus groups were conducted in the FRANK friends school.
Recruitment
Of the 30 students invited to be peer supporters, 29 attended the recruitment meeting and 26 attended
both off-site training days.
Acceptability of the FRANK friends intervention to peer supporters
The peer nomination process was perceived as inclusive and fair as it reflected the opinion of everyone in
the year group.
It was a positive experience for peer supporters as they felt respected by their peers and believed that they
were suitable for the role as they had a wide social network.
Recruitment meeting
Peer supporters mentioned that they were given sufficient and clear information about the study and the
role of a peer supporter. They noted the informal and friendly setting of the recruitment meeting, which
put them at ease to speak freely and decide whether or not to participate in the study:
It was sort of an introduction because if people didn’t feel like they were right for what they were
doing or they didn’t – wouldn’t enjoy it then they could just leave, and I think that was important
’cause it’s a comfortable environment where you’re not forced to do anything.
FRANK friends school, peer supporter 1
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Training days
In general, peer supporters enjoyed the 2-day training and were keen to increase their knowledge about
drugs. Most of them felt that they had received the right amount of information. Some peer supporters
commented that it was easy to learn and retain facts on drugs as the facts were short and relevant for
their age:
. . . wasn’t complicated, long-worded facts that we’d easily forget about by the next day, it was like
short facts that would stick in our mind and they clearly have from the training.
FRANK friends school, peer supporter 2
And the fact that we concentrated on the most likely ones for our age, it wasn’t like all loaded on us,
it was just the three ones ones that we were probably gonna be dealing with.
FRANK friends school, peer supporter 3
Most peer supporters found the training on conversation skills particularly useful because it increased their
confidence in initiating conversations with their peers. It also taught peer supporters ways to bring up
drugs in conversations and respond to the reactions of their peers in different situations:
There was this one activity where we had like a piece of paper and it gave us a situation to talk to
them about and like how we had to act so then we knew how to respond to what they were feeling
like or what they were acting like.
FRANK friends school, focus group 3, peer supporter 15
However, a few supporters thought that the conversations felt forced and might not be practical in the
real world:
. . . but I think the techniques that we got taught you couldn’t really do it in real life and like we were
practising conversations, it just felt awkward and like forced.
FRANK friends school, peer supporter 5
Follow-up sessions
Attendance at the four in-person follow-up sessions ranged from 16 to 21 peer supporters out of the
26 who were trained. The content and duration of the follow-up sessions were acceptable to peer
supporters. Peer supporters used the follow-up sessions to reinforce the knowledge that they had
gained during training and also to obtain support around conversations from trainers and fellow
peer supporters:
Some conversations like people didn’t think that the facts were true. But then like we spoke to the
people [trainer] and they explained what we could do if that happened.
FRANK friends school, peer supporter 4
Peer supporters were required to visit the Talk to FRANK website to complete some activities in a
couple of the follow-up sessions. The activity was well received by peer supporters as it was interactive
and fun:
I think the video [health effects of cannabis] was very helpful as well because it’s, more people prefer
to watch videos than be told all the time and if they wa, like watch that it was quite appealing to
other people as well.
FRANK friends school, focus group 5, peer supporter 20
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However, a few peer supporters mentioned that the follow-up sessions were less engaging than the 2-day
training session and that that might have a negative impact on attendance:
I think some of the follow ups were quite, quite slow . . . I was just waiting for something . . . And I
think less people started turning up and then it felt, it didn’t feel as special then.
FRANK friends school, focus group 1, peer supporter 9
Peer supporter conversations and use of the diaries
Twenty out of the 26 peer supporters returned their diary. All diaries noted at least one or more informal
conversation. The majority of peer supporters recorded that they had had face-to-face conversations. This
allowed peer supporters to gauge and respond to the reactions of their peers through reading their facial
expressions and body language:
Face to face you can react like on the spot of what they’re thinking and what they’re looking like, so
you can see if they’re look – if they’re looking scared or if they’re looking nervous then you can try
and support them through whatever they’re going through.
FRANK friends school, peer supporter 3
Some peer supporters felt that text messages and social media were not an appropriate medium by which
to communicate information about drugs:
It was easier to bring it into the conversation, whereas like when you’re [text] messaging them it
comes out like of nowhere.
FRANK friends school, peer supporter 4
Peer supporters used the diaries in several ways, including to reflect on conversations that they had had
and remind themselves of the facts that they had learned:
The diaries helped a lot because they could see how the conversations went and if they didn’t go well
then we were able to write what didn’t go well and what did go well.
FRANK friends school, focus group 5, peer supporter 19
It had like the facts on, top five facts so we could always go back to there if we forgot to say
something, to remember it so that was really good for reminding us.
FRANK friends school, focus group 5, peer supporter 19
Fidelity of implementation
In the FRANK friends training days, across the 25 activities, 13 were delivered in full, nine had minor
deviations from the manual and three were not delivered at all.
Refinements to the +FRANK and FRANK friends interventions: what changed from
stage 1
The outcomes of the process evaluation were presented to the TMG. The TMG then agreed some
amendments to the +FRANK and FRANK friends interventions. Nearly all of the refinements were made to
both the +FRANK intervention and the FRANK friends intervention as a result of the process evaluation
undertaken at stage 2 (Table 7). Peer supporters were contacted by e-mail or text message after training
with the contact details for the Talk to FRANK website and were sent updates when news items or new
drugs were added to the website. Peer supporters were also sent reminders to have conversations and
bring their diary to follow-up sessions. The training day agenda was reordered and the timings of activities
were amended to accurately reflect the time recorded during observations. Activities deemed to be
non-essential were changed to be ‘optional’ and could be delivered at the trainers’ discretion if time allowed.
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Refinements unique to the +FRANK intervention included e-follow-up sessions 2 and 3 changing to
in-person follow-up sessions in which trainers go into the school to deliver tasks. Follow-up session 4 was
dropped and the content was covered in follow-up session 3.
Figures 5 and 6 show the refined intervention logic models for the +FRANK and FRANK friends
interventions, respectively.
Stage 3: external pilot trial
The external pilot trial was a parallel-group, four-arm cRCT with school as the unit of randomisation.
Recruitment and retention
Forty schools were invited to take part in the external pilot cRCT (Figure 7). Because of delays in contracting
and the requirement to deliver the intervention in the autumn 2014 term, we oversampled schools to
reduce the time needed to recruit the required 12 schools. Eight schools declined to participate, with seven
citing staff workload and another already having a smoking prevention intervention, Operation Smoke
Storm,51 planned. Twelve schools did not return telephone or e-mail messages. Twenty schools responded
that they were interested in participating. Two schools were unable to meet the study manager and the
lead ASSIST trainer, one because of staff absence and the other not providing a reason. Eighteen schools
were visited, with one unable to commit that year because of changes in staffing and one withdrawing as
the amount of money offered to recompense for time was not considered to be enough. Two schools were
recruited to take part in the feasibility testing of the interventions and two were held in reserve.
Twelve schools were randomised into the four trial arms, three to the ASSIST intervention, three to the
+FRANK intervention, three to the FRANK friends intervention and three to the usual practice arm. There
were 1692 students Year 8 aged 13–14 years across the 12 schools. Of these, 125 (7.4%) were withdrawn
by the schools, were opted out by parents, opted out themselves or were not at school when the main or
absentee surveys took place. This left 1567 students (92.6% of those eligible) who completed the baseline
assessment, with 347 attending ASSIST schools, 419 attending +FRANK schools, 440 attending FRANK
friends schools and 361 attending usual practice schools.
TABLE 7 Changes made to the +FRANK and FRANK friends interventions
Intervention element Refinements made
Recruitment meeting l Production of a recruitment booklet for peer supporters, to include information on both the
practicalities of the day, such as information on travel and food, and an overview of the
training content
Training day l ‘What is a drug?’ activity amended to have two sections: first, naming drugs and, second,
sorting them
l Reordering of activities and amended timings
l Clarifying statement to describe legal highs
l FRANK chat – amended instructions to create a more realistic experience of conversations
and provide emphasis on using peer supporters’ top 5 facts
l Information islands – information on the cards reduced and worksheets for peer supporters
to include headings to guide what peer supporters need to look for from the information
l To integrate the Talk to FRANK website more actively into the training day overall, refer to
the A-Z when discussing what is a drug.
l The inclusion of hands-on resources for a resource table
Follow-up sessions l Removal of the e-follow-up element and replacement with one additional face-to-face
meeting (+FRANK only)
l Amend instructions for trainers so that they collect peer supporter contact information as
part of the training
l Use text and e-mail messaging with peer supporters as a prompt for attendance at the
follow-up sessions
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FIGURE 5 +FRANK logic model.
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FIGURE 6 FRANK friends logic model. The ASSIST intervention is not given as part of the FRANK friends intervention.
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Schools allocated to
usual practice
(n = 3)
Eligible pupils
(n = 388)
• Withdrawn by school, n = 0
• Parental withdrawal, n = 11
• Pupils opt-out, n = 2
• Absent, n = 14
• Moved schools, n = 15c
• Absent, n = 4d
Participated
(n = 361, 93%)
Participated
(n = 342, 95%)
Cluster sizes 129, 82 and 131
Schools allocated to
ASSIST
(n = 3)
Eligible pupils
(n = 382)
• Withdrawn by school, n = 9
• Parental withdrawal, n = 18
• Pupil opt-out, n = 3
• Absent, n = 5
• Moved schools, n = 28
• Absent, n = 4
Participated
(n = 347, 91%)
Participated
(n = 315, 91%)
Cluster sizes 112, 110 and 93
Schools allocated to +FRANK
(n = 3)
Eligible pupils
(n = 452)
• Withdrawn by school, n = 0
• Parental withdrawal, n = 17
• Pupil opt-out, n = 8
• Absent, n = 8
• Moved schools, n = 23c
• Absent, n = 5
Participated
(n = 419, 93%)
Participated
(n = 391, 93%)
Cluster sizes 136, 155 and 100
Schools allocated to
FRANK friends 
(n = 3)
Eligible pupils
(n = 470)
• Withdrawn by school, n = 12
• Parental withdrawal, n = 7
• Pupil opt-out, n = 3
• Absent, n = 8
• Moved schools, n = 21
• Absent, n = 7
Participated
(n = 440, 94%)
Participated
(n = 412, 94%)
Cluster sizes 108, 211 and 93
Schools visited by research team
(n = 18)
Schools
(n = 12)
Schools interested 
(n = 20)
Schools invited
(n = 40)
Baseline
data
Baseline
data
18-month
follow-up
18-month
follow-up
• Declined, n = 8
• No response, n = 12
• School unable to commit to data collection, n = 1
• School withdrew, n = 1b
• Schools recruited to be schools for feasibility testing, n = 2
• School held in reserve, n = 2
• School withdrew, n = 1a
• School unable to meet, n = 1
FIGURE 7 Trial CONSORT diagram. a, Because of staff absence; b, because the amount of money offered to recompense for time was not considered to be enough; c, three
students started home schooling between baseline and follow-up; d, one student was suspended from school during the follow-up data collection period.
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All schools allocated to the intervention arms received the intervention as planned. All 12 schools took part
in the 18-month follow-up. Across the four arms, 107 students (6.8% of the baseline respondents) did not
take part in the follow-up, with 84 moving school, 20 not being at school when the survey was administered
and three starting home schooling. This left 1460 (93.2%) students who completed the 18-month follow-up,
315 (90.8%) in the ASSIST arm, 391 (93.3%) in the +FRANK arm, 412 (93.6%) in the FRANK friends arm
and 342 (94.7%) in the usual practice arm.
Characteristics of trial participants at baseline
Categorical data
The categorical baseline characteristics and outcome measures for the trial participants are summarised in
Tables 8 and 9, respectively.
There was an equal distribution of male and female participants across the trial arms, with 52.5%, 50.7%,
51.1% and 54.5% of male participants in the +FRANK, usual practice, FRANK friends and ASSIST arms,
respectively. Ethnicity was evenly distributed, with very few non-white participants in each arm. About
20% of participants were in receipt of FSMs, with a slightly higher percentage in the +FRANK arm. The
average percentage of students in receipt of FSMs in Wales is 17.5%.52 Housing tenure and living with an
employed adult were not evenly balanced. There was a higher percentage of students resident in social
housing (16.0% vs. 11.1%, 12.3% and 9.5%) and living without an adult in employment (16.7% vs.
11.4%, 12.7% and 12.4%) in the +FRANK than in the usual practice, FRANK friends and ASSIST arms,
respectively. Spending money was fairly evenly distributed, with 32.3% of students having between £5.00
and £9.99 to spend per week.
The indicative primary outcome in this study was the lifetime prevalence of illicit drug use. Overall, 4.1% of
baseline respondents reported that they had ever tried drugs. There was an imbalance between the arms,
with a slightly higher prevalence in the usual practice arm (6.4%) than in the FRANK friends (4.5%), ASSIST
(3.2%) and +FRANK (2.6%) arms. This compares with 7% of 12-year-olds and 11% of 13-year-olds in the
2014 Smoking, Drinking and Drug Use survey.6 The most commonly used drugs were cannabis (2.4%) and
GGAs (2.2%), with all other drugs having a prevalence across all arms of < 1% (see Appendix 1, Table 18).
Table 19 (see Appendix 1) shows the frequency of use of each drug in the past week, 30 days and 12 months.
Of the 65 students who had ever tried drugs, 36.9% used cannabis in the past 12 months, 9.2% used
cannabis in the past 30 days and 6.2% used cannabis in the last week. For GGAs, use in the past 12 months,
30 days and last week was 36.9%, 9.2% and 7.7%, respectively. Of the 38 students who had ever tried
cannabis, 23.7% screened positive for dependency on the CAST.38
Numerical variables
The mean age of participants was 12.6 years (SD 0.30 years) across all arms. Students who reported
smoking at least one cigarette a week completed the FTND and HSI. Only 15 students reported smoking at
least one cigarette a week and the median number of cigarettes smoked per week was 3.0 (interquartile
range 1.03 to 35.0). Twelve participants completed all of the items on the FTND and HSI. There was some
evidence of floor effects, with a median score of 0 on the HSI and 0.5 on the FTND. There was evidence of
ceiling effects on the quality of life measure, the CHU-9D, with median and mean scores of 0.915 and
0.887, respectively, across all students (see Appendix 1, Table 22).
Missing data
There were very few missing responses. For questions on gender, FSM entitlement, parental employment
and spending money, missing responses ranged between 0% and 2.5%, with no discernible difference
across arms. In total, 2% of participants did not provide information on lifetime illicit drug use, with
slightly more missing data in the +FRANK arm (4.1%) than in the other arms (usual practice 1.9%, FRANK
friends 0.9%, ASSIST 1.4%). With regard to the CAST, 21% of responses were missing. In total, 5% of
responses for ever having tried and weekly smoking, around 3% of responses for ever having consumed
an alcoholic drink and 10% of responses on the A-SAQ were missing, with comparable numbers of
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TABLE 8 Summary of the categorical baseline characteristics by trial arm and overall
Variable
Baseline data: distribution over categories by trial arm (%)
+FRANK
(n= 419)
Usual practice
(n= 361)
FRANK friends
(n= 440)
ASSIST
(n= 347)
Overall
(n= 1567)
Gender
Missing 0.0 0.0 0.0 0.0 0.0
Male 52.5 50.7 51.1 54.5 52.1
Ethnicity
Missing 1.4 0.6 0.7 1.2 1.0
White British 93.8 81.7 85.0 93.9 88.6
White not British 2.1 1.7 3.0 1.2 2.0
Mixed race 1.4 2.8 2.0 1.7 2.0
Asian or Asian British 0.5 7.8 7.0 1.2 4.1
Black or black British 0.2 2.5 0.7 0.3 0.9
Other 0.5 3.0 1.6 0.6 1.4
Do you have FSMs?
Missing 3.6 1.7 1.6 2.6 2.4
No 66.6 72.3 71.8 73.5 70.9
Yes 22.2 18.0 20.2 17.6 19.7
I don’t know 7.6 8.0 6.4 6.3 7.1
Are any of the adults you live with in full- or part-time work?
Missing 0.7 0.6 0.5 0.9 0.6
No 16.7 11.4 12.7 12.4 13.4
Yes 69.7 72.3 73.6 72.1 71.9
I don’t know 12.9 15.8 13.2 14.7 14.0
What kind of house or flat do you live in?
Missing 0.5 1.1 1.1 0.9 0.9
One rented from the council or a housing
association
16.0 11.1 12.3 9.5 12.4
One rented from a landlord 12.6 11.4 9.3 10.7 11.0
One owned by your family (including one
with a mortgage)
44.9 49.9 55.9 54.8 51.3
Other 0.7 1.9 0.7 1.7 1.2
I don’t know/not sure 25.3 24.7 20.7 22.5 23.2
How much do you have to spend for yourself each week?
Missing 1.4 1.9 1.4 1.7 1.6
I don’t have any money to spend 5.5 4.7 8.6 5.2 6.1
< £5 17.2 19.7 20.0 17.9 18.7
£5.00–9.99 33.9 28.8 31.4 35.2 32.3
£10.00–14.99 21.7 19.4 16.4 15.0 18.2
£15.00–19.99 11.0 10.0 8.4 13.3 10.5
≥ £20 9.3 15.5 13.9 11.8 12.6
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TABLE 9 Summary of the categorical baseline outcome measures by trial arm and overall
Variable
Baseline data: distribution over categories by trial arm (%)
+FRANK
(n= 419)
Usual practice
(n= 361)
FRANK friends
(n= 440)
ASSIST
(n= 347)
Overall
(n= 1567)
Lifetime illicit drug use
Missing 4.1 1.9 0.9 1.4 2.1
Yes 2.6 6.4 4.5 3.2 4.1
No 93.3 91.7 94.5 95.4 93.7
Lifetime cannabis use
Missing 3.1 0.3 0.5 0.6 1.1
Yes 1.7 3.9 2.5 1.7 2.4
No 95.2 95.8 97.0 97.7 96.4
Lifetime GGA use
Missing 3.3 1.1 0.5 1.4 1.6
Yes 1.4 3.9 2.0 1.4 2.2
No 95.5 95.0 97.5 97.1 96.2
CASTa
Missing 28.6 14.3 18.2 33.3 21.1
Screened positive for dependency
(score of ≥ 4)
28.6 21.4 36.4 0.0 23.7
Ever tried smoking, even if a puff?
Missing 6.2 4.2 4.5 5.2 5.0
Yes 11.0 10.8 10.7 6.6 9.9
Weekly smoking statusb
Missing 6.2 4.2 4.5 5.2 5.0
Yes 0.5 0.3 1.1 0.3 0.6
Ever consumed a whole alcoholic drink?
Missing 2.1 3.0 4.3 2.3 3.0
Yes 25.1 25.8 18.0 31.4 24.6
A-SAQc
Missing 6.7 11.8 10.1 8.3 9.1
Heavy episodic alcohol used 28.6 37.6 32.9 21.1 29.5
a Information recorded only for those who had ever tried cannabis.
b Weekly smoking defined as smoking at least one cigarette a week.
c Information recorded only for those who had consumed a whole alcoholic drink.
d Participants screened positive if boys had drunk eight or more standard drinks or girls had drunk six or more standard
drinks (one standard drink is equivalent to 1 unit; 1 unit is approximately 8 g of pure alcohol) on one occasion less than
monthly or more frequently and they were aged ≤ 15 years.
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missing data across the arms. Twelve out of 15 respondents who smoked one cigarette or more a week
answered all questions on the FNTD and HSI. Finally, 11% of participants did not complete all items on the
CHU-9D.
Characteristics of the outcome measures at the 18-month follow-up
Of the 107 students who did not take part at the 18-month follow-up, 14 (13.1%) reported lifetime illicit
drug use at baseline. Of the 1460 students retained, 51 (3.5%) had used illicit drugs at baseline, suggesting
that drug use was more common in students who did not take part at follow-up.
Categorical data
The indicative primary and secondary outcome measures collected at the 18-month follow-up are reported
in Table 10. Across all trial participants the prevalence of illicit drug use was 11.6%. The lifetime prevalence
of illicit drug use in the ASSIST (9.5%) and FRANK friends (9.7%) arms was similar, with a higher prevalence
of use found in the +FRANK (15.1%) and usual practice (11.7%) arms. These differences between trial
arms should be interpreted with caution. There was a wide variation in prevalence across schools, from
4.6% to 17.6%, and within arms, with prevalence ranging from 4.6% to 13.3% in the FRANK friends arm.
There was an imbalance at baseline, with a higher level of socioeconomic disadvantage in the +FRANK arm.
The ICC was 0.003 for lifetime prevalence of illicit drug use for the comparison between the usual practice
arm and the FRANK friends arm and < 1 × 10–8 for the comparison between the usual practice arm and the
+FRANK arm.
TABLE 10 Summary of the categorical outcomes at the 18-month follow-up by trial arm and overall
Variable
18-month follow-up data: distribution over categories by trial arm (%)
+FRANK
(n= 391)
Usual practice
(n= 342)
FRANK friends
(n= 412)
ASSIST
(n= 315)
Overall
(n= 1460)
Lifetime illicit drug use
Missing 1.5 3.2 1.2 0.6 1.6
Yes 15.1 11.7 9.7 9.5 11.6
No 83.4 85.1 89.1 89.8 86.8
Lifetime cannabis use
Missing 0.3 0.3 0.2 0.3 0.3
Yes 10.7 7.6 6.6 7.0 8.0
No 89.0 92.1 93.2 92.7 91.7
Lifetime GGA use
Missing 0.0 0.6 0.2 0.3 0.3
Yes 5.4 3.2 2.9 4.4 4.0
No 94.6 96.2 96.8 95.2 95.8
Lifetime use of legal highs
Missing 0.0 0.6 0.2 0.3 0.3
Yes 2.6 1.5 1.2 1.6 1.7
No 97.4 98.0 98.5 98.1 98.0
continued
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The most commonly used drugs were, in rank order, cannabis (8.0%), GGAs (4.0%), legal highs (1.7%) and
cocaine (1.0%). All other drugs had an overall prevalence of < 1% (see Appendix 1, Table 20). Of the 169
students who reported drug use, the majority of use had been in the past 12 months [cannabis 58.6%,
GGA 19.5%, legal highs 11.5%, cocaine 5.9%) (see Appendix 1, Table 21). The use of cannabis (21.9%) in
the last 30 days was more common than the use of GGAs (5.3%), legal highs (3.0%) and cocaine (2.4%)
in the last 30 days, with cannabis (8.9%) and cocaine (1.2%) the only drugs that were used by > 1% of
participants in the last week. Some students provided an illogical response for drug use over different periods,
for example using in the last week but not in the last month, but this was rare, with only six students making
this error. In total, 35% of the 117 students who ever reported trying cannabis screened positive for
cannabis dependency.
Around one-quarter (23.9%) of students had tried smoking, with prevalence slightly higher in the +FRANK
arm (28.1%) and lower in the FRANK friends arm (19.2%) than in the usual practice arm (24.9%) or
ASSIST arm (23.8%). Weekly smoking was very rare, at 2.4% in the overall sample. With regard to the
TABLE 10 Summary of the categorical outcomes at the 18-month follow-up by trial arm and overall (continued )
Variable
18-month follow-up data: distribution over categories by trial arm (%)
+FRANK
(n= 391)
Usual practice
(n= 342)
FRANK friends
(n= 412)
ASSIST
(n= 315)
Overall
(n= 1460)
Lifetime cocaine use
Missing 0.0 1.5 0.2 0.3 0.5
Yes 1.3 1.2 0.2 1.3 1.0
No 98.7 97.4 99.5 98.4 98.6
CASTa
Missing 19.0 7.7 22.2 0.0 13.7
Screened positive for dependency
(score of ≥ 4)
28.6 34.6 48.1 31.8 35.0
Ever tried smoking, even if a puff?
Missing 2.6 4.4 1.0 2.2 2.5
Yes 28.1 24.9 19.2 23.8 23.9
Weekly smoking statusb
Missing 2.6 4.4 1.0 2.2 2.5
Yes 3.6 2.6 1.7 1.6 2.4
Ever consumed a whole alcoholic drink?
Missing 16.6 12.9 10.0 10.5 12.5
Yes 45.8 40.9 37.1 51.4 43.4
A-SAQc
Missing 0.0 0.7 0.0 0.0 0.2
Heavy episodic alcohol used 40.2 50.7 36.6 35.8 40.5
a Information recorded only for those who had ever tried cannabis.
b Weekly smoking defined as smoking at least one cigarette a week.
c Information recorded only for those who had consumed a whole alcoholic drink.
d Participants screened positive if boys had drunk eight or more standard drinks or girls had drunk six or more standard
drinks (one standard drink is equivalent to 1 unit; 1 unit is approximately 8 g of pure alcohol) on one occasion less than
monthly or more frequently and they were aged ≤ 15 years.
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other outcome measures, the prevalence of consuming a whole alcoholic drink had nearly doubled since
baseline, to 43.4% overall. Of those who had consumed a whole alcoholic drink, around 40.5% screened
positive for heavy episodic alcohol consumption on the A-SAQ, with fewer screening positive in the ASSIST
arm (35.8%) and more screening positive in the usual practice arm (50.7%).
The prevalence of the categorical intermediary variables outlined in the logic model are described in
Appendix 1 (see Table 23). Overall, students’ perceived prevalence of drug use in their year was 52.3%;
26.5% had been offered drugs in the last year, 55.5% had had a conversation with a school friend about
drugs; 10.3% had visited the Talk to FRANK website; 17.8% had talked to a peer supporter about the
harms of drugs; and 37.9% said that they would get help for themselves or a friend from the Talk to
FRANK website.
Numerical variables
A summary of the numerical indicative secondary outcome measures is shown in Table 11. The five-number
summaries show a lot of variation within arms in the number of cigarettes smoked a week. Across the
54 students who reported smoking one cigarette a week, the number of cigarettes smoked per week ranged
from 1 to 100, with a median of 6.0, a mean of 14.4 and a SD of 18.9. There was an imbalance between
trial arms, with a median of 8.0 cigarettes a week in the FRANK friends arm, 4.0 in the usual practice arm,
6.5 in the +FRANK arm and 10.0 in the ASSIST arm. There were very low scores on the FTND and HSI
measures of nicotine dependence. Overall, the median score on the HSI was 2.0 (range 0.0–9.0) and on the
FTND was 0.0 (range 0.0–5.0), suggesting a very low level of dependence on nicotine, reflecting the small
number of cigarettes smoked a day. There were very high scores across all students on the measure of
quality of life, the CHU-9D, with a median and mean score of 0.888 and 0.865, respectively, out of a
maximum of 1.
The prevalence of the numerical intermediary variables outlined in the logic model is described in Appendix 1
(see Table 24). Across all students, the perceived percentage of students who took drugs in their year group
ranged from 0% to 100%, with a median of 5.0%, mean of 11.9% and SD of 16.2%. The knowledge
about drugs score ranged from 1 to 8, with a median of 6.0, mean of 5.6 and SD of 1.3.
Missing data
At the 18-month follow-up, levels of missing data were low. For questions on lifetime illicit drug use, only
1.6% of students overall did not provide a response. Only four (0.3%) students overall did not provide
data on lifetime cannabis, GGA and legal high use and seven (0.5%) did not provide data on cocaine use.
There was a similar proportion of missing data across arms for drug use questions. Missing responses on
the CAST were higher at 13.7%, probably because of the requirement to answer six questions. In total,
2.5% of students did not provide data on ever having tried and weekly smoking and around 12% of
responses on ever having consumed an alcoholic drink were missing. Among those who had drunk a
whole alcoholic drink, only one person did not answer the A-SAQ screening question. Among the 54
students who smoked one cigarette or more a week, 14.8% had missing data on the HSI and 9.3% had
missing data on the FNTD. Around 7% had missing data on the CHU-9D.
Exploratory effectiveness analysis
We examined the effectiveness of the interventions on the indicative primary and secondary outcomes and
intermediary variables (see Appendix 1, Tables 25–27). It was not possible to estimate effects for cannabis
or GGA use in the past 30 days, cannabis dependency, weekly smoking status or ever having visited the
Talk to FRANK website, as there were too few cases at baseline per arm.
The odds of lifetime drug use at the 18-month follow-up were marginally lower in the +FRANK arm than in
the usual practice arm [n = 561, 12.4% vs. 13.4%; odds ratio (OR) 0.96, 95% CI 0.58 to 1.59]. The odds of
lifetime drug use were lower in the FRANK friends arm than in the usual practice arm (n = 576, 9.3% vs.
13.4%; OR 0.70, 95% CI 0.39 to 1.24). The odds of lifetime drug use were also marginally lower in the
ASSIST arm than in the usual practice arm (n = 497, 8.7% vs. 11.1%; OR 0.81, 95% CI 0.46 to 1.42).
DOI: 10.3310/phr05070 PUBLIC HEALTH RESEARCH 2017 VOL. 5 NO. 7
© Queen’s Printer and Controller of HMSO 2017. This work was produced by White et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
39
TABLE 11 Summary of numerical outcome measures at the 18-month follow-up by trial arm and overall
Variable (potential scale range) Trial arm n Missing (%) Minimum 25th centile Median 75th centile Maximum Mean SD
FTND (0–10)a +FRANK 19 5.0 0.0 0.0 0.0 2.0 5.0 0.9 1.4
Usual practice 15 11.8 0.0 0.0 1.0 2.0 4.0 1.1 1.4
FRANK friends 9 10.0 0.0 0.0 0.0 2.0 4.0 1.1 1.5
ASSIST 6 14.3 0.0 0.0 0.0 0.0 2.0 0.3 0.8
Overall 49 9.3 0.0 0.0 0.0 2.0 5.0 1.0 1.3
HSI (0-6)a +FRANK 16 20.0 0.0 0.5 2.0 3.5 9.0 2.3 2.4
Usual practice 15 11.8 0.0 1.0 2.0 4.0 6.0 2.5 1.9
FRANK friends 9 10.0 0.0 0.0 2.0 3.0 6.0 2.0 2.3
ASSIST 6 14.3 0.0 0.0 0.0 0.0 3.0 0.5 1.2
Overall 46 14.8 0.0 0.0 2.0 3.0 9.0 2.1 2.1
Number of cigarettes smoked in an
average weeka
+FRANK 20 0.0 1.0 2.0 6.5 17.5 100.0 15.1 23.5
Usual practice 17 0.0 1.0 2.0 4.0 20.0 50.0 13.8 17.2
FRANK friends 10 0.0 2.0 4.0 8.0 11.0 32.0 10.3 9.3
ASSIST 7 0.0 1.0 1.0 10.0 42.0 50.0 19.4 20.9
Overall 54 0.0 1.0 2.0 6.0 20.0 100.0 14.4 18.9
CHU-9D (0–1) +FRANK 391 7.4 0.4 0.8 0.9 0.9 1.0 0.9 0.1
Usual practice 342 5.8 0.3 0.8 0.9 1.0 1.0 0.9 0.1
FRANK friends 412 6.3 0.3 0.8 0.9 1.0 1.0 0.9 0.1
ASSIST 315 7.6 0.3 0.8 0.9 1.0 1.0 0.9 0.1
Overall 1460 6.8 0.3 0.8 0.9 1.0 1.0 0.9 0.1
a Information recorded only for participants who reported smoking one or more cigarette a week and who did not tick the box ‘I do not smoke now’.
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The overall direction of effects for the FRANK friends arm across the secondary outcomes and hypothesised
intermediary variables indicated a potential positive effect; for the +FRANK and ASSIST arms the pattern
was mixed.
In exploratory subgroup analyses, interaction terms indicated that the effects of the +FRANK and FRANK
friends interventions were comparable in baseline lifetime drug users and baseline lifetime non-drug users
(see Appendix 1, Table 28).
Reliability of measures of illicit drug use
We examined the possibility of false-positive responding by including a fictitious drug, semeron, in the
measure of lifetime drug use. False-positive responding was very rare, with only two participants at
baseline and three at follow-up saying that they had ever taken the fictitious drug.
We also examined the reliability of measures of lifetime drug use by calculating the proportion of lifetime
drug use that was recanted, whereby baseline drug users responded that they had never used drugs at
follow-up. Out of the 65 drug users at baseline, 27 (41.5%) recanted reports of lifetime use at follow-up.
The level of recanting was 14.8% (n = 4) in the +FRANK arm and 29.6% (n = 8) in the FRANK friends arm,
with levels of 48.2% (n = 13) in the usual practice arm and 7.4% (n = 2) in the ASSIST arm. There was a
wide variation across sites and within arms; no recanting was found in five schools, one school each had
one two, three and four cases, two schools had five cases and one school had seven cases. As two-thirds
of lifetime drug use occurred after the baseline assessment, the removal of students who recanted had
a minimal effect on drug use prevalence (removed 12.0%, not removed 11.6%). The low number of
baseline users and students who recanted mean that these results should be interpreted with caution as
small differences in absolute numbers can appear to be large differences in prevalence.
To further explore recanting we examined changes in other time-invariant variables. Between baseline
and follow-up, the gender of seven students changed and 109 (7.0%) provided a different date of birth.
After removing errors in the date of birth provided, including putting the date of the data collection or
using an adjacent month but the correct date and year (e.g. 24 June 2002, 24 May 2002), 47 (3.0%)
dates of birth changed between baseline and follow-up.
Assessment of costs
Intervention costs
The estimated cost of delivering the +FRANK intervention was approximately £1942 per school (Table 12)
or £13.87 per student. The majority of the costs related to the time (estimated to be 3.5 working days)
spent by the two intervention delivery staff members preparing for and delivering the intervention and
follow-up sessions. The other substantial cost related to the hire of the venue, student transport and
catering for the off-site training sessions. The estimated cost of delivering the FRANK friends intervention
was approximately one-third higher, at £3041 per school (£20.69 per student; Table 13), reflecting some
economies in training students to be peer supporters for both the ASSIST intervention and the +FRANK
intervention. Tables 12 and 13 do not include the opportunity cost of the teacher accompanying students
on the training day; some schools may decide to pay for supply teacher time to cover this absence.
It is important to note that the +FRANK intervention, unlike the FRANK friends intervention, has the
requirement that schools have already delivered the ASSIST intervention. As the ASSIST intervention has
approximately the same cost as the FRANK friends intervention, delivery of the ASSIST intervention
(£3041) + the FRANK intervention (£1942) would have an estimated cost per school of £4983.
Process evaluation
Quantitative and qualitative data were used to determine whether or not the progression criteria were
met (see Table 4 for criteria). Quantitative data are presented first, followed by qualitative data, organised
according to the progression criteria that they address.
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TABLE 12 Estimated cost per school of delivering the +FRANK intervention
Resource item Units Cost (£)
Administration per school (3 hours of band 3 staff time,
contacting schools, arranging venues, preparing materials)
3 hours 28.14
Intervention delivery staff time per school (0.5 days of
preparation + 0.5 days for day recruitment + 1 training
day + 3 half-day follow ups = 3.5 days)
26.25 hours 333.64
Senior intervention delivery staff time per school (0.5 days
of preparation + 0.5 days for day recruitment + 1 training
day + 3 half-day follow ups = 3.5 days)
26.25 hours 400.58
Intervention delivery staff travel expenses per school for training
days and follow-ups
200 miles 134.00
Room hire, student transport and catering
School 1 1 day 723.00
School 2 1 day 792.00
School 3 1 day 1119.00
Average 878
Consumables per school
Text messaging 50.00
Training materials 49.17
Printing 68.27
Average total cost per school 1941.80
TABLE 13 Estimated cost per school of delivering the FRANK friends intervention
Resource item Units Cost (£)
Administration per school (6 hours of band 3 staff time,
contacting schools, arranging venues, preparing materials)
6 hours 56.28
Intervention delivery staff time per school (0.5 days of
preparation + 0.5 days for the survey + 0.5 days for
recruitment + 2 training days+ 4 half-day follow-ups = 5.5 days)
41.3 hours 524.29
Senior intervention delivery staff time per school (0.5 days of
preparation + 0.5 days for the survey + 0.5 days for
recruitment + 2 training days+ 4 half-day follow-ups = 5.5 days)
41.3 hours 630.24
Intervention delivery staff travel expenses per school for training
days and follow-ups
400 miles 268.00
Room hire, student transport, catering
School 1 2 days 1592.16
School 2 2 days 1244.00
School 3 2 days 1346.90
Average 1394.35
Consumables per school
Text messaging 50.00
Training materials 49.17
Printing 68.27
Average total cost per school 3040.60
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Quantitative data
Tables 14 and 15 show that the progression criteria assessing the feasibility of implementing the +FRANK
and FRANK friends interventions, respectively, were met.
In the three +FRANK schools, we examined the percentage of Year 8 peer supporters who were renominated
in Year 9. Of the 78 ASSIST Year 8 peer supporters, 50 (64.1%) were renominated, 24 (30.8%) were not
and four (5.1%) were lost to follow-up by Year 9. This suggests that around one-third of students nominated
as being the most influential by their peers in Year 9 were not trained in the +FRANK intervention.
Qualitative data
Interviews were conducted after intervention delivery was completed (i.e. after the last follow-up) with
66 participants across the three +FRANK and three FRANK friends schools. This included 36 peer supporters
(19 in +FRANK schools), 11 members of the intervention delivery team (all worked on both interventions),
eight parents (two from +FRANK schools), 10 school staff members (five from +FRANK schools) and a
public health commissioner. Some of the peer supporter interviews were conducted as paired interviews.
TABLE 14 Process evaluation quantitative results: +FRANK intervention
School ID
Total n invited
to ASSIST
training
Total n
ASSIST
trained % trained
Total n peer
supporters invited
to +FRANK training
Total n peer
supporters
+FRANK trained % trained
1. ≥ 75% of Year 8 ASSIST peer supporters are recruited and retrained as +FRANK peer supporters in Year 9
Site 3 28a 17 61 15 14 93
Site 4 28 25 89 25 23 92
Site 6 22 22 100 22 20 91
School ID
Recruitment
meeting (%)
Training
day (%) Follow-up 1 (%) Follow-up 2 (%) Follow-up 3 (%)
Intervention
delivered in
full
2. PHW staff delivered the +FRANK training in full in all three intervention schools
Site 3 100 (n = 3) 100 (n= 20) 100 (n = 1) 100 (n = 1) 100 (n= 3) Yes
Site 4 100 (n = 3) 100 (n= 20) 100 (n = 1) 100 (n = 1) 100 (n= 3) Yes
Site 6 100 (n = 3) 100 (n= 20) 100 (n = 1) 100 (n = 1) 100 (n= 3) Yes
School ID
Total n peer supporters
trained
Total n peer supporters who had at
least one conversation
% reporting at least one
conversation
3a. ≥ 75% of +FRANK peer supporters report having at least one or more informal conversations with their
peers at school about drug-related risks/harms
Site 3 14 14 100
Site 4 23 22 96
Site 6 20 16 80
School ID
Total n peer supporters
trained
Total n peer supporters who had at
least one contact with PHW
% who had contact with PHW
staff
3b. ≥ 75% of +FRANK peer supporters report at least one contact with PHW staff, either during a follow-up visit
or via e-mail, text or Facebook (Facebook Inc, Menlo Park, CA, USA)
Site 3 14 14 100
Site 4 23 23 100
Site 6 20 20 100
a Six removed by school, five not trained.
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TABLE 15 Process evaluation quantitative results: FRANK friends intervention
School ID Total n peer supporters invited Total n peer supporters trained % trained
1. ≥ 75% of Year 9 students nominated are recruited and trained as FRANK friends peer supporters
Site 1 23 22 96
Site 2 45 34 76
Site 7 20 15 75
School ID
Recruitment
meeting (%) Training day 1 (%) Training day 2 (%) Follow-up 1 (%) Follow-up 2 (%) Follow-up 3 (%) Follow-up 4 (%)
Intervention
delivered in full
2. PHW staff deliver the FRANK friends training in full in all three intervention schools
Site 1 100 (n= 3) 100 (n= 19) 100 (n= 9) 100 (n= 1) 100 (n= 1) 100 (n= 1) 100 (n= 3) Yes
Site 2 100 (n= 3) 100 (n= 19) 100 (n= 9) 100 (n= 1) 100 (n= 1) 100 (n= 1) 100 (n= 3) Yes
Site 7 100 (n= 3) 100 (n= 19) 100 (n= 9) 100 (n= 1) 100 (n= 1) 100 (n= 1) 100 (n= 3) Yes
School ID Total n peer supporters trained
Total n peer supporters who had at least one
conversation
% of peer supporters reporting at least one
conversation
3a. ≥ 75% of FRANK friends peer supporters report having at least one or more informal conversations with their peers at school about drug-related risks/harms
Site 1 22 22 100
Site 2 34 27 82
Site 7 15 15 100
School ID Total n peer supporters trained Total n peer supporters who had at least one contact
% of peer supporters reporting at least one contact
with PHW staff
3b. ≥ 75% of FRANK friends peer supporters report ongoing contact with PHW staff throughout the year via a follow-up visit
Site 1 22 22 100
Site 2 34 34 100
Site 7 15 15 100
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A similar number of interviews was conducted across each school. The characteristics of the participants
who were interviewed are summarised in Appendix 1 (see Table 17).
Across the interviews a number of themes emerged, as detailed in the following sections.
Adaptation of the ASSIST peer-led approach to drug prevention and peer-led delivery
Peer supporters, parents, school staff and the public health commissioner found the peer-led approach
acceptable. Peer supporters reported that it was beneficial to understand the possible harms and effects of drugs:
I think it’s really helpful and especially when we get to take part and then the feedback to our peers
and it’s just really helpful for people and keeps them safe if they know the facts.
School 2, peer supporter 171
It’s a good role, because you can help people, educate people about drugs.
School 7, peer supporter 51
Parents were comfortable with their children taking on the role of a peer supporter and having informal
conversations with their peers about the harms of drug use. One parent thought that students may find a
peer-led drug prevention intervention more acceptable than other forms of drug education:
I broadly approve of both the method and the sort of the anti-drug message that the peer-to-peer,
because clearly there is a gap in that respect, you know children would not tend to look at me for
instance for information . . . you know, telling children that it’s not legal clearly is not working.
School 1, parent 1
The public health commissioner also noted the value of a peer-led approach to drug prevention:
Erm, well it’s not like anything I have come across previously because I think most of the ones that
have been tried have either been you know what I call traditional educational packages, then delivered
by teachers or others, or even peers because that is, you know peer education is something
fundamentally different.
Public health commissioner
Peer nomination process
The peer nomination process was perceived as being acceptable to the majority of peer supporters, parents
and teachers. Most peer supporters reported that being selected by their peers was a positive experience:
I was really flattered, when they said that we’ve been chosen by our friends and everything, I was
really shocked and surprised, but flattered at the same time.
School 3, peer supporter 140
Peer supporters also noted that they thought being nominated by peers was more credible than if they
had been selected by teachers for the role. A few peer supporters and teachers were surprised at the
nomination of some individuals:
School 7, peer supporter 74: I think a few weren’t really suitable I thought.
Interviewer: OK, what made them not suitable? What was it about them?
School 7, peer supporter 74: Erm, some of them are like really naughty in school and they haven’t
done much really, how can I explain it? Like they, they’re not very, erm, polite to people. So I was,
I was really like taken aback when I seen that they were on there.
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Of the peer supporters and teachers who were surprised about which students were nominated, all reported
that these students behaved well during the off-site training. Teachers felt that the nomination process
resulted in a good mix of students from across the year group, who might not have been selected by teachers:
I think that those students, you know for social reasons they are very engaging and they are confident
and I think that’s what they look up to but sometimes that confidence comes not through sort of
maybe academic but maybe because of their street cred. Erm and often I think perhaps we wouldn’t,
as teachers, select them.
School 4, teacher 2, SMT
Off-site peer supporter training
Many of the peer supporters and teachers appreciated activities that encouraged the practising of
conversations. Some commented on the particular benefits of practising conversations:
They [the trainers] would say that it is hard to have conversations, especially at our age, but they
would manage to build your confidence up, and we even had like a little session where you kind of
practised with one another, having a conversation. And that, it just made me feel that I could literally
do anything.
School 6, peer supporter paired interview 1, peer supporters 67 and 52
Acceptability of having conversations about drugs
The majority of parents and teachers found it acceptable for the peer supporters to be disseminating
information to their peers about the risks of drug use during informal conversations. Some teachers and
peer supporters felt that students in this year group had not yet learned much about the harms of drug
use and so this made the job easier as it would be something that they were interested in hearing about:
We have learned quite a lot about smoking over the years. But drugs is a bit, you know, it’s like
untouched upon subject, like I’ve never, you know, been sat down and taught about drugs.
School 3, peer supporter paired interview 1, peer supporter 46
I think with the majority of my friends, erm, they haven’t tried drugs, and like me, they didn’t know a
lot, so when I would come back and tell them a few facts, they would be really interested and I think
that helped, because they wanted to know more . . . They were like really interested, didn’t know a
lot, so when I was coming to tell them they were erm, kind of overjoyed that they were learning
something different all the time.
School 6, peer supporter paired interview 1, peer supporters 67 and 52
The fact that drug use is less prevalent than smoking was discussed as being both a facilitator of and a
barrier to having conversations about drugs. Some school staff felt that the illegality of drug use reduces its
acceptability, but for others the illegality was seen as a facilitator of having conversations:
When you talk to them, yes, they had had conversations, and I wonder whether it’s a bit easier to talk
about that, rather than smoking, because drugs is, you know, an illegal action, whereas quite a lot of
people smoke, even if . . . at certain ages it’s usual, but it’s more acceptable to young people.
School 3, teacher 1, school contact
Some +FRANK peer supporters felt that the lack of drug use among their peers made it easier to broach
the subject compared with smoking:
It was . . . I don’t know . . . it felt easier to do them on drugs instead of smoking, because it just felt
like that, like . . . hardly anyone would be doing that.
School 4, peer supporter 15
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Reducing barriers to initiating conversations
The fact that the training provided interesting and appropriately sized ‘facts’ to be used in conversations
was valued by some peer supporters:
They told us facts that we can take into our conversations with other people . . . the facts was only
small facts so it was easy to remember.
School 7, peer supporter 83
In general, peer supporters found that short, memorable facts were useful, especially for initiating
conversations with their peers. Memorable facts mainly fell into two categories: first, shocking facts about
potential health risks, which often focused on GGAs, and, second, those that contradicted commonly held
myths about drugs, such as the prevalence of drug use in their age group or the addictive nature of cannabis:
With the glues, gases and aerosols, erm, they’re easy to get access to and I was completely shocked
when I heard erm, the sudden sniffing death, that . . . that like literally blew me over. I think it really
erm, stunned a lot of people.
School 3, peer supporter 140
It like surprised a lot of people . . . Like lots of people thought 15% was very low. I thought like a lot
more people took drugs . . . 15%, that’s pretty low I think. It just like stuck in my brain like whoa this
isn’t what I thought.
School 2, peer supporter 84
The one about one in 10 people get addicted to cannabis when they smoke it. So it’s like they know
to not smoke it in case they do get addicted.
School 7, peer supporter 51
Face-to-face compared with electronic means of communication
Some peer supporters reported that having conversations face-to-face was easier, and more appropriate,
than doing so by text message or social media. It was felt to be of particular importance when discussing
such a sensitive topic because being able to read non-verbal cues helped with gauging the reactions of
their peers to the conversation:
Also if you’re sat with the boys, straight away you can tell how they feel about the conversation. You
can tell if they’re nervous, they’re surprised. By text, if they go ‘wow, I never knew that’, you don’t
know, that could be sarcastic, that could be whatever.
School 2, peer supporter 89
The potential for misunderstandings to be caused when communicating by text message or social media
was also of concern to peer supporters:
I think it was more easy to understand face to face. Me and some of my friends have had
conversations about it on the phone. But I think if . . . if I was texting it, maybe they would take it the
wrong way. Because you can read the text and think, oh, they’re having a go at me or something,
so read it the wrong way. So I was afraid to do that. I think it was more easy and relevant to speak
face to face with people instead. I think it’s easier to express your feelings face to face, because you
can just come out with it, and it’s harder on social media.
School 3, peer supporter 140
Some peer supporters commented that it would be strange to start a conversation about drugs on social
media as this is not what they use it for normally.
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Follow-up sessions
Most peer supporters reported that the follow-up sessions were helpful for refreshing knowledge and
prompted them to continue to have conversations with their peers:
Interviewer: And the follow-up sessions, what did you think of these?
School 1, peer supporter paired interview 1, peer supporter 18: Yeah just a good reminder, just with
the time gaps in between, it just helped you refresh.
School 1, peer supporter paired interview 1, peer supporter 70: Recapping overall facts, so if you’d
forgotten one, you’d be like oh yeah I had forgotten about that one and then use that in the next
conversation and you’d remember it then.
Trainers were able to provide guidance during follow-up sessions on having conversations:
Like if you were stuck on conversations . . . they [trainers] were always there to like straight, help you
straightway like so they were always there straightway.
School 4, peer supporter 61
Some peer supporters and teachers commented that the follow-up sessions were less engaging than the
training day(s), partly because they were carried out at school:
I think they started to get boring towards the end really, towards the end, we didn’t really do anything
to do with it really.
School 4, peer supporter 97
I know it’s not a lesson and the guys running it aren’t teachers, I do appreciate that . . . but just to
stimulate and engage the kids . . . I just felt it could be a little bit more zippy in those follow-up sessions.
School 1, teacher 1, school contact and SMT
Trainers
All peer supporters perceived the trainers to be friendly and helpful. This increased peer supporters’ desire
to engage with the intervention:
I think I liked it because they were friendly enough, and they were like more like people than other
ones because they try to be like too serious and that can get really boring and you like don’t
take notice.
School 1, peer supporter 34
All peer supporters reported that they felt comfortable raising issues or concerns with the trainers:
I think the . . . trainers . . . themselves were friendly and encouraging so we knew we could go to
them at any time and it was very like secure.
School 1, peer supporter paired interview 1, peer supporter 70
The majority of peer supporters were also confident that trainers would be able to provide credible and
accessible information:
I think they were knowledgeable because every time one of us asked them a question about a certain
drug or something they’d have an answer straight away, they knew what they were saying.
School 7, peer supporter 99
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Peer supporters from the +FRANK intervention were pleased to work with the trainers who they had
worked with during the ASSIST intervention.
Well it was a good thing that we had [trainer] again because like we kind of already knew him and
like his way of like doing the programme.
School 4, peer supporter 61
Usefulness of the Talk to FRANK website
Most of the peer supporters and trainers stated that the Talk to FRANK website was a useful resource
to support their roles. Trainers used the website when they did not know the answer to a question.
Most peer supporters found the website accessible in terms of layout and access from mobile phones,
with age-appropriate content:
It wasn’t hard to understand either. That was straight forward as well. I think it’s really useful because
if I don’t know any information and [my friends] ask me something, I could literally go on my phone,
quickly type in Talk to FRANK website and I could go on there and even if I don’t know where to get
the information, it’s clear to click on something, oh there’s the information they need and then
tell them.
School 7, peer supporter 99
There was more facts on there, there was more names of drugs, there was personal experiences, so it
was all helpful if you were still having the conversations.
School 4, peer supporter 61
Peer supporters also used the website if asked a question that they could not answer. The A-Z of drugs
drop-down menu, which provided a glossary of drugs, was cited as being a useful feature when they were
asked a question that they could not answer:
There’s loads of like different names of drugs isn’t it and they have like all the names on there, so it’s
like if one person says to me what’s that, they can have a look and it tells you what it is like.
School 2, peer supporter 171
Peer supporters found the personal stories of drug misuse posted on the website useful:
Quite useful, because it has stories on there from people who’ve suffered from drug use.
School 4, peer supporter 97
Importance of contact teachers
All trainers noted the importance of having contact teachers who were supportive and who encouraged
peer supporters to engage with the intervention, as well as being well organised:
He’s the teacher we always go to if you have a problem or something, we’re told to go to him . . .
So yeah it’s good.
School 1, peer supporter paired interview 1, peer supporter 70
And you know, I had different people e-mailing me from the school, at different times, even
communication within the school you know, with each other they didn’t know what each other were
doing and I was kind of like the middle person at one point.
Trainer 1
One peer supporter did not feel well supported as the contact teacher was too busy. Another peer
supporter stated that non-teaching staff should not take on the role of a contact teacher as they may not
have the authority required and peer supporters may not listen to them.
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Interaction between the school context and the intervention
Across schools there was variation in the commitment of contact teachers, support provided for peer
supporters and the visibility and ease of organisation of the intervention. Most trainers and teachers stated
that having the buy-in and commitment of the school, especially the SMT and contact teacher, was vital in
ensuring that the intervention was implemented as planned:
Senior leadership need to buy into it and make sure that, you know, that the contact teacher is
engaged, has the time to actually commit to the programme and gain an understanding of the
programme erm and they need to be supporting it from a whole school approach so you know even
form tutors should be saying in form tutoring, you know we’ve got students that have engaged in
this, how’s it going, you know they should be encouraging it throughout the school rather than just in
the 1-hour sessions that we book it in.
Trainer 2
Some teachers commented that members of school staff needed to champion the intervention for the
students to take it seriously:
I think [the contact teacher] should be a member of staff who’s interested, and is willing to support
the programme, and to keep supporting it as it goes through, I think that’s really important, because if
you’re not positive yourself, you’re not going to give weight to the programme.
School 3, teacher 1, school contact
Unintended benefits of being a peer supporter
Many peer supporters, teachers and parents thought the peer supporter role brought broader benefits,
including increased confidence and improved communication skills, which they linked to future career
prospects and examination success:
Yes, yes, for future jobs, they can be more like . . . gives us the skills, like communication skills.
School 1, peer supporter 46
Interviewer: Did you get any feedback from your parents about what they thought?
School 3, peer supporter paired interview 2, peer supporter 150: I just told my mum about it and she
said that’s good, really good on you. Like she was like for when you go to university and stuff.
School 3, peer supporter paired interview 2, peer supporter 352: My mum was pleased because she
said it improved my confidence and she said like she can see and I’ve improved others.
Could help with different exams I guess in school, like the oral exam things and presentations
in English.
School 1, teacher 1, school contact and SMT
Several teachers commented that nominated students would be more likely to become engaged in other
activities within the school as they were recognised as having matured as a result of the additional peer
supporter role:
Well now that they’re, they’re aware of the facts, they can take on a teacher role can’t they really
they, they can make students aware. Or they can speak to their, their, you know, their um classes
about it. They could give talks about it couldn’t they? You know, so when we’re doing, there’s usually
a drug awareness week isn’t there. You could actually involve them. Within their form classes. Or even
in the assembly.
School 7, teacher 2, SMT
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Some of them [peer supporters] are already involved in other groups as well, er . . . you know, they have
the option to join these groups or . . . for the School Council they’re nominated. So it could be that er
. . . you know, some of them finding a . . . that haven’t been nominated before . . . That actually, they’ve
got a voice and . . . And they could be sort of nominated in future for things like the School Council.
School 3, teacher 2, school contact
Comparing the +FRANK and FRANK friends interventions
In the +FRANK intervention, the intervention was delivered in Year 9 but peer supporters were those
nominated in Year 8. Some peer supporters commented that they might not have been renominated if the
nomination process was repeated, whereas others felt that they would have been. One teacher felt that
friendship groups and those who were influential did not change between Year 8 and Year 9.
I think it doesn’t change greatly [from Year 8 to Year 9] and it doesn’t change greatly throughout
school. Those people who are what we’d call ringleaders then, they tend to remain quite a force
throughout the time.
School 4, teacher 2, SMT
In the +FRANK intervention the off-site training of peer supporters takes place over 1 day whereas in the
ASSIST and FRANK friends interventions training takes place over 2 days. All of the trainers commented
that they were pushed for time to cover all of the contents of the +FRANK intervention in 1 day, leading
to them ‘rushing’ to deliver the full training (Trainer 2). As the +FRANK training was new to them they
needed time to become familiar with the delivery, which may in part have accounted for this pressure, but
an awareness of being observed to meet the learning objectives of the activities added extra pressure:
I think we really struggled for timing and fitting everything in and it seemed quite chaotic I suppose,
we tried to make sure everything was covered and um I think we were all quite conscious of making
sure that we were ticking the right boxes along the way as well.
Trainer 3
One trainer commented that the gap between the ASSIST intervention and the +FRANK intervention was
potentially over a year and so peer supporters would have benefited from receiving a refresher session on
conversation skills, which was not possible within a 1-day training course:
I just felt erm, yeah, there wasn’t enough time. I know they’ve already done day 2 of ASSIST but I did
feel we could have spent a little more time on discussing the skills . . . Erm, you do need to have time
to concentrate on the skills and recap all their communication skills and their teamwork . . . It’s not just
about them learning about the facts.
Trainer 1
At one site, peer supporters would have liked the +FRANK training to have been carried out over 2 days:
Too much for 1 day, they should spread it out over 2 days.
School 4, peer supporter group interview 1, peer supporter 91
One trainer noted that peer supporters were disappointed that it was a 1-day training course rather than a
2-day course as in the ASSIST intervention. As a result, peer supporters were less engaged, which the
trainer also felt could be because of the lack of novelty:
I think because they had 2 days’ training the year before, it was a little bit of a disappointment, erm,
I know there were some at recruitment, we said actually just 1 day this time. You know you could see
they were a bit like oh, I think that comes down to the fact that every kid wants 1 or 2 days off school
and plus they knew what to expect this time around.
Trainer 1
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Trainers noted that the 2 days of training in the FRANK friends intervention meant that they felt more
relaxed as they had time to answer questions and had greater flexibility over the timings of the activities.
The extra day of training gave trainers a ‘breathing space’ (trainer 1). They were also more experienced at
delivering the training on drugs as the delivery of the +FRANK intervention preceded the delivery of the
FRANK friends intervention.
There was no consistent message from trainers with regard to which intervention to roll out in the future.
Two trainers felt that the FRANK friends intervention was better at securing student engagement and
providing support than the +FRANK intervention:
Yeah, it’s been a bit of a mix but you know I would say if it was to be rolled out long term then
probably FRANK friends is more effective in that it’s a new experience for the peer supporters to get
the 2 days of training so they look at the skills and they get the facts, they get the four follow-ups but
I think what is essential is that initial stage the school really understand what it is that they’re
engaging on and you know that they support it from the offset.
Trainer 2
Another trainer found it hard to judge as the +FRANK and FRANK friends schools were very different:
Um I think, well it feels like, I think, it’s really hard to say which one I think um has worked the best
+FRANK or FRANK friends. Because there’s a vast difference between um through FRANK friends
schools.
Trainer 4
Modifications for future delivery
Three parents would have liked more detailed information or somewhere to refer to for more information:
Erm, I know, I know it was only a brief, brief letter, you know what I mean, er, it would have been
nice some sort of website on there or something, because I didn’t see anything like that on there.
School 4, parent 1
Some teachers and students noted that there was a low level of awareness of the interventions in the
schools. They suggested that in the future the intervention should be more widely publicised in schools:
School 3, peer supporter paired interview 1, peer supporters 46 and 51: Teachers weren’t educated on
what we’re actually doing . . . There’s been a few times when it’s been like oh you guys, you’ve got
FRANK. OK, well the teacher’s been like what’s FRANK?
Interviewer: OK, so there’s something here then about the way the school shares the information.
School 3, peer supporter paired interview 1, peer supporters 46 and 51: Trying to like tell the teachers.
So like they’ve been chosen by their peers as influential members. Because I know that now that our
head teacher gave us our certificates. I know that he knows now that our group is, you know, well
behaved and influential. We might get asked to do other things. Which maybe we would fit the role
of, so it would be nice if other teachers knew that too. So if they ever wanted something like that.
I do think with perhaps regards to what we’re doing in school is perhaps . . . embedding it a little bit
more from a school perspective . . . I think you know so making sure there are regular erm, regular
sort of erm announcements and notices to all of our learners that these learners are in school. Perhaps
making sure we’ve got a display up and running because we did have a display up and running when
they did erm the ASSIST course . . . So they know there are people they can go to for that support.
School 6, teacher 2, SMT
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Chapter 4 Discussion
We have successfully developed two school-based peer-led interventions to prevent illicit drug usein young people aged 13–14 years. We used a three-stage design to coproduce the interventions
with stakeholders, test their feasibility and refine them, before conducting an external pilot cRCT.
This chapter presents the main findings of the study against our objectives and suggests modifications
that should be incorporated into a fully powered cRCT.
Objective 1: adaptation of the ASSIST intervention to drug prevention
and development of the +FRANK and FRANK friends interventions
In stage 1 we used a three-phase framework to adapt intervention materials from the ASSIST intervention
to deliver information from the Talk to FRANK website to an older year group, as well as prototyping new
content and delivery methods. The process took 18 months and consisted of 42 activities, including
consultations with young people in Years 8 and 9, staff from drug charities who delivered drug education,
health promotion specialists, ASSIST peer supporters, the lead author of the ASSIST RCT23 and a DECIPHer
IMPACT trainer (which licenses and trains all ASSIST delivery staff). By doing so we were able to address
any potential issues with the intervention content, delivery process and fit to the school context that might
arise during implementation.
We conducted a scoping review of population-level prevalence studies on drug use in the UK and RCTs of
peer-led drug prevention. The latest population-based prevalence study in the UK showed that the lifetime
prevalence of any drug use more than doubled between 13 (11%) and 15 (24%) years of age.6 This led us
to target delivery to UK Year 9 students (aged 13–14 years). In this prevalence study, cannabis (13 years:
2.8%; 15 years: 15.8%) and GGAs (13 years: 3.7%; 15 years: 1.9%) had the highest lifetime prevalence
in 13- to 15-year-olds.6 At the age of 15 years, magic mushrooms, cocaine, speed, mephedrone and legal
highs also had a prevalence of > 1%.6 Consultation with local drug agencies suggested that there was a
problem with steroid use in South Wales. We therefore chose to focus the interventions on these drugs,
with the time devoted in the training of intervention delivery staff and peer supporters proportional to
their lifetime prevalence.
The consultations with stakeholders led us to develop intervention activities focused on delivering
information from the Talk to FRANK website on the risks of illicit drug use for short- and long-term health,
the legal consequences of a caution or conviction for possession (e.g. restricted job and travel prospects),
the potential impacts on educational performance, the risks of school suspensions and exclusions and the
potential shame and stress caused to family members from drug use. We then used an iterative process
of prototyping intervention materials through repeated delivery and interviews with trainers and peer
supporters to identify problems and make amendments.
Objective 2: test the feasibility of the +FRANK and FRANK friends
interventions
Assessing the acceptability of the +FRANK and FRANK friends interventions to trainers,
students, parents and members of school staff and exploring the barriers to and
facilitators of implementation
In stage 2 we conducted a process evaluation examining the delivery and receipt of the +FRANK and FRANK
friends interventions in one school each. Two members of the research team made independent observations
of all intervention activities, including follow-up sessions. In the +FRANK intervention we carried out seven
observations, collected 34 evaluation forms and conducted 13 interviews with peer supporters and trainers.
DOI: 10.3310/phr05070 PUBLIC HEALTH RESEARCH 2017 VOL. 5 NO. 7
© Queen’s Printer and Controller of HMSO 2017. This work was produced by White et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
53
In the FRANK friends intervention, we carried out 15 observations, collected evaluation forms of the training
from 47 peer supporters and trainers, conducted 29 interviews with peer supporters, trainers and teachers
(including members of the SMT) and held five focus groups with peer supporters.
We assessed peer supporter attendance during the interventions. In the +FRANK school, 12 of the 14 peer
supporters attended follow-up sessions 1 and 4, which were carried out in person. Only one peer supporter
completed the e-follow-up sessions. In the FRANK friends school, between 16 and 21 of the 26 trained
peer supporters attended the four follow-up sessions. Independent observations of intervention delivery and
interviews with trainers found that some activities were too long, others were too short and the sequencing
of activities could be improved.
Fidelity of delivery
In the +FRANK intervention, across the 15 activities, five were delivered in full, eight had minor deviations
and two were not delivered at all. In the FRANK friends intervention, across the 25 activities, 13 were
delivered in full, nine had minor deviations and three were not delivered at all. The observations suggested
that some trainers had struggled to switch off from the coproduction stage.
Refining the interventions
The attendance records, interviews and structured observations led to changes in the +FRANK
intervention. We removed the electronic follow-up sessions and dropped the final follow-up in which peer
supporters received a certificate from the trainers. These were replaced with three face-to-face follow-ups.
Other changes applied across both interventions, including changes in the content and sequencing of peer
supporter training activities and highlighting in the instruction manual which activities were essential and
which were optional. These barriers to delivery would not have been identified and the accompanying
refinements would not have been made without this initial feasibility testing.
Objective 3: conduct an external pilot cluster randomised controlled trial
of the +FRANK and FRANK friends interventions
In the stage 3 external pilot cRCT, all progression criteria for the +FRANK and FRANK friends interventions
were met.
Assessing the feasibility and acceptability of the refined interventions to trainers,
students, parents and school staff
The process evaluation involved 66 interviews with peer supporters, PHW intervention delivery staff, school
staff including members of the SMT, PSHE leads and contact teachers and a commissioner of public health
interventions. Independent structured observations of the delivery of all intervention activities (n = 195;
n = 111 for the FRANK friends intervention) were made by two members of the research team.
In the +FRANK arm, 92% of the ASSIST peer supporters were recruited and retrained and 92% of the
peer supporters reported at least one conversation and all reported a contact with intervention delivery
staff. In the FRANK friends arm, 82% of the peer supporters were trained and 94% of the peer supporters
reported at least one conversation and all reported a contact with intervention delivery staff. The success in
meeting these criteria is likely to reflect that the ASSIST training materials that we adapted had been
adequately tested and refined. Our study design also allowed for stakeholder concerns to be elicited and
addressed before implementation.
The qualitative analysis suggested that most elements of the interventions were acceptable to students,
teachers and parents:
l School setting. Teachers and parents noted that schools were an acceptable environment to deliver
drug education to young people. Trainers and teachers thought that involving someone from the
SMT and having a committed contact teacher were needed to facilitate intervention delivery.
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l Peer nomination. The ASSIST peer nomination approach to intervention delivery was regarded as
preferable and more credible by parents and the public health commissioner than didactic drug
education in schools.
l Peer supporter role. Peer supporters reported feeling comfortable having conversations about drugs
with their school friends, particularly with regard to the risks of drug use for health,. They thought that
the training on communication skills would help in oral examinations and with their future employment.
Teachers reported that they thought that the peer supporter training had increased some students’
confidence and they had involved them in other school activities.
l Follow-up sessions. Peer supporters noted that follow-up sessions were helpful and acted as a prompt
to continue having conversations with peers. This may in part be because trainers were perceived to be
friendly, credible and knowledgeable.
l The Talk to FRANK website. The website was perceived positively, with peer supporters noting that it
was easy to access (including by mobile phone) and to understand. In particular, the A-Z feature was
cited as a commonly used feature when they were asked a question about a drug they did not know.
Assessing the fidelity of delivery of the interventions by trainers
All +FRANK and FRANK friends intervention activities (100%) were delivered as intended. This is a
substantial improvement in meeting the essential learning objectives from that found for intervention
delivery in stage 2. This may be attributed to amendments made to the intervention manuals, content,
timings and sequencing based on requests by trainers and discussions by the IDG. Trainers are likely to
have improved their knowledge of the materials and delivery and the questions that are commonly asked
by students. Trainers’ awareness of being observed and scored may also have improved adherence.
Comparing the feasibility and acceptability of the +FRANK and FRANK
friends interventions
The progression criteria relating to feasibility and acceptability were met for the +FRANK and FRANK
friends interventions. However, the process evaluation indicated that the hypothesised intervention logic
may not hold as well for the +FRANK intervention as for the FRANK friends intervention. In the +FRANK
schools, students completed the peer nomination process in Year 8 and Year 9. Around one-third of the
+FRANK peer supporters were not nominated as being the most influential by their peers in Year 9. This
meant that other students who were perceived to be influential in Year 9 were not trained to be peer
supporters. This is a potential barrier to the diffusion of the messages from the Talk to FRANK website as
the intervention logic model for the ASSIST intervention is predicated on peers being perceived as
influential and a sufficient proportion (17.5% in the ASSIST intervention) of these influential peers
being trained.
Although we were able to re-recruit 92% of Year 8 ASSIST peer supporters to reprise their role as a +FRANK
peer supporter in Year 9, the number of peer supporters available to train in the +FRANK intervention is
limited by the number of ASSIST peer supporters. In the FRANK friends intervention, if a parent or student
does not consent to attend training, the student with the next highest number of nominations is invited, thus
maintaining an ideal 17.5% of the year group trained. In the +FRANK intervention this cannot occur and so
a lower proportion of students may be trained. Consequently, the diffusion of information is reduced as
there would be a smaller number of peer supporters relative to other students.
Trainers reported feeling rushed in terms of delivering the content in the +FRANK intervention as training
took place over 1 day, whereas the FRANK friends training took place over 2 days and the trainers could
spend more time on activities and answering questions. One trainer and two peer supporters mentioned
that more training on communication skills was needed. One trainer also noted that +FRANK peer
supporters were disappointed that training took place over only 1 day as they were expecting the training
to last for 2 days, as in the ASSIST intervention.
For these reasons, we recommend that the FRANK friends intervention is taken forward to a full-scale trial.
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Assessing trial recruitment and retention rates
Of the 40 schools invited to participate, 12 provided no response and eight declined to participate. Of the
12 who provided no response, it is not clear whether they would have participated. Of the 18 schools
visited by the research team, only one withdrew and another could not commit to the data collections.
Of the 16 remaining schools, 12 took part in the cRCT, two were kept in reserve and two were used in the
stage 2 feasibility testing. Because of delays in the contracting process, we deliberately oversampled schools
to be invited to ensure that 12 schools were recruited by the start of the school term. In any subsequent
trial we would have a longer recruitment period and would anticipate a higher rate of recruitment.
The 12 schools recruited were randomised and retained at the 18-month follow-up. In total, 93% of
eligible students were recruited at baseline and retained at the 18-month follow-up. The retention of
schools might be attributed to the signing of a memorandum of understanding by a member of the SMT.
The memorandum of understanding clearly laid out the timing of the intervention delivery and data
collections. Schools were also paid to supervise data collections. The high recruitment and retention rates
were probably the result of the recruitment and data collection processes that we had refined during other
school-based studies. We monitored recruitment and retention rates and conducted multiple follow-up
collections for absent students.
Pilot outcome measures
We found low rates of missing data for almost all variables. The highest rate of incomplete data (23%) was
for the CAST measure of cannabis dependency at baseline. As the lifetime prevalence of cannabis use was
only 2.4%, this represented eight people not completing the measure. This measure may not have been
completed because of a combination of the measure requiring six responses, a need for clearer signposting
in the filter questions or lack of comprehension. At follow-up, 13.7% of responses were missing on the
CAST. This reduction in the proportion of missing responses on the CAST may be the result of changes
made to the follow-up questionnaire to improve the filtering of cannabis users or improvements in
understanding of the instructions. There was some evidence of floor effects for the measures of nicotine
dependence, with median scores at baseline of 0 on the HSI and 0.5 on the FTND. At follow-up, the median
score was 2.0 on the FTND and 0.0 on the HSI. This suggests that there may be limited value in assessing
nicotine dependence in this age group in the UK as levels of dependency are low.
The prevalence of lifetime drug use at baseline was 4.1%. The most commonly used drugs were cannabis
(2.4%) and GGAs (2.2%); all other drugs had a prevalence of < 1%. At the 18-month follow-up, the
prevalence of lifetime drug use was 11.6%. The ICC for illicit drug prevalence at follow-up for the
comparison between usual practice and the FRANK friends intervention was 0.003 and for the comparison
between usual practice and the +FRANK intervention was < 1 × 10–8. These estimates suggest that,
between 13 and 15 years of age, the prevalence of lifetime drug use nearly triples, which provides
justification for our decision to deliver the interventions to this age group.
The most common drugs used were cannabis (8.0%), GGAs (4.0%), legal highs (1.7%) and cocaine (1%).
Of those who used, the majority had done so in the past 12 months. Use of cannabis in the last 30 days
(21.9%) was more common than use of GGA (5.3%) in the last 30 days, with cannabis (8.9%) and
cocaine (1.2%) the only drugs that were used by > 1% of students in the last week. In total, 35% of the
117 students who reported ever trying cannabis screened positive for cannabis dependency. The pattern of
lifetime prevalence of specific drugs, with cannabis and GGA being the most prevalent, replicates that
found in the most recent population-based study in the UK.6
The lifetime prevalence of illicit drug use at 18 months was 9.5% in the ASSIST arm, 9.7% in the FRANK
friends arm, 15.1% in the +FRANK arm and 11.7% in the usual practice arm. There was an imbalance in
baseline risk factors for drug use, with living without an adult in employment53 and in social housing54,55
more common in the +FRANK arm than in the other arms. This imbalance is likely to be attributable to
the small number of schools per arm. In a larger full-scale trial, a larger number of schools would be
randomised into each arm, thus reducing the potential for imbalances. As the sample size in this study was
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not determined by a formal power calculation but by convenience, effect sizes should be interpreted with
caution as there is a risk of a type 2 error with underpowered comparisons. In an adequately powered trial
we could be more confident that a sufficient number of students were included in the analysis to detect a
difference across arms.
Of the 65 drug users at baseline, 27 (41.5%) recanted use in the follow-up survey. The recanting of
lifetime drug use has been found in a number of prospective cohort studies.56,57 The rate that we found
was slightly lower than those recorded in other UK-based studies, such as the Belfast Youth Development
Study (63.8% for 10 illicit drugs assessed at between 12 and 15 years of age),58 but higher than those in
the ALSPAC birth cohort [14.4% cannabis, 25.2% other illicit drugs (cocaine, amphetamines, inhalants,
sedatives, hallucinogens, opioids), assessed at between 14 and 18 years of age],59 although our survey was
undertaken with students of a different age range. These studies found that recanting is less common in
adolescents reporting higher levels of cannabis use.58,59 As prevalence was lower in this study than in the
previous studies, partly because of population-level declines in the prevalence of drug use,58,59 selection of
a younger age group than in these analyses and a shorter follow-up period, we might expect higher rates
of recanting in our study. Importantly, we found the highest rates of recanting in the usual practice arm,
suggesting that this was not attributable to performance bias, in which participants change responses after
exposure to the intervention.
It has been suggested that recanting is less likely to be the result of intentional distortion but rather the
result of poor comprehension, forgetfulness or even carelessness.56,57 Consistent with this suggestion, we
found that between baseline and follow-up, seven students’ gender changed and 47 (3.0%) students
changed their date of birth. An alternative explanation is that recanting may be logical. The perception by
students of whether their use of a drug constituted ‘trying it’, or in the case of GGAs ‘to get high’, may
change with age, comprehension and exposure to drug use. One suggestion for addressing the issue of
recanting would be to use objective biomarkers of drug exposure. Unfortunately, objective measures
of cannabis use have a poor sensitivity in population surveys, even for heavy daily users, over periods of
> 3 months.60,61 This would preclude identification of a significant proportion of lifetime cannabis use in
our study as around 40% had not used cannabis in the past 12 months. This is in addition to other
problems of using biomarkers of lifetime drug use, including there being no test currently available for all
controlled substances if taken > 3 months ago and there being no test at all for novel psychoactive
substances. These limitations are in addition to the likely pragmatic, methodological (e.g. response bias)
and ethical (e.g. acceptability to students and parents) barriers to collecting hair samples on thousands of
young people. For these reasons, self-report measures have recently been described as still representing
the ‘gold standard’ in assessing the use of illicit drugs.61
Recording the delivery costs and piloting methods for assessing cost-effectiveness
The interventions were developed and delivered at an affordable average cost per school. The estimated
cost per school for the +FRANK intervention was £1942 (£13.87 per student) and for the FRANK friends
intervention was £3041 (£20.69 per student). It is important to note that schools could not receive the
+FRANK intervention alone as there is a requirement to receive the ASSIST intervention first. As the ASSIST
intervention is of the same intensity as the FRANK friends intervention it has the same cost implications as
the FRANK friends intervention. This means that the approximate costs of the ASSIST plus +FRANK
interventions are those of the FRANK friends plus +FRANK interventions (£4983).
Assessments of the cost-effectiveness of school-based drug prevention interventions are relatively scarce.
When economic evaluations have been performed, cost-effectiveness analyses are available only for studies
conducted in the USA,62 and neither of the two peer-led programmes20,21 have examined cost-effectiveness.
Our study provides preliminary information on the costs borne by the NHS, as public health services reside
in the NHS in Wales. The study has demonstrated that it is feasible to conduct an economic evaluation
alongside a pilot cRCT of a school-based intervention to prevent drug use. However, to fully judge the
cost-effectiveness of the intervention the within-trial estimates of intervention costs, and the prevalence of
drug use, would need to be extrapolated over the lifetime of participants.63
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Objective 4: determine the design, structures, resources and partnerships
necessary for a full-scale trial to take place
For the definitive trial we propose a two-arm cRCT (randomisation at school level), with integrated economic
and process evaluations. The hypothesis for the full-scale trial would be that the FRANK friends intervention
is more effective and cost-effective at preventing illicit drug use in young people (aged 13–14 years) than a
control condition of usual practice. The primary outcome would be lifetime illicit drug use. The secondary
outcome measures would be all those used in the 18-month follow-up in the external pilot cRCT, except for
the FTND41 and HSI.41,42
Strengths and limitations
We collected both quantitative and qualitative data to assess the acceptability of the +FRANK and FRANK
friends interventions and trial assessments and methods. This approach enabled triangulation of data to
strengthen the internal and external validity of the findings. Focus group and interview data from teachers,
students and parents enabled an in-depth exploration of their experiences and views of the interventions.
This information was used in stages 1 and 2 to refine the intervention.
We used a robust qualitative methodology for data collection, analysis and reporting from a large sample,
allowing detailed exploration of the core elements of the intervention and saturation of dominant themes.
The students, teachers and parents who took part in the focus groups and interviews were, however, a
self-selecting sample. Those who did not take part may have given different responses from those who did
choose to participate. For example, the students who volunteered may have been those who were more
receptive to information on the harms of drugs. Similarly, parents who were interviewed may have been
more engaged in their child’s schooling than those who were not. However, teachers and students were
forthcoming when discussing what they did not like about the interventions.
A further strength of the study was the contribution of key stakeholders to the delivery and
implementation of the school-based drug prevention interventions. These stakeholders included students,
ASSIST trainers, parents, teachers (SMT and other roles) and, in addition to young people who had
received the ASSIST intervention, the lead trainer of ASSIST delivery staff, drug agency staff, older
adolescents and a public health commissioner. The involvement and contribution of stakeholders was
integral to the development, refinement and evaluation of the interventions.
Conclusions
The +FRANK and FRANK friends peer-led drug prevention interventions were acceptable to peer supporters,
teachers and parents. It was feasible to conduct a cRCT of these interventions in a school setting with
young people age 13–14 years. The process evaluation indicated that the FRANK friends intervention was
preferred over the +FRANK intervention. Qualitative, quantitative and economic evidence suggests that
there should be a follow-on full-scale cRCT of the FRANK friends intervention.
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Appendix 1
TABLE 16 Measure of knowledge about drugs
Have a go at answering whether you think the following statements
are true or false (please mark an X in one box on every line) True False
1. People under 18 cannot get arrested for possession of cannabis
2. Cannabis is the main illegal drug that under 18s receive specialist
drug treatment for
3. Cannabis addiction occurs in about 10% of users
4. A caution for a cannabis-related offence can stop you visiting the USA
5. If a young person is caught with cannabis, their parent or guardian will
be contacted by the police
6. 60% of 16- to 24-year-olds have taken an illegal drug
7. If a young person is caught with cannabis the school can permanently
exclude them
8. You can die the first time you sniff or inhale a GGA
TABLE 17 Characteristics of participants interviewed in the external pilot cRCT post intervention (n= 66)
Intervention Group Gender n
Not applicable Public Health Commissioner 1
Both FRANK Friends and +FRANK Intervention delivery trainer Male 2
Female 9
FRANK Friends Peer supporters Male 9
Female 8
Parents Male 3
Female 3
School staff School contact teacher 3
SMT 2
+FRANK Peer supporters Male 12
Female 7
Parents Male 1
Female 1
School Staff School contact teacher 3
SMT 2
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TABLE 18 Baseline: ever tried specific drugs by trial arm and overall (ranked by total prevalence)
In your life have you ever tried . . . Response
Trial arm
Total (N= 1567)+FRANK (N= 419) Usual practice (N= 361) FRANK friends (N= 440) ASSIST (N= 347)
n % n % n % n % n %
Cannabis? Missing 13 3.1 1 0.3 2 0.5 2 0.6 18 1.1
No 399 95.2 346 95.8 427 97.0 339 97.7 1511 96.4
Yes 7 1.7 14 3.9 11 2.5 6 1.7 38 2.4
Inhaling or sniffing GGAs to get ‘high’? Missing 13 3.1 4 1.1 2 0.5 5 1.4 24 1.5
No 399 95.2 343 95.0 429 97.5 337 97.1 1508 96.2
Yes 7 1.7 14 3.9 9 2.0 5 1.4 35 2.2
Cocaine? Missing 12 2.9 4 1.1 2 0.5 3 0.9 21 1.3
No 406 96.9 354 98.1 435 98.9 342 98.6 1537 98.1
Yes 1 0.2 3 0.8 3 0.7 2 0.6 9 0.6
Legal highs? Missing 12 2.9 5 1.4 3 0.7 3 0.9 23 1.5
No 406 96.9 353 97.8 434 98.6 342 98.6 1535 98.0
Yes 1 0.2 3 0.8 3 0.7 2 0.6 9 0.6
Steroids? Missing 12 2.9 3 0.8 2 0.5 3 0.9 20 1.3
No 405 96.7 355 98.3 436 99.1 342 98.6 1538 98.1
Yes 2 0.5 3 0.8 2 0.5 2 0.6 9 0.6
Ritalin? Missing 12 2.9 4 1.1 2 0.5 3 0.9 21 1.3
No 406 96.9 354 98.1 434 98.6 343 98.8 1537 98.1
Yes 1 0.2 3 0.8 4 0.9 1 0.3 9 0.6
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In your life have you ever tried . . . Response
Trial arm
Total (N= 1567)+FRANK (N= 419) Usual practice (N= 361) FRANK friends (N= 440) ASSIST (N= 347)
n % n % n % n % n %
Amphetamines? Missing 13 3.1 4 1.1 2 0.5 3 0.9 22 1.4
No 404 96.4 353 97.8 437 99.3 343 98.8 1537 98.1
Yes 2 0.5 4 1.1 1 0.2 1 0.3 8 0.5
Ecstasy? Missing 12 2.9 4 1.1 5 1.1 3 0.9 24 1.5
No 406 96.9 355 98.3 432 98.2 343 98.8 1536 98.0
Yes 1 0.2 2 0.6 3 0.7 1 0.3 7 0.4
Mephedrone? Missing 12 2.9 4 1.1 2 0.5 2 0.6 20 1.3
No 407 97.1 354 98.1 436 99.1 343 98.8 1540 98.3
Yes 0 0.0 3 0.8 2 0.5 2 0.6 7 0.4
Poppers? Missing 13 3.1 4 1.1 2 0.5 3 0.9 22 1.4
No 405 96.7 356 98.6 435 98.9 342 98.6 1538 98.1
Yes 1 0.2 1 0.3 3 0.7 2 0.6 7 0.4
Semeron? Missing 13 3.1 3 0.8 2 0.5 4 1.2 22 1.4
No 406 96.9 358 99.2 437 99.3 342 98.6 1543 98.5
Yes 0 0.0 0 0.0 1 0.2 1 0.3 2 0.1
Other drugs? Missing 10 2.4 1 0.3 2 0.5 2 0.6 15 1.0
No 409 97.6 360 99.7 437 99.3 345 99.4 1551 99.0
Yes 0 0.0 0 0.0 1 0.2 0 0.0 1 0.1
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TABLE 19 Baseline: ever tried specific drugs over the past week, 30 days and 12 months by trial arm and overall (ranked by total 12-month prevalence)
Have you tried . . . Response
Trial arm
Total (N= 1567)+FRANK (N= 419) Usual practice (N= 361) FRANK friends (N= 440) ASSIST (N= 347)
n % n % n % n % n %
Inhaling or sniffing GGAs to get
‘high’ in the last week?
Missing 18 4.3 10 2.8 5 1.1 10 2.9 43 2.7
No 401 95.7 348 96.4 434 98.6 336 96.8 1519 96.9
Yes 0 0.0 3 0.8 1 0.2 1 0.3 5 0.3
Illogical 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Inhaling or sniffing GGAs to get
‘high’ in the last 30 days?
Missing 18 4.3 11 3.0 5 1.1 9 2.6 43 2.7
No 401 95.7 347 96.1 434 98.6 336 96.8 1518 96.9
Yes 0 0.0 3 0.8 1 0.2 2 0.6 6 0.4
Illogical 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Inhaling or sniffing GGAs to get
‘high’ in the last 12 months?
Missing 17 4.1 10 2.8 4 0.9 7 2.0 38 2.4
No 397 94.7 344 95.3 428 97.3 334 96.3 1503 95.9
Yes 5 1.2 7 1.9 8 1.8 6 1.7 26 1.7
Illogical 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Cannabis in the last week? Missing 20 4.8 9 2.5 5 1.1 8 2.3 42 2.7
No 398 95.0 350 97.0 433 98.4 338 97.4 1519 96.9
Yes 1 2 2 6 1 02 0 0.0 4 0.3
Illogical 0 0.0 0 0.0 1 0.2 1 0.3 2 0.1
Cannabis in the last 30 days? Missing 20 4.8 9 2.5 5 1.1 8 2.3 42 2.7
No 398 95.0 349 96.7 432 98.2 338 97.4 1517 96.8
Yes 1 0.2 3 0.8 2 0.5 0 0.0 6 0.4
Illogical 0 0.0 0 0.0 1 0.2 1 0.3 2 0.1
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Have you tried . . . Response
Trial arm
Total (N= 1567)+FRANK (N= 419) Usual practice (N= 361) FRANK friends (N= 440) ASSIST (N= 347)
n % n % n % n % n %
Cannabis in the last 12 months? Missing 16 3.8 7 1.9 5 1.1 7 2.0 35 2.2
No 398 95.0 344 95.3 428 97.3 336 96.8 1506 96.1
Yes 5 1.2 10 2.8 6 1.4 3 0.9 24 1.5
Illogical 0 0.0 0 0.0 1 0.2 1 0.3 2 0.1
Cocaine in the last week? Missing 19 4.5 9 2.5 5 1.1 8 2.3 41 2.6
No 400 95.5 352 97.5 434 98.6 338 97.4 1524 97.3
Yes 0 0.0 0 0.0 1 0.2 1 0.3 2 0.1
Illogical 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Cocaine in the last 30 days? Missing 19 4.5 10 2.8 5 1.1 8 2.3 42 2.7
No 400 95.5 351 97.2 434 98.6 338 97.4 1523 97.2
Yes 0 0.0 0 0.0 1 0.2 1 0.3 2 0.1
Illogical 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Cocaine in the last 12 months? Missing 18 4.3 10 2.8 4 0.9 8 2.3 40 2.6
No 400 95.5 351 97.2 434 98.6 337 97.1 1522 97.1
Yes 1 0.2 0 0.0 2 0.5 2 0.6 5 0.3
Illogical 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Amphetamines in the last week? Missing 18 4.3 9 2.5 5 1.1 8 2.3 40 2.6
No 401 95.7 351 97.2 435 98.9 338 97.4 1525 97.3
Yes 0 0.0 1 0.3 0 0.0 0 0.0 1 0.1
Illogical 0 0.0 0 0.0 0 0.0 1 0.3 1 0.1
continued
D
O
I:10.3310/phr05070
PU
BLIC
H
EA
LTH
RESEA
RCH
2017
VO
L.5
N
O
.7
©
Q
ueen
’s
Printer
and
C
ontroller
of
H
M
SO
2017.
This
w
ork
w
as
produced
by
W
hite
et
al.
under
the
term
s
of
a
com
m
issioning
contract
issued
by
the
Secretary
of
State
for
H
ealth.
This
issue
m
ay
be
freely
reproduced
for
the
purposes
of
private
research
and
study
and
extracts
(or
indeed,
the
fullreport)
m
ay
be
included
in
professionaljournals
provided
that
suitable
acknow
ledgem
ent
is
m
ade
and
the
reproduction
is
not
associated
w
ith
any
form
of
advertising.
A
pplications
for
com
m
ercialreproduction
should
be
addressed
to:
N
IH
R
Journals
Library,
N
ationalInstitute
for
H
ealth
Research,
Evaluation,
Trials
and
Studies
C
oordinating
C
entre,
A
lpha
H
ouse,
U
niversity
of
Southam
pton
Science
Park,
Southam
pton
SO
16
7N
S,
U
K
.
69
TABLE 19 Baseline: ever tried specific drugs over the past week, 30 days and 12 months by trial arm and overall (ranked by total 12-month prevalence) (continued )
Have you tried . . . Response
Trial arm
Total (N= 1567)+FRANK (N= 419) Usual practice (N= 361) FRANK friends (N= 440) ASSIST (N= 347)
n % n % n % n % n %
Amphetamines in the last 30 days? Missing 18 4.3 9 2.5 5 1.1 8 2.3 40 2.6
No 400 95.5 351 97.2 434 98.6 338 97.4 1523 97.2
Yes 1 0.2 1 0.3 1 0.2 0 0.0 3 0.2
Illogical 0 0.0 0 0.0 0 0.0 1 0.3 1 0.1
Amphetamines in the last 12 months? Missing 18 4.3 9 2.5 4 0.9 8 2.3 39 2.5
No 400 95.5 351 97.2 434 98.6 338 97.4 1523 97.2
Yes 1 0.2 1 0.3 2 0.5 0 0.0 4 0.3
Illogical 0 0.0 0 0.0 0 0.0 1 0.3 1 0.1
Legal highs in the last week? Missing 19 4.5 9 2.5 5 1.1 8 2.3 41 2.6
No 400 95.5 351 97.2 434 98.6 338 97.4 1523 97.2
Yes 0 0.0 1 0.3 0 0.0 1 0.3 2 0.1
Illogical 0 0.0 0 0.0 1 0.2 0 0.0 1 0.1
Legal highs in the last 30 days? Missing 19 4.5 9 2.5 5 1.1 8 2.3 41 2.6
No 400 95.5 351 97.2 434 98.6 338 97.4 1523 97.2
Yes 0 0.0 1 0.3 0 0.0 1 0.3 2 0.1
Illogical 0 0.0 0 0.0 1 0.2 0 0.0 1 0.1
Legal highs in the last 12 months? Missing 18 4.3 9 2.5 5 1.1 8 2.3 40 2.6
No 399 95.2 351 97.2 434 98.6 338 97.4 1522 97.1
Yes 2 0.5 1 0.3 0 0.0 1 0.3 4 0.3
Illogical 0 0.0 0 0.0 1 0.2 0 0.0 1 0.1
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Have you tried . . . Response
Trial arm
Total (N= 1567)+FRANK (N= 419) Usual practice (N= 361) FRANK friends (N= 440) ASSIST (N= 347)
n % n % n % n % n %
Ecstasy in the last week? Missing 18 4.3 11 3.0 5 1.1 8 2.3 42 2.7
No 401 95.7 350 97.0 434 98.6 338 97.4 1523 97.2
Yes 0 0.0 0 0.0 0 0.0 1 0.3 1 0.1
Illogical 0 0.0 0 0.0 1 0.2 0 0.0 1 0.1
Ecstasy in the last 30 days? Missing 18 4.3 11 3.0 5 1.1 8 2.3 42 2.7
No 401 95.7 350 97.0 434 98.6 338 97.4 1523 97.2
Yes 0 0.0 0 0.0 0 0.0 1 0.3 1 0.1
Illogical 0 0.0 0 0.0 1 0.2 0 0.0 1 0.1
Ecstasy in the last 12 months? Missing 18 4.3 11 3.0 5 1.1 8 2.3 42 2.7
No 400 95.5 350 97.0 433 98.4 338 97.4 1521 97.1
Yes 1 0.2 0 0.0 1 0.2 1 0.3 3 0.2
Illogical 0 0.0 0 0.0 1 0.2 0 0.0 1 0.1
Steroids in the last week? Missing 18 4.3 9 2.5 4 0.9 8 2.3 39 2.5
No 400 95.5 352 97.5 436 99.1 338 97.4 1526 97.4
Yes 1 0.2 0 0.0 0 0.0 0 0.0 1 0.1
Illogical 0 0.0 0 0.0 0 0.0 1 0.3 1 0.1
Steroids in the last 30 days? Missing 18 4.3 10 2.8 4 0.9 8 2.3 40 2.6
No 400 95.5 351 97.2 435 98.9 338 97.4 1524 97.3
Yes 1 0.2 0 0.0 1 0.2 0 0.0 2 0.1
Illogical 0 0.0 0 0.0 0 0.0 1 0.3 1 0.1
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TABLE 19 Baseline: ever tried specific drugs over the past week, 30 days and 12 months by trial arm and overall (ranked by total 12-month prevalence) (continued )
Have you tried . . . Response
Trial arm
Total (N= 1567)+FRANK (N= 419) Usual practice (N= 361) FRANK friends (N= 440) ASSIST (N= 347)
n % n % n % n % n %
Steroids in the last 12 months? Missing 18 4.3 10 2.8 4 0.9 8 2.3 40 2.6
No 400 95.5 350 97.0 435 98.9 338 97.4 1523 97.2
Yes 1 0.2 1 0.3 1 0.2 0 0.0 3 0.2
Illogical 0 0.0 0 0.0 0 0.0 1 0.3 1 0.1
Poppers in the last week? Missing 18 4.3 9 2.5 4 .9 8 2.3 39 2.5
No 401 95.7 351 97.2 434 98.6 337 97.1 1523 97.2
Yes 0 0.0 1 0.3 0 0.0 0 0.0 1 0.1
Illogical 0 0.0 0 0.0 2 0.5 2 0.6 4 0.3
Poppers in the last 30 days? Missing 18 4.3 9 2.5 4 .9 8 2.3 39 2.5
No 401 95.7 351 97.2 434 98.6 337 97.1 1523 97.2
Yes 0 0.0 1 0.3 0 0.0 0 0.0 1 0.1
Illogical 0 0.0 0 0.0 2 0.5 2 0.6 4 0.3
Poppers in the last 12 months? Missing 18 4.3 9 2.5 4 0.9 8 2.3 39 2.5
No 400 95.5 351 97.2 434 98.6 337 97.1 1522 97.1
Yes 1 0.2 1 0.3 0 0.0 0 0.0 2 0.1
Illogical 0 0.0 0 0.0 2 0.5 2 0.6 4 0.3
Ritalin in the last week? Missing 18 4.3 9 2.5 5 1.1 8 2.3 40 2.6
No 401 95.7 352 97.5 434 98.6 338 97.4 1525 97.3
Yes 0 0.0 0 0.0 0 0.0 1 0.3 1 0.1
Illogical 0 0.0 0 0.0 1 0.2 0 0.0 1 0.1
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Have you tried . . . Response
Trial arm
Total (N= 1567)+FRANK (N= 419) Usual practice (N= 361) FRANK friends (N= 440) ASSIST (N= 347)
n % n % n % n % n %
Ritalin in the last 30 days? Missing 18 4.3 10 2.8 5 1.1 8 2.3 41 2.6
No 401 95.7 351 97.2 434 98.6 338 97.4 1524 97.3
Yes 0 0.0 0 0.0 0 0.0 1 0.3 1 0.1
Illogical 0 0.0 0 0.0 1 0.2 0 0.0 1 0.1
Ritalin in the last 12 months? Missing 18 4.3 10 2.8 5 1.1 8 2.3 41 2.6
No 400 95.5 351 97.2 434 98.6 338 97.4 1523 97.2
Yes 1 0.2 0 0.0 0 0.0 1 0.3 2 0.1
Illogical 0 0.0 0 0.0 1 0.2 0 0.0 1 0.1
Mephedrone in the last week? Missing 18 4.3 10 2.8 5 1.1 8 2.3 41 2.6
No 401 95.7 351 97.2 434 98.6 338 97.4 1524 97.3
Yes 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Illogical 0 0.0 0 0.0 1 0.2 1 0.3 2 0.1
Mephedrone in the last 30 days? Missing 18 4.3 10 2.8 5 1.1 8 2.3 41 2.6
No 401 95.7 351 97.2 434 98.6 338 97.4 1524 97.3
Yes 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Illogical 0 0.0 0 0.0 1 0.2 1 0.3 2 0.1
Mephedrone in the last 12 months? Missing 18 4.3 10 2.8 4 0.9 8 2.3 40 2.6
No 401 95.7 351 97.2 434 98.6 338 97.4 1524 97.3
Yes 0 0.0 0 0.0 1 0.2 0 0.0 1 0.1
Illogical 0 0.0 0 0.0 1 0.2 1 0.3 2 0.1
Semeron in the last week? Missing 18 4.3 9 2.5 5 1.1 8 2.3 40 2.6
No 401 95.7 352 97.5 434 98.6 338 97.4 1525 97.3
Yes 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Illogical 0 0.0 0 0.0 1 0.2 1 0.3 2 0.1
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TABLE 19 Baseline: ever tried specific drugs over the past week, 30 days and 12 months by trial arm and overall (ranked by total 12-month prevalence) (continued )
Have you tried . . . Response
Trial arm
Total (N= 1567)+FRANK (N= 419) Usual practice (N= 361) FRANK friends (N= 440) ASSIST (N= 347)
n % n % n % n % n %
Semeron in the last 30 days? Missing 18 4.3 10 2.8 5 1.1 8 2.3 41 2.6
No 401 95.7 351 97.2 434 98.6 338 97.4 1524 97.3
Yes 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Illogical 0 0.0 0 0.0 1 0.2 1 0.3 2 0.1
Semeron in the last 12 months? Missing 18 4.3 10 2.8 5 1.1 8 2.3 41 2.6
No 401 95.7 351 97.2 433 98.4 338 97.4 1523 97.2
Yes 0 0.0 0 0.0 1 0.2 0 0.0 1 0.1
Illogical 0 0.0 0 0.0 1 0.2 1 0.3 2 0.1
Some other drug in the last week? Missing 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
No 418 99.8 361 100.0 440 100.0 347 100.0 1566 99.9
Yes 1 0.2 0 0.0 0 0.0 0 0.0 1 0.1
Illogical 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Some other drug in the last 30 days? Missing 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
No 418 99.8 361 100.0 440 100.0 347 100.0 1566 99.9
Yes 1 0.2 0 0.0 0 0.0 0 0.0 1 0.1
Illogical 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Some other drug in the last 12 months? Missing 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
No 418 99.8 361 100.0 440 100.0 347 100.0 1566 99.9
Yes 1 0.2 0 0.0 0 0.0 0 0.0 1 0.1
Illogical 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
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TABLE 20 Follow-up: ever tried specific drugs by trial arm and overall (ranked by total prevalence)
In your life have you ever tried . . . Response
Trial arm
Total (N= 1460)+FRANK (N= 391) Usual practice (N= 342) FRANK friends (N= 412) ASSIST (N= 315)
n % n % n % n % n %
Cannabis? Missing 1 0.3 1 0.3 1 0.2 1 0.3 4 0.3
No 348 89.0 315 92.1 384 93.2 292 92.7 1339 91.7
Yes 42 10.7 26 7.6 27 6.6 22 7.0 117 8.0
Inhaling or sniffing GGAs to get ‘high’? Missing 0 0.0 2 0.6 1 0.2 1 0.3 4 0.3
No 370 94.6 329 96.2 399 96.8 300 95.2 1398 95.8
Yes 21 5.4 11 3.2 12 2.9 14 4.4 58 4.0
Legal highs? Missing 0 0.0 2 0.6 1 0.2 1 0.3 4 0.3
No 381 97.4 335 98.0 406 98.5 309 98.1 1431 98.0
Yes 10 2.6 5 1.5 5 1.2 5 1.6 25 1.7
Cocaine? Missing 0 0.0 5 1.5 1 0.2 1 0.3 7 0.5
No 386 98.7 333 97.4 410 99.5 310 98.4 1439 98.6
Yes 5 1.3 4 1.2 1 0.2 4 1.3 14 1.0
Ecstasy? Missing 1 0.3 4 1.2 1 0.2 1 0.3 7 0.5
No 384 98.2 336 98.2 410 99.5 313 99.4 1443 98.8
Yes 6 1.5 2 0.6 1 0.2 1 0.3 10 0.7
Tranquillisers? Missing 0 0.0 2 0.6 1 0.2 1 0.3 4 0.3
No 386 98.7 337 98.5 410 99.5 313 99.4 1446 99.0
Yes 5 1.3 3 0.9 1 0.2 1 0.3 10 0.7
LSD? Missing 0 0.0 4 1.2 1 0.2 1 0.3 6 0.4
No 385 98.5 337 98.5 411 99.8 312 99.0 1445 99.0
Yes 6 1.5 1 0.3 0 0.0 2 0.6 9 0.6
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TABLE 20 Follow-up: ever tried specific drugs by trial arm and overall (ranked by total prevalence) (continued )
In your life have you ever tried . . . Response
Trial arm
Total (N= 1460)+FRANK (N= 391) Usual practice (N= 342) FRANK friends (N= 412) ASSIST (N= 315)
n % n % n % n % n %
Amphetamines? Missing 0 0.0 2 0.6 1 0.2 1 0.3 4 0.3
No 387 99.0 338 98.8 410 99.5 313 99.4 1448 99.2
Yes 4 1.0 2 0.6 1 0.2 1 0.3 8 0.5
Mephedrone? Missing 0 0.0 3 0.9 2 0.5 2 0.6 7 0.5
No 386 98.7 338 98.8 409 99.3 313 99.4 1446 99.0
Yes 5 1.3 1 0.3 1 0.2 0 0.0 7 0.5
Steroids? Missing 0 0.0 2 0.6 1 0.2 1 0.3 4 0.3
No 388 99.2 338 98.8 411 99.8 312 99.0 1449 99.2
Yes 3 0.8 2 0.6 0 0.0 2 0.6 7 0.5
Heroin? Missing 0 0.0 3 0.9 1 0.2 1 0.3 5 0.3
No 390 99.7 336 98.2 410 99.5 313 99.4 1449 99.2
Yes 1 0.3 3 0.9 1 0.2 1 0.3 6 0.4
Magic mushrooms? Missing 2 0.5 6 1.8 5 1.2 2 0.6 15 1.0
No 386 98.7 333 97.4 407 98.8 313 99.4 1439 98.6
Yes 3 0.8 3 0.9 0 0.0 0 0.0 6 0.4
Crack? Missing 1 0.3 3 0.9 1 0.2 1 0.3 6 0.4
No 388 99.2 336 98.2 411 99.8 314 99.7 1449 99.2
Yes 2 0.5 3 0.9 0 0.0 0 0.0 5 0.3
Ketamine? Missing 0 0.0 3 0.9 1 0.2 1 0.3 5 0.3
No 388 99.2 337 98.5 411 99.8 314 99.7 1450 99.3
Yes 3 0.8 2 0.6 0 0.0 0 0.0 5 0.3
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In your life have you ever tried . . . Response
Trial arm
Total (N= 1460)+FRANK (N= 391) Usual practice (N= 342) FRANK friends (N= 412) ASSIST (N= 315)
n % n % n % n % n %
Ritalin? Missing 0 0.0 3 0.9 1 0.2 1 0.3 5 0.3
No 389 99.5 337 98.5 410 99.5 314 99.7 1450 99.3
Yes 2 0.5 2 0.6 1 0.2 0 0.0 5 0.3
Poppers? Missing 1 0.3 2 0.6 1 0.2 1 0.3 5 0.3
No 389 99.5 339 99.1 409 99.3 313 99.4 1450 99.3
Yes 1 0.3 1 0.3 2 0.5 1 0.3 5 0.3
Methadone? Missing 0 0.0 3 0.9 1 0.2 1 0.3 5 0.3
No 389 99.5 337 98.5 411 99.8 314 99.7 1451 99.4
Yes 2 0.5 2 0.6 0 0.0 0 0.0 4 0.3
Semeron? Missing 0 0.0 2 0.6 1 0.2 1 0.3 4 0.3
No 389 99.5 339 99.1 411 99.8 314 99.7 1453 99.5
Yes 2 0.5 1 0.3 0 0.0 0 0.0 3 0.2
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TABLE 21 Follow-up: ever tried specific drugs over the past week, 30 days and 12 months by trial arm and overall (ranked by total 12-month prevalence)
Have you tried . . . Response
Trial arm
Total (N= 1460)+FRANK (N= 391) Usual practice (N= 342) FRANK friends (N= 412) ASSIST (N= 315)
n % n % n % n % n %
Cannabis in the last week? Missing 22 5.6 21 6.1 10 2.4 10 3.2 63 4.3
No 362 92.6 316 92.4 397 96.4 299 94.9 1374 94.1
Yes 5 1.3 4 1.2 2 0.5 5 1.6 16 1.1
Illogical 2 0.5 1 0.3 3 0.7 1 0.3 7 0.5
Cannabis in the last 30 days? Missing 19 4.9 17 5.0 6 1.5 9 2.9 51 3.5
No 360 92.1 315 92.1 393 95.4 296 94.0 1364 93.4
Yes 10 2.6 9 2.6 10 2.4 9 2.9 38 2.6
Illogical 2 0.5 1 0.3 3 0.7 1 0.3 7 0.5
Cannabis in the last 12 months? Missing 9 2.3 12 3.5 4 1.0 4 1.3 29 2.0
No 344 88.0 308 90.1 383 93.0 289 91.7 1324 90.7
Yes 36 9.2 21 6.1 22 5.3 21 6.7 100 6.8
Illogical 2 0.5 1 0.3 3 0.7 1 0.3 7 0.5
Inhaling or sniffing GGAs to get ‘high’
in the last week?
Missing 16 4.1 20 5.8 12 2.9 11 3.5 59 4.0
No 374 95.7 322 94.2 396 96.1 304 96.5 1396 95.6
Yes 0 0.0 0 0.0 1 0.2 0 0.0 1 0.1
Illogical 1 0.3 0 0.0 3 0.7 0 0.0 4 0.3
Inhaling or sniffing GGAs to get ‘high’
in the last 30 days?
Missing 15 3.8 19 5.6 14 3.4 10 3.2 58 4.0
No 371 94.9 320 93.6 394 95.6 304 96.5 1389 95.1
Yes 4 1.0 3 0.9 1 0.2 1 0.3 9 0.6
Illogical 1 0.3 0 0.0 3 0.7 0 0.0 4 0.3
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Have you tried . . . Response
Trial arm
Total (N= 1460)+FRANK (N= 391) Usual practice (N= 342) FRANK friends (N= 412) ASSIST (N= 315)
n % n % n % n % n %
Inhaling or sniffing GGAs to get
‘high’ in the last 12 months?
Missing 12 3.1 18 5.3 12 2.9 8 2.5 50 3.4
No 364 93.1 319 93.3 390 94.7 299 94.9 1372 94.0
Yes 14 3.6 5 1.5 7 1.7 8 2.5 34 2.3
Illogical 1 0.3 0 0.0 3 0.7 0 0.0 4 0.3
Legal highs in the last week? Missing 19 4.9 19 5.6 15 3.6 12 3.8 65 4.5
No 371 94.9 323 94.4 397 96.4 303 96.2 1394 95.5
Yes 1 0.3 0 0.0 0 0.0 0 0.0 1 0.1
Illogical 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Legal highs in the last 30 days? Missing 20 5.1 18 5.3 16 3.9 11 3.5 65 4.5
No 370 94.6 321 93.9 396 96.1 303 96.2 1390 95.2
Yes 1 0.3 3 0.9 0 0.0 1 0.3 5 0.3
Illogical 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Legal highs in the last 12 months? Missing 19 4.9 18 5.3 14 3.4 10 3.2 61 4.2
No 367 93.9 318 93.0 393 95.4 301 95.6 1379 94.5
Yes 5 1.3 6 1.8 5 1.2 4 1.3 20 1.4
Illogical 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Cocaine in the last week? Missing 18 4.6 20 5.8 14 3.4 12 3.8 64 4.4
No 372 95.1 320 93.6 397 96.4 303 96.2 1392 95.3
Yes 0 0.0 1 0.3 1 0.2 0 0.0 2 0.1
Illogical 1 0.3 1 0.3 0 0.0 0 0.0 2 0.1
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TABLE 21 Follow-up: ever tried specific drugs over the past week, 30 days and 12 months by trial arm and overall (ranked by total 12-month prevalence) (continued )
Have you tried . . . Response
Trial arm
Total (N= 1460)+FRANK (N= 391) Usual practice (N= 342) FRANK friends (N= 412) ASSIST (N= 315)
n % n % n % n % n %
Cocaine in the last 30 days? Missing 18 4.6 20 5.8 15 3.6 10 3.2 63 4.3
No 372 95.1 320 93.6 396 96.1 303 96.2 1391 95.3
Yes 0 0.0 1 0.3 1 0.2 2 0.6 4 0.3
Illogical 1 0.3 1 0.3 0 0.0 0 0.0 2 0.1
Cocaine in the last 12 months? Missing 18 4.6 20 5.8 15 3.6 10 3.2 63 4.3
No 370 94.6 319 93.3 395 95.9 301 95.6 1385 94.9
Yes 2 0.5 2 0.6 2 0.5 4 1.3 10 0.7
Illogical 1 0.3 1 0.3 0 0.0 0 0.0 2 0.1
Steroids in the last week? Missing 20 5.1 17 5.0 15 3.6 12 3.8 64 4.4
No 371 94.9 322 94.2 397 96.4 303 96.2 1393 95.4
Yes 0 0.0 2 0.6 0 0.0 0 0.0 2 0.1
Illogical 0 0.0 1 0.3 0 0.0 0 0.0 1 0.1
Steroids in the last 30 days? Missing 19 4.9 18 5.3 16 3.9 12 3.8 65 4.5
No 371 94.9 321 93.9 396 96.1 303 96.2 1391 95.3
Yes 1 0.3 2 0.6 0 0.0 0 0.0 3 0.2
Illogical 0 0.0 1 0.3 0 0.0 0 0.0 1 0.1
Steroids in the last 12 months? Missing 19 4.9 19 5.6 16 3.9 12 3.8 66 4.5
No 369 94.4 320 93.6 395 95.9 300 95.2 1384 94.8
Yes 3 0.8 2 0.6 1 0.2 3 1.0 9 0.6
Illogical 0 0.0 1 0.3 0 0.0 0 0.0 1 0.1
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Have you tried . . . Response
Trial arm
Total (N= 1460)+FRANK (N= 391) Usual practice (N= 342) FRANK friends (N= 412) ASSIST (N= 315)
n % n % n % n % n %
Tranquillisers in the last week? Missing 20 5.1 20 5.8 15 3.6 12 3.8 67 4.6
No 370 94.6 322 94.2 396 96.1 303 96.2 1391 95.3
Yes 1 0.3 0 0.0 0 0.0 0 0.0 1 0.1
Illogical 0 0.0 0 0.0 1 0.2 0 0.0 1 0.1
Tranquillisers in the last 30 days? Missing 19 4.9 20 5.8 16 3.9 11 3.5 66 4.5
No 370 94.6 322 94.2 395 95.9 303 96.2 1390 95.2
Yes 2 0.5 0 0.0 0 0.0 1 0.3 3 0.2
Illogical 0 0.0 0 0.0 1 0.2 0 0.0 1 0.1
Tranquillisers in the last 12 months? Missing 19 4.9 20 5.8 15 3.6 11 3.5 65 4.5
No 367 93.9 321 93.9 394 95.6 303 96.2 1385 94.9
Yes 5 1.3 1 0.3 2 0.5 1 0.3 9 0.6
Illogical 0 0.0 0 0.0 1 0.2 0 0.0 1 0.1
Amphetamines in the last week? Missing 19 4.9 21 6.1 15 3.6 12 3.8 67 4.6
No 372 95.1 321 93.9 396 96.1 303 96.2 1392 95.3
Yes 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Illogical 0 0.0 0 0.0 1 0.2 0 0.0 1 0.1
Amphetamines in the last 30 days? Missing 18 4.6 20 5.8 16 3.9 13 4.1 67 4.6
No 371 94.9 321 93.9 395 95.9 302 95.9 1389 95.1
Yes 2 0.5 1 0.3 0 0.0 0 0.0 3 0.2
Illogical 0 0.0 0 0.0 1 0.2 0 0.0 1 0.1
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TABLE 21 Follow-up: ever tried specific drugs over the past week, 30 days and 12 months by trial arm and overall (ranked by total 12-month prevalence) (continued )
Have you tried . . . Response
Trial arm
Total (N= 1460)+FRANK (N= 391) Usual practice (N= 342) FRANK friends (N= 412) ASSIST (N= 315)
n % n % n % n % n %
Amphetamines in the last 12 months? Missing 18 4.6 20 5.8 16 3.9 15 4.8 69 4.7
No 368 94.1 321 93.9 394 95.6 300 95.2 1383 94.7
Yes 5 1.3 1 0.3 1 0.2 0 0.0 7 0.5
Illogical 0 0.0 0 0.0 1 0.2 0 0.0 1 0.1
Heroin in the last week? Missing 17 4.3 20 5.8 15 3.6 12 3.8 64 4.4
No 373 95.4 321 93.9 397 96.4 303 96.2 1394 95.5
Yes 1 0.3 0 0.0 0 0.0 0 0.0 1 0.1
Illogical 0 0.0 1 0.3 0 0.0 0 0.0 1 0.1
Heroin in the last 30 days? Missing 17 4.3 20 5.8 16 3.9 12 3.8 65 4.5
No 372 95.1 321 93.9 396 96.1 303 96.2 1392 95.3
Yes 2 0.5 0 0.0 0 0.0 0 0.0 2 0.1
Illogical 0 0.0 1 0.3 0 0.0 0 0.0 1 0.1
Heroin in the last 12 months? Missing 18 4.6 20 5.8 16 3.9 12 3.8 66 4.5
No 370 94.6 321 93.9 395 95.9 301 95.6 1387 95.0
Yes 3 0.8 0 0.0 1 0.2 2 0.6 6 0.4
Illogical 0 0.0 1 0.3 0 0.0 0 0.0 1 0.1
Ecstasy in the last week? Missing 19 4.9 21 6.1 15 3.6 12 3.8 67 4.6
No 372 95.1 319 93.3 396 96.1 303 96.2 1390 95.2
Yes 0 0.0 1 0.3 0 0.0 0 0.0 1 0.1
Illogical 0 0.0 1 0.3 1 0.2 0 0.0 2 0.1
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Have you tried . . . Response
Trial arm
Total (N= 1460)+FRANK (N= 391) Usual practice (N= 342) FRANK friends (N= 412) ASSIST (N= 315)
n % n % n % n % n %
Ecstasy in the last 30 days? Missing 19 4.9 20 5.8 16 3.9 12 3.8 67 4.6
No 372 95.1 319 93.3 395 95.9 303 96.2 1389 95.1
Yes 0 0.0 2 0.6 0 0.0 0 0.0 2 0.1
Illogical 0 0.0 1 0.3 1 0.2 0 0.0 2 0.1
Ecstasy in the last 12 months? Missing 19 4.9 20 5.8 16 3.9 13 4.1 68 4.7
No 370 94.6 319 93.3 394 95.6 302 95.9 1385 94.9
Yes 2 0.5 2 0.6 1 0.2 0 0.0 5 0.3
Illogical 0 0.0 1 0.3 1 0.2 0 0.0 2 0.1
Ritalin in the last week? Missing 19 4.9 20 5.8 15 3.6 11 3.5 65 4.5
No 372 95.1 319 93.3 397 96.4 303 96.2 1391 95.3
Yes 0 0.0 1 0.3 0 0.0 1 0.3 2 0.1
Illogical 0 0.0 2 0.6 0 0.0 0 0.0 2 0.1
Ritalin in the last 30 days? Missing 19 4.9 20 5.8 16 3.9 11 3.5 66 4.5
No 372 95.1 319 93.3 396 96.1 303 96.2 1390 95.2
Yes 0 0.0 1 0.3 0 0.0 1 0.3 2 0.1
Illogical 0 0.0 2 0.6 0 0.0 0 0.0 2 0.1
Ritalin in the last 12 months? Missing 20 5.1 20 5.8 16 3.9 11 3.5 67 4.6
No 370 94.6 318 93.0 394 95.6 302 95.9 1384 94.8
Yes 1 0.3 2 0.6 2 0.5 2 0.6 7 0.5
Illogical 0 0.0 2 0.6 0 0.0 0 0.0 2 0.1
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TABLE 21 Follow-up: ever tried specific drugs over the past week, 30 days and 12 months by trial arm and overall (ranked by total 12-month prevalence) (continued )
Have you tried . . . Response
Trial arm
Total (N= 1460)+FRANK (N= 391) Usual practice (N= 342) FRANK friends (N= 412) ASSIST (N= 315)
n % n % n % n % n %
LSD in the last week? Missing 19 4.9 21 6.1 15 3.6 12 3.8 67 4.6
No 371 94.9 319 93.3 397 96.4 303 96.2 1390 95.2
Yes 1 0.3 0 0.0 0 0.0 0 0.0 1 0.1
Illogical 0 0.0 2 0.6 0 0.0 0 0.0 2 0.1
LSD in the last 30 days? Missing 19 4.9 20 5.8 16 3.9 12 3.8 67 4.6
No 371 94.9 319 93.3 396 96.1 303 96.2 1389 95.1
Yes 1 0.3 1 0.3 0 0.0 0 0.0 2 0.1
Illogical 0 0.0 2 0.6 0 0.0 0 0.0 2 0.1
LSD in the last 12 months? Missing 19 4.9 20 5.8 16 3.9 11 3.5 66 4.5
No 370 94.6 319 93.3 395 95.9 303 96.2 1387 95.0
Yes 2 0.5 1 0.3 1 0.2 1 0.3 5 0.3
Illogical 0 0.0 2 0.6 0 0.0 0 0.0 2 0.1
Mephedrone in the last week? Missing 19 4.9 19 5.6 15 3.6 12 3.8 65 4.5
No 372 95.1 323 94.4 397 96.4 303 96.2 1395 95.5
Yes 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Illogical 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Mephedrone in the last 30 days? Missing 19 4.9 19 5.6 16 3.9 12 3.8 66 4.5
No 372 95.1 323 94.4 396 96.1 303 96.2 1394 95.5
Yes 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Illogical 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
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Have you tried . . . Response
Trial arm
Total (N= 1460)+FRANK (N= 391) Usual practice (N= 342) FRANK friends (N= 412) ASSIST (N= 315)
n % n % n % n % n %
Mephedrone in the last 12 months? Missing 19 4.9 20 5.8 16 3.9 13 4.1 68 4.7
No 369 94.4 322 94.2 395 95.9 302 95.9 1388 95.1
Yes 3 0.8 0 0.0 1 0.2 0 0.0 4 0.3
Illogical 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Poppers in the last week? Missing 18 4.6 20 5.8 14 3.4 12 3.8 64 4.4
No 373 95.4 321 93.9 398 96.6 303 96.2 1395 95.5
Yes 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Illogical 0 0.0 1 0.3 0 0.0 0 0.0 1 0.1
Poppers in the last 30 days? Missing 17 4.3 20 5.8 14 3.4 11 3.5 62 4.2
No 373 95.4 321 93.9 398 96.6 303 96.2 1395 95.5
Yes 1 0.3 0 0.0 0 0.0 1 0.3 2 0.1
Illogical 0 0.0 1 0.3 0 0.0 0 0.0 1 0.1
Poppers in the last 12 months? Missing 18 4.6 20 5.8 14 3.4 11 3.5 63 4.3
No 372 95.1 321 93.9 397 96.4 303 96.2 1393 95.4
Yes 1 0.3 0 0.0 1 0.2 1 0.3 3 0.2
Illogical 0 0.0 1 0.3 0 0.0 0 0.0 1 0.1
Crack in the last week? Missing 19 4.9 20 5.8 15 3.6 12 3.8 66 4.5
No 372 95.1 322 94.2 397 96.4 303 96.2 1394 95.5
Yes 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Illogical 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
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TABLE 21 Follow-up: ever tried specific drugs over the past week, 30 days and 12 months by trial arm and overall (ranked by total 12-month prevalence) (continued )
Have you tried . . . Response
Trial arm
Total (N= 1460)+FRANK (N= 391) Usual practice (N= 342) FRANK friends (N= 412) ASSIST (N= 315)
n % n % n % n % n %
Crack in the last 30 days? Missing 18 4.6 20 5.8 16 3.9 12 3.8 66 4.5
No 372 95.1 322 94.2 396 96.1 303 96.2 1393 95.4
Yes 1 0.3 0 0.0 0 0.0 0 0.0 1 0.1
Illogical 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Crack in the last 12 months? Missing 19 4.9 20 5.8 16 3.9 12 3.8 67 4.6
No 371 94.9 321 93.9 395 95.9 303 96.2 1390 95.2
Yes 1 0.3 1 0.3 1 0.2 0 0.0 3 0.2
Illogical 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Magic mushrooms in the last week? Missing 19 4.9 20 5.8 15 3.6 12 3.8 66 4.5
No 371 94.9 321 93.9 397 96.4 303 96.2 1392 95.3
Yes 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Illogical 1 0.3 1 0.3 0 0.0 0 0.0 2 0.1
Magic mushrooms in the last 30 days? Missing 19 4.9 20 5.8 16 3.9 12 3.8 67 4.6
No 371 94.9 321 93.9 396 96.1 303 96.2 1391 95.3
Yes 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Illogical 1 0.3 1 0.3 0 0.0 0 0.0 2 0.1
Magic mushrooms in the last 12 months? Missing 19 4.9 20 5.8 16 3.9 12 3.8 67 4.6
No 370 94.6 320 93.6 395 95.9 303 96.2 1388 95.1
Yes 1 0.3 1 0.3 1 0.2 0 0.0 3 0.2
Illogical 1 0.3 1 0.3 0 0.0 0 0.0 2 0.1
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Have you tried . . . Response
Trial arm
Total (N= 1460)+FRANK (N= 391) Usual practice (N= 342) FRANK friends (N= 412) ASSIST (N= 315)
n % n % n % n % n %
Semeron in the last week? Missing 19 4.9 20 5.8 15 3.6 12 3.8 66 4.5
No 372 95.1 322 94.2 397 96.4 303 96.2 1394 95.5
Yes 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Illogical 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Semeron in the last 30 days? Missing 18 4.6 20 5.8 16 3.9 12 3.8 66 4.5
No 372 95.1 322 94.2 396 96.1 303 96.2 1393 95.4
Yes 1 0.3 0 0.0 0 0.0 0 0.0 1 0.1
Illogical 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Semeron in the last 12 months? Missing 19 4.9 20 5.8 16 3.9 12 3.8 67 4.6
No 371 94.9 322 94.2 395 95.9 303 96.2 1391 95.3
Yes 1 0.3 0 0.0 1 0.2 0 0.0 2 0.1
Illogical 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Ketamine in the last week? Missing 18 4.6 20 5.8 15 3.6 12 3.8 65 4.5
No 373 95.4 322 94.2 397 96.4 303 96.2 1395 95.5
Yes 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Illogical 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Ketamine in the last 30 days? Missing 18 4.6 20 5.8 16 3.9 12 3.8 66 4.5
No 373 95.4 322 94.2 396 96.1 303 96.2 1394 95.5
Yes 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Illogical 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
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TABLE 21 Follow-up: ever tried specific drugs over the past week, 30 days and 12 months by trial arm and overall (ranked by total 12-month prevalence) (continued )
Have you tried . . . Response
Trial arm
Total (N= 1460)+FRANK (N= 391) Usual practice (N= 342) FRANK friends (N= 412) ASSIST (N= 315)
n % n % n % n % n %
Ketamine in the last 12 months? Missing 20 5.1 20 5.8 16 3.9 12 3.8 68 4.7
No 370 94.6 322 94.2 395 95.9 303 96.2 1390 95.2
Yes 1 0.3 0 0.0 1 0.2 0 0.0 2 0.1
Illogical 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Methadone in the last week? Missing 18 4.6 21 6.1 15 3.6 12 3.8 66 4.5
No 373 95.4 321 93.9 397 96.4 303 96.2 1394 95.5
Yes 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Illogical 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Methadone in the last 30 days? Missing 18 4.6 21 6.1 16 3.9 12 3.8 67 4.6
No 373 95.4 321 93.9 396 96.1 303 96.2 1393 95.4
Yes 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Illogical 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Methadone in the last 12 months? Missing 19 4.9 21 6.1 16 3.9 12 3.8 68 4.7
No 371 94.9 321 93.9 395 95.9 303 96.2 1390 95.2
Yes 1 0.3 0 0.0 1 0.2 0 0.0 2 0.1
Illogical 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Some other drug in the last week? Missing 1 0.3 0 0.0 0 0.0 0 0.0 1 0.1
No 390 99.7 342 100.0 412 100.0 315 100.0 1459 99.9
Yes 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Illogical 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
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Have you tried . . . Response
Trial arm
Total (N= 1460)+FRANK (N= 391) Usual practice (N= 342) FRANK friends (N= 412) ASSIST (N= 315)
n % n % n % n % n %
Some other drug in the last 30 days? Missing 1 0.3 0 0.0 0 0.0 0 0.0 1 0.1
No 390 99.7 342 100.0 412 100.0 315 100.0 1459 99.9
Yes 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Illogical 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Some other drug in the last 12 months? Missing 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
No 390 99.7 342 100.0 412 100.0 315 100.0 1459 99.9
Yes 1 0.3 0 0.0 0 0.0 0 0.0 1 0.1
Illogical 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
LSD, lysergic acid diethylamide.
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TABLE 22 Summary of numerical outcome measures at baseline by trial arm and overall
Variable (potential scale range) Trial arm n Missing (%) Minimum 25th centile Median 75th centile Maximum Mean SD
FTND (0–10)a +FRANK 2 50.0 0.0 0.0 4.5 9.0 9.0 4.5 6.36
Usual practice 4 20.0 0.0 0.0 0.5 2.0 3.0 1.0 1.41
FRANK friends 5 0.0 0.0 0.0 1.0 1.0 1.0 0.6 0.55
ASSIST 1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NA
Overall 12 20.0 0.0 0.0 0.5 1.0 9.0 1.3 2.57
HSI (0–6)a +FRANK 2 50.0 0.0 0.0 2.5 5.0 5.0 2.5 3.54
Usual practice 4 20.0 0.0 0.0 0.0 1.5 3.0 0.8 1.50
FRANK friends 5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.00
ASSIST 1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NA
Overall 12 20.0 0.0 0.0 0.0 0.0 5.0 0.7 1.61
Number of cigarettes smoked
in an average weeka
+FRANK 4 0.0 1.0 1.5 3.5 52.5 100.0 27.0 48.70
Usual practice 5 0.0 1.0 1.0 1.0 3.0 10.0 3.2 3.90
FRANK friends 5 0.0 3.0 8.0 35.0 40.0 175.0 52.2 70.53
ASSIST 1 0.0 3.0 3.0 3.0 3.0 3.0 3.0 NA
Overall 15 0.0 1.0 1.0 3.0 35.0 175.0 25.9 49.02
CHU-9D (0–1) +FRANK 419 10.3 0.426 0.802 0.878 0.931 1.000 0.858 0.105
Usual practice 361 8.2 0.326 0.826 0.897 0.952 1.000 0.870 0.109
FRANK friends 440 10.9 0.326 0.812 0.886 0.952 1.000 0.863 0.105
ASSIST 347 10.8 0.488 0.839 0.898 0.952 1.000 0.873 0.100
Overall 1567 10.7 0.416 0.845 0.915 0.952 1.000 0.887 0.095
NA, not applicable.
a Information recorded only for participants who reported smoking one or more cigarettes a week and who did not tick the box ‘I do not smoke now’.
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TABLE 23 Summary of intermediary variables at the 18-month follow-up by trial arm and overall
Variable
18-month follow-up data: distribution over categories by trial arm (%)
+FRANK (n= 391) Usual practice (n= 342) FRANK friends (n= 412) ASSIST (n= 315) Overall (n= 1460)
Perceived prevalence of lifetime drug use in year group
Missing 13.8 16.4 18.0 17.8 16.4
Anyone in year group has tried 58.3 58.2 41.3 53.0 52.3
None 27.9 25.4 40.8 29.2 31.2
Drug offers in last year
Missing 1.8 0.6 1.7 1.0 1.3
Any 29.4 27.5 21.4 28.6 26.5
None 68.8 71.9 76.9 70.5 72.2
Conversations with school friends about drugs
Missing 2.3 1.2 1.5 1.6 1.6
Any 57.0 55.0 59.7 48.9 55.5
None 40.7 43.9 38.8 49.5 42.8
Ever visited the Talk to FRANK website?
Missing 3.3 3.2 2.7 1.9 2.8
Yes 13.0 1.5 15.3 9.8 10.3
No 83.6 95.3 82.0 88.3 86.9
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TABLE 23 Summary of intermediary variables at the 18-month follow-up by trial arm and overall (continued )
Variable
18-month follow-up data: distribution over categories by trial arm (%)
+FRANK (n= 391) Usual practice (n= 342) FRANK friends (n= 412) ASSIST (n= 315) Overall (n= 1460)
Ever talked to a peer supporter about the harms of taking drugs?
Missing 2.0 0.6 1.0 1.6 1.3
Yes 23.3 12.0 20.1 14.3 17.8
No 55.5 60.2 57.0 63.2 58.7
Don’t know 19.2 27.2 21.8 21.0 22.2
Would you get help for yourself or a friend from the Talk to FRANK website you or he/she had a problem?
Missing 0.0 0.0 0.0 0.0 0.0
Yes 35.8 36.3 44.4 33.7 37.9
No 64.2 63.7 55.6 66.3 62.1
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TABLE 24 Summary of intermediary numerical measures at the 18-month follow-up by trial arm and overall
Variable (potential scale range) Trial arm n Missing (%) Minimum 25th centile Median 75th centile Maximum Mean SD
Perceived percentage of students in
your year who take drugs (0–100%)
+FRANK 385 1.5 0.0 2.0 5.0 20.0 80.0 13.3 16.1
Usual practice 336 1.8 0.0 1.0 5.0 17.5 100.0 12.2 16.6
FRANK friends 402 2.4 0.0 1.0 5.0 15.0 100.0 12.2 17.4
ASSIST 310 1.6 0.0 2.0 4.0 10.0 100.0 9.4 13.7
Overall 1433 1.8 0.0 2.0 5.0 15.0 100.0 11.9 16.2
Knowledge about drugs score (1–8) +FRANK 362 7.4 2.0 5.0 6.0 7.0 8.0 5.6 1.3
Usual practice 324 5.3 2.0 5.0 6.0 6.0 8.0 5.5 1.3
FRANK friends 387 6.1 2.0 5.0 6.0 7.0 8.0 5.7 1.4
ASSIST 295 6.3 1.0 4.0 5.0 6.0 8.0 5.4 1.3
Overall 1368 6.3 1.0 5.0 6.0 7.0 8.0 5.6 1.3
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TABLE 25 Odds ratios and 95% CIs for the indicative primary and secondary outcomes and categorical intermediary variablesa
Variable
ASSIST vs. usual practice
(reference)
+FRANK vs. usual practice
(reference)
FRANK friends vs. usual
practice (reference)
+FRANK vs. ASSIST
(reference)
n OR 95% CI n OR 95% CI n OR 95% CI n OR 95% CI
Indicative primary outcome
Lifetime illicit drug use 497 0.81 0.46 to 1.42 561 0.96 0.58 to 1.59 576 0.70 0.39 to 1.24 550 1.21 0.71 to 2.08
Indicative secondary outcomes
Cannabis use in lifetime 508 1.11 0.49 to 2.48 573 1.17 0.45 to 3.05 590 0.65 0.17 to 2.46 553 1.05 0.54 to 2.05
Cannabis use in past 12 months 486 1.40 0.66 to 2.97 541 1.41 0.60 to 3.34 570 0.82 0.33 to 2.06 529 0.94 0.42 to 2.09
GGA use in lifetime 507 1.59 0.62 to 4.08 573 1.66 0.71 to 3.86 589 0.87 0.31 to 2.44 554 1.13 0.51 to 2.50
GGA use in past 12 months 476 1.85 0.48 to 7.14 534 2.86 0.84 to 9.73 555 1.12 0.29 to 4.36 526 1.58 0.51 to 4.88
Ever having tried smoking (even if a puff) 497 1.18 0.69 to 2.01 559 1.10 0.64 to 1.90 583 0.65 0.32 to 1.29 540 0.93 0.59 to 1.46
Ever having consumed a whole alcoholic drink 454 1.50 0.74 to 3.02 497 1.26 0.71 to 2.23 530 0.75 0.35 to 1.58 481 0.82 0.57 to 1.19
Engages in heavy episodic alcohol use (A-SAQ)b 471 0.94 0.60 to 1.49 532 0.84 0.55 to 1.29 542 0.53 0.31 to 0.90 537 0.89 0.58 to 1.36
Intermediary variables
Perceived prevalence of lifetime drug use in year groupc 333 1.14 0.70 to 1.84 369 0.98 0.49 to 1.96 382 0.43 0.14 to 1.27 350 0.84 0.46 to 1.54
Any drug offers in last yeard 502 1.41 0.92 to 2.17 568 1.09 0.57 to 2.09 582 0.78 0.44 to 1.41 546 0.72 0.36 to 1.45
Any conversations with school friends about drugse 495 0.82 0.57 to 1.18 554 1.25 0.89 to 1.77 569 1.38 0.98 to 1.94 535 1.53 1.07 to 2.18
Ever visited Talk to FRANK websitef 496 3.16 0.32 to 1.72 561 12.64 4.47 to 35.74 576 14.25 4.54 to 4.70 538 3.99 0.72 to 2.22
a All models were adjusted for baseline values (except lifetime measures of drug, cannabis and GGA use, ever tried smoking and consumed whole alcoholic drink), gender, age, FSM
entitlement and residence with an adult in employment and are multilevel with children within school; shaded cells indicate no clustering (an ICC of 1 × 10–8) and thus a single-level
model was used instead.
b Participants screened positive if boys had drunk eight or more standard drinks or girls had drunk six or more standard drinks (one standard drink is equivalent to 1 unit; 1 unit is
approximately 8 g of pure alcohol) on one occasion less than monthly or more frequently and they were aged ≤ 15 years.
c No school friends have tried vs. any tried.
d No drug offers vs. any offers.
e None vs. any conversations.
f Never visited website.
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TABLE 26 Coefficients and 95% CIs for numerical intermediary variablesa
Variable
ASSIST vs. usual practice
(reference)
+FRANK vs. usual practice
(reference)
FRANK friends vs. usual practice
(reference) +FRANK vs. ASSIST (reference)
n Coefficient 95% CI n Coefficient 95% CI n Coefficient 95% CI n Coefficient 95% CI
Intermediary variables
Perceived percentage of students
in your year who take drugs
497 –1.22 –3.77 to 1.33 563 2.01 –4.45 to 8.47 571 –2.42 –10.95 to
6.10
544 2.80 –3.79 to 9.39
Knowledge about drugs score 448 0.01 –0.33 to 0.36 493 0.09 –0.13 to 0.31 513 0.32 0.03 to 0.62 485 0.11 –0.17 to 0.39
a All models were adjusted for baseline values, gender, age, FSM entitlement and residence with an adult in employment and are multilevel with children within school; shaded cells
indicate no clustering (an ICC of 1 × 10–8) and thus a single-level model was used instead.
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TABLE 27 Risk differences and 95% CIs (percentage points scale) for the indicative primary outcome, secondary outcomes and intermediary variables by trial arma
Variable
ASSIST vs. usual practice
(reference)
+FRANK vs. usual practice
(reference)
FRANK friends vs. usual
practice (reference)
+FRANK vs. ASSIST
(reference)
n RD 95% CI n RD 95% CI n RD 95% CI n RD 95% CI
Indicative primary outcome
Lifetime illicit drug use 497 –2.10 –7.75 to 3.55 561 –0.42 –5.99 to 5.15 576 –3.45 –9.53 to 2.63 550 1.94 –3.39 to 7.26
Indicative secondary outcomes
Cannabis use in lifetime 508 0.48 –5.22 to 6.19 573 1.01 –6.19 to 8.20 590 –1.13 –9.31 to 7.04 553 0.44 –4.50 to 5.38
Cannabis use in past 12 months 486 2.06 –2.53 to 6.65 541 2.27 –3.15 to 7.69 570 -0.62 –5.43 to 4.20 529 –0.25 –5.66 to 5.17
GGA use in lifetime 507 1.68 –1.78 to 5.13 573 2.02 –1.30 to 5.33 589 –0.35 –3.92 to 3.22 554 0.54 –3.03 to 4.12
GGA use in past 12 months 476 1.20 –1.46 to 3.87 534 2.68 –0.49 to 5.85 555 0.17 –1.94 to 2.28 526 1.31 –2.30 to 4.92
Ever having tried smoking (even if a puff) 497 2.91 –7.66 to 13.47 559 2.05 –8.76 to 12.84 583 –5.11 –17.26 to 7.04 540 –1.22 –9.93 to 7.49
Ever having consumed a whole alcoholic drink 454 10.75 –6.81 to 28.31 497 6.67 –8.81 to 22.16 530 –7.41 –25.27 to 10.46 481 –4.67 –13.56 to 4.21
Engages in heavy episodic alcohol use (A-SAQ)b 471 –0.92 –8.22 to 6.37 532 –2.88 –9.97 to 4.21 542 –8.74 –17.20 to –0.29 537 –1.90 –8.83 to 5.02
Intermediary variables
Perceived prevalence of lifetime drug use in
year groupc
333 2.56 –7.11 to 12.22 369 0.15 –14.98 to
15.27
382 –15.06 –39.39 to 9.26 350 –3.07 –14.71 to 8.58
Any drug offers in last yeard 502 5.96 –1.35 to 13.28 568 1.61 –9.91 to 13.13 582 –2.66 –12.30 to 6.98 546 –4.57 –17.11 to 7.96
Any conversations with school friends about
drugse
495 –4.82 –13.53 to 3.88 554 5.42 –2.84 to 13.68 569 7.75 –0.38 to 15.88 535 9.94 1.61 to 18.28
Ever visited Talk to FRANK websitef 496 4.87 –5.45 to 15.19 561 14.63 10.19 to 19.07 576 14.79 8.24 to 21.34 538 9.28 –1.67 to 20.22
RD, risk difference.
a All models were adjusted for baseline values (except lifetime measures of drug, cannabis and GGA use, ever tried smoking and consumed whole alcoholic drink), gender, age, FSM
entitlement and residence with an adult in employment and are multilevel with children within school; shaded cells indicate no clustering (an ICC of 1 × 10–8) and thus a single-level
model was used instead.
b Participants screened positive if boys had drunk eight or more standard drinks or girls had drunk six or more standard drinks (one standard drink is equivalent to 1 unit; 1 unit is
approximately 8 g of pure alcohol) on one occasion less than monthly or more frequently and they were aged ≤ 15 years.
c No school friends have tried vs. any tried.
d No drug offers vs. any offers.
e None vs. any conversations.
f Never visited website.
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TABLE 28 Odds ratio and 95% CIs for the interaction term between arm and lifetime illicit drug use at baseline: indicative secondary outcomes and intermediary variablesa
Variable
ASSIST vs. usual practice
(reference)
+FRANK vs. usual practice
(reference)
FRANK friends vs. usual
practice (reference)
+FRANK vs. ASSIST
(reference)
n OR 95% CI n OR 95% CI n OR 95% CI n OR 95% CI
Indicative secondary outcomes
Cannabis use in lifetime 500 0.79 0.07 to 8.64 557 0.68 0.09 to 4.88 584 0.60 0.10 to 3.75 539 0.90 0.07 to 11.40
Cannabis use in past 12 months 485 2.61 0.07 to 4.42 538 2.10 0.22 to 9.88 568 1.07 0.15 to 7.57 527 1.14 0.03 to 41.82
GGA use in lifetime 499 5.65 0.33 to 97.86 557 1.42 0.12 to 6.83 583 1.55 0.12 to 0.41 540 0.25 0.02 to 4.05
GGA use in past 12 months 475 16.74 0.38 to 729.45 531 3.02 0.12 to 7.30 553 0.82 0.03 to 4.67 524 0.27 0.01 to 7.17
Ever having tried smoking (even if a puff) 489 0.54 0.05 to 5.78 543 0.75 0.11 to 5.34 577 0.75 0.14 to 4.15 526 1.55 0.12 to 20.06
Ever having consumed a whole alcoholic drink 446 0.27 0.01 to 5.03 484 0.27 0.03 to 2.75 524 0.30 0.04 to 2.30 470 1.20 0.06 to 23.52
Engages in heavy episodic alcohol use (A-SAQ)b 463 2.61 0.21 to 32.30 517 1.26 0.14 to 0.97 536 0.83 0.11 to 6.57 524 0.83 0.06 to 11.48
Intermediary variables
Perceived prevalence of lifetime drug use in year groupc 489 0.60 0.04 to 9.36 357 0.08 0.01 to 1.42 378 0.50 0.02 to 0.27 521 0.31 0.02 to 4.71
Any drug offers in last yeard 583 2.87 0.25 to 32.94 552 1.14 0.14 to 9.13 576 1.37 0.21 to 8.83 607 0.32 0.02 to 5.96
Any conversations with school friends about drugse 487 2.57 0.20 to 33.16 538 0.31 0.04 to 2.39 563 1.27 0.23 to 7.04 521 0.11 0.01 to 2.00
Ever visited Talk to FRANK websitef 490 0.47 0.01 to 27.59 545 0.08 < 0.01 to 2.21 570 0.13 0.01 to 2.60 526 0.05 0.01 to 2.03
a All models were adjusted for baseline values (except lifetime measures of drug, cannabis and GGA use, ever tried smoking and consumed whole alcoholic drink), gender, age, FSM
entitlement and residence with an adult in employment and are multilevel with children within school; shaded cells indicate no clustering (an ICC of 1 × 10–8) and thus a single-level
model was used instead.
b Participants screened positive if boys had drunk eight or more standard drinks or girls had drunk six or more standard drinks (one standard drink is equivalent to 1 unit; 1 unit is
approximately 8 g of pure alcohol) on one occasion less than monthly or more frequently and they were aged ≤ 15 years.
c No school friends have tried vs. any tried.
d No drug offers vs. any offers.
e None vs. any conversations.
f Never visited website.
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